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ABSTRACT 
 
Siphonaria zelandica, a pulmonate mollusk, has been the subject of many natural 
product isolation studies by several, independent research groups. These studies have yielded 
several polypropionate structures (e.g. 4, 6, 8, and 10), which, upon careful inspection, were 
proposed to be related. There has been speculation that none of these isolated structures (4, 6, 
8, and 10) are biosynthetic products, but are artifacts of isolation. Instead, it has been 
proposed that an unstable, acyclic precursor, such as 14/15 is the biosynthetic product 
produced by this mollusk; the putative acyclic precursor has not been isolated or synthesized. 
None of the synthetic studies on this series of compounds have attempted to address the 
potential relationships between these structures or speak to their status as natural products.  
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This work describes the enantioselective synthesis of the putative acyclic precursor 
14/15 and its isomerization to siphonarin B (4). This was the first enantioselective synthesis 
of siphonarin B (4). Siphonarin B (4) was shown to readily undergo a retro-Claisen 
rearrangement to afford baconipyrone C (6) and concurrently undergo a retro-Claisen 
rearrangement/aldol cascade to provide baconipyrone A (6). This was the first total synthesis 
of baconipyrone A (6) through an unprecedented retro-Claisen rearrangement/aldol cascade 
and the first total synthesis of baconipyone C (8) by a “biomimetic” route versus the classical 
esterification route. The fourth compound in this series of potentially related compounds, 
caloundrin B (10), was never observed despite a careful search of each reaction crude where 
it may have been present. 
The relationships between these compounds were probed and it was found, that under 
the conditions examined, the putative acyclic precursor 14/15 is not a biosynthetic product. 
Instead, siphonarin B (4) or perhaps caloundrin B (10), are the most likely biosynthetic 
products of the mollusk. Baconipyrone C (8) is not a precursor of baconipyrone A (6). The 
processes responsible for baconipyrones A (6) and C (8) are irreversible. As had been 
previously hypothesized, baconipyrones A (6) and C (8) are most likely artifacts of isolation 
(i.e., not natural products). The missing link in this series of compounds is caloundrin B (10) 
and its isomerization and rearrangement behavior.  
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INTRODUCTION 
 
1.1 Introduction to structures, relationships, isolation, and biosynthesis  
1.1.1 Siphonariid mollusks and examples of isolated structures  
Siphonariid mollusks are non-descript animals found in temperate and tropical ocean 
intertidal zones – the area of coastline dry at low tide and underwater at high tide –
throughout the world.  These limpet-like creatures, sometimes referred to as false limpets, are 
superbly adapted to their environment with both a primitive lung and gills and may represent 
an evolutionary link between land and sea mollusks.1 Of all the pulmonates,i the siphonariids 
are considered the most primitive.2   
Despite their non-descript outward appearance and primitive evolutionary status, these 
organisms are credited with being the grand architects of an incredibly diverse array of 
complex polypropionate natural products.3  The polypropionates produced by siphonariid 
mollusks have been classified into three groups (Figure 1)4: simple (cf. denticulatin A (1),5 
and muamvatin (3),6 -pyrones (cf. diemenensin (2)7), and -pyrone containing (cf. 
siphonarins A (5)8 and B (4)8 and baconipyrones A - D  (6 - 9)4). Interestingly, these animals 
produce the same polypropionate secondary metabolite profile regardless of geographical 
location.9 
 
 
                                                 
i A subclass of gastropod, comprising one half of all mollusk species. 
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Figure 1.1 Siphonariid polypropionate classification 
Upon careful inspection and analysis, the rich structural diversity can be attributed to 
varying intramolecular cyclization events that occur along the heavily oxygenated carbon 
backbone.2, 10 For example, the production of -pyrones from 1,3,5-triones, dihydro-4-
pyrones and tetrahydro-2-hydroxypyrones from 5-hydroxy-1,3-diones, and spiroacetals from 
9-hydroxy-1,5-diones. It has been suggested that some of the polypropionate secondary 
metabolites produced by the siphonariids may be related through unstable acyclic precursors 
that undergo different cyclization events. Such a connection was proposed for several 
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seemingly different -pyrone-containing decapropionate metabolites: siphonarin B (4), 
baconipyrones A (6) and C (8) and caloundrin B (10)9 (Figure 1.2).11    
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Figure 1.2 Potentially related siphonariid decapropionates 
1.1.2 Proposed relationships between siphonariid polypropionates 
The baconipyrones A (8) and C (6) are rare examples of polypropionate natural 
products containing a non-contiguous carbon skeleton.4, 11, 12 Their formation was originally 
proposed to occur through a rearrangement of the parent decapropionate, most likely 
siphonarin B (4), which was contemporaneously co-isolated (Figure 1.3).4  
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Figure 1.3 Proposed formation of baconipyrones A (8) and C (8) 
Caloundrin B (10) and siphonarin B (4) were proposed to be related via alternative 
cyclization modes, attributable to the orientation of the C-8 methyl (C-6,8 syn vs. C-6,8 anti); 
C-8 is flanked by two carbonyls and is expected to be readily epimerizable (Figure 1.4).9, 11  
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Figure 1.4 Alternative contiguous carbon skeleton cyclization modes  
It was proposed that the configuration at C-8 controls the cyclization preference because of 
destabilizing syn-pentane interactions between the C-8 and C-10 methyl groups in 13 and the 
C-6 and C-8 methyl in 16 (i.e., the alternative cyclization modes presented in Figure 1.4).11 
These destabilizing interactions are highlighted in structures 13a and 16a (Figure 1.5). 
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Figure 1.5 Destabilizing syn-pentane interactions  
These analyses led to a refinement in the hypothesis surrounding the formation and 
relationships between these compounds (4, 6, 8, and 10) and, as a result of this analysis, 
significant doubt was placed upon their natural product status. It was proposed that 
siphonarin B (4) and caloundrin B (10) may be formed non-enzymatically (i.e., formation 
and abundance governed by each compound’s relative stability) from an unstable acylic 
precursor, such as 14 and 15. However, even the unstable acyclic precursors 14 and 15 may 
not be real natural products because the -pyrone moiety was suggested to be a result of 
isolation.ii, 3, 11   
                                                 
ii Spontaneous formation, during isolation, of the -pyrone from a 1,3,5-triketone is unlikely (vide infra).  
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Additional doubt about the natural product status of some of these structures is 
presented by baconipyrone C (6). This structure has been detected numerous times in 
independent isolation studies,4, 12 as would be expected if it were biosynthetically produced 
by the mollusk. However, a later, “careful”, reexamination of S. baconiiii, 13 extracts by 
Garson, based on the notion that these structures may be artifacts of isolation, found no trace 
of baconipyrone C (8); siphonarin B (4), as expected, was isolated from this study.12 It was 
proposed that a delicate precursor, susceptible to a retro-Claisen rearrangement (cf. 11, 
Figure 1.3), might be the real natural product and that baconipyrone A (6) and C (8) might 
owe their origin to events transpiring outside the organism. Retro-Claisen rearrangements 
have been shown to occur in similar systems,12, 14-17 but a “biomimetic” synthesis of 
baconipyrone C (8) has not been demonstrated and retro-Claisen rearrangement/aldol 
cascades leading to baconipyrone A (6), or even a simple model compound, appears to be 
unprecedented. 
Despite the number of observations supporting the aforementioned hypotheses, there 
remains a significant, unanswered problem regarding the origin of this series of compounds. 
If their formation was non-enzymatic (i.e., under thermodynamic control), then it should be 
expected that siphonarin B (4) and caloundrin B (10) would be isolated in a ratio reflecting 
their relative stabilities. Siphonarin B (4) has been isolated numerous times in independent 
studies by several different research groups.4, 8, 9 Caloundrin B (10), however, has been 
observed and isolated just once.9 Realistically, caloundrin B (10) should have been observed 
on more than just this one occasion given the number of isolation studies that these mollusks 
have “participated” in.  
                                                 
iii S. baconi is synonomous with S. zelandica. 
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The same arguments apply to siphonarin A (5) and baconipyones B (7) and D (9). 
These compounds are C-20 desmethyl analogues of 4, 6, and 8, respectively. No C-20 
desmethyl compound analogous to caloundrin B (10) has been isolated. 
1.1.3 Isolation and structure determination 
Siphonarin B (4) was the first of these related polypropionates to be isolated and 
characterized.8 The sample originated from a collection of S. zelandica obtained from New 
South Wales, Australia in an approximate yield of 0.05 mg/animal. The structure was 
determined by NMR comparison to siphonarin A (5) whose structure and relative 
configuration was unambiguously determined by X-ray diffraction studies. 
Baconipyrones A (6) and C (8) were later isolated and characterized from a collection 
of S. Baconi obtained near Melbourne, Australia in an approximate yield of 0.05 and 0.016 
mg/animal, respectively.4  Co-isolated with baconipyrones A (6) and C (8) were siphonarin A 
(5) and baconipyrones B (7), and D (9). The structures of baconipyrones A (6) and C (8) 
were determined on the basis of NMR comparison and biosynthetic considerations to 
baconipyrone B (7), whose structure and relative configuration was unambiguously 
determined by X-ray diffraction studies.  
Caloundrin B (10) was the last of these four related structures to be isolated.9 It 
originated from a sample of S. zelandica obtained from Shelley and Kings Beach, Caloundra, 
Australia in an approximate yield of 0.01 mg/animal and was the only structure in this series 
of compounds that was not isolated and characterized by Faulkner and co-workers. Expecting 
to find only siphonarins A (5) and B (4), Garson and co-workers described the discovery of 
this new metabolite (co-isolated with 4 and 5) as surprising. The structure was determined by 
extensive NMR studies and comparison to related structures. During the course of the NMR 
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studies to determine the structure, caloundrin B (10) decomposed.iv Attempts, under 
unspecified conditions, to generate more caloundrin B (10) from siphonarin B (4) were 
unsuccessful.  
1.1.4 Siphonariid polypropionate biosynthesis 
 There are two conceivable possibilities for the biosynthesis of siphonariid 
polypropionates: direct condensation of propionate units (pathway A, Figure 1.6) or through 
a polyacetate chain and methylation by S-adenosyl methionine (pathway B, Figure 1.6).1, 3  
Examples of both possibilities are well documented in the literature for other organisms 
known to produce polypropionates.18  
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Figure 1.6 Biosynthetic possibilities 
Garson and Faulkner, as part of their long standing investigation into the 
polypropionates produced by siphonariid mollusks, investigated the biosynthesis of 
                                                 
iv Isolation included aqueous extraction and extensive chromatography. Decomposition occurred in the NMR 
tube, following isolation. 
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denticulatin (1) (Figure 1.7).18 This investigation was the first reported effort into 
establishing the biosynthetic origin of the compounds produced by siphonariid mollusks. 
Through injection of sodium [1-14C]propionate into the foot muscle of S. denticulata and by 
transdermal uptake of sodium [1-14C]propionate from inoculated aquarium water, it was 
shown conclusively that the biosynthesis of denticulatin (1) is of propionate origin (i.e., 
pathway A, Figure 1.6).  
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24
 
 
Figure 1.7 Biosynthetic studies on denticulatin (1) 
An intriguing problem in the biosynthesis of the siphonariid polypropionates is the 
direction of chain growth, which cannot be simply determined by inspection due to a 
decarboxylation event that occurs during biosynthesis. Two modes of chain extension are 
possible in that chain propagation may proceed from C-1 to C-19 or in the reverse manner. 
Garson et al. investigated this issue in the siphonarins (4 and 5), concurrent to confirming the 
propionate origin of these molecules (i.e., verification of the previous conclusion regarding 
siphonariid polypropionate biosynthesis).19 
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Figure 1.8 Biosynthetic studies on the siphonarins 
Garson reasoned that the problem could be solved by determining the origin of C-19 
in siphonarin A (5) by “feeding” experiments (via injection in the foot muscle of S. 
zelandica) of sodium [1-14C]propionate (Figure 1.8). Depending on direction of chain 
growth, C-19 would either show 14C labeling from incorporation of sodium [1-14C]propionate 
or not; siphonarin A (5) is constructed through condensation of 9 propionate units and 1 
acetate unit.v In addition to confirming the propionate origin of 4 and 5, it was definitively 
shown that there was no incorporation of 14C in any of the acetate-related degradation 
compounds isolated following degradation experiments. Thus, the direction of chain growth 
was determined to be C-19 to C-1. By analogy, siphonarin B (4) was also reasoned to grow 
C-19 to C-1. These studies also confirmed the de novo biosynthesis of these compounds as 
opposed to bioaccumulation from food sources.1 
Garson, Goodman, and Paterson rationalized that the other siphonariid 
polypropionate metabolites should be assembled in a similar manner on the basis that the 
                                                 
v Siphonarin B (4) is constructed from 10 propionate units. 
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isolated structures are related.11 A comparison of the acyclic structures of the siphonarin B 
(4), muamvatin (3), and denticulatin (1) all show a common tetrapropionate motif near the 
terminus of the chain that shares similarity with Cane, Celmer, and Westley’s model20 for 
polyether antibiotic biogenesis (Figure 1.9). This observation suggests a genetic 
commonality between bacteria and the siphonariids, but, to date, no common proteins have 
been disclosed.2, 11, 19 
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Figure 1.9 Biosynthetic model 
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1.2 Synthetic studies on these related siphonariid polypropionates 
1.2.1 Synthetic studies on baconipyrone C (6): establishment of absolute configuration 
 A key unresolved issue in the study of baconipyrone C (6), and of all these related 
compounds, was the determination of absolute configuration. Paterson elected to tackle this 
issue through the synthesis of a known siphonariid polypropionate degradation product, 
carboxylic acid 40 (the known degradation product is actually ent-40, vide infra) (Scheme 
1.1).21 
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Scheme 1.1 
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The carbon skeleton of the carboxylic acid fragment was constructed via three aldol 
reactions. Starting from Roche ester derivative 31,vi, 22 two unselective titanium (IV)-
mediated aldol reactions produced the carbon skeleton required to access a key intermediate, 
-pyrone aldehyde 35. Subjection of diol 33 to DMP oxidation followed by Yamamura’s -
pyrone conditions23, 24 gave the desired -pyrone 34 in moderate yield. Hydrogenolysis, 
followed by oxidation gave the reportedly sensitive (i.e., prone to racemization) -pyrone 
aldehyde 35.  
To complete the carbon skeleton of the target (40), a Sn(II)-mediated aldol reaction25 
between -pyrone aldehyde 35 and 36vii, 21 was conducted. The oxidation states of the aldol 
adduct were then reversed in addition to setting the last stereogenic center via a Evans-
Tishchenko26, 27 reduction. The orthogonal protecting groups were removed and PMB diol 39 
was oxidized over a two (2) step sequence to the corresponding keto-acid. Finally, the PMB 
group was removed via hydrogenolysis to give carboxylic acid 40. 
The carboxylic acid matched the reported spectroscopic data8 for this fragment and 
the corresponding fragment of baconipyrone C (8).4 However, the optical rotation 
(synthetic:21 []D +115 (c 0.5, CH2Cl2)) was not of the same sign as the isolated material 
(natural:8 []D -87 (c 0.052, CH2Cl2)). This suggested that the siphonariid polypropionates 
were enantiomeric to carboxylic acid 40 (i.e, ent-40). 
1.2.2 Total syntheses of baconipyrone C (8) 
To date, there are two reported syntheses of baconipyrone C (8)28, 29 and one report on 
the enantioselective synthesis of the unnatural antipode (ent-8).30 All three synthetic efforts 
                                                 
vi Available in 3 steps, 88% overall yield from methyl (R)-3-hydroxy-2-methylpropionate. 
vii Available in 3 steps, 86% overall yield from methyl (S)-3-hydroxy-2-methylpropionate. 
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were designed around disconnection at the ester linkage, but featured significantly different 
approaches and methodologies to construct each fragment (41 and 42) (Figure 1.10). No 
attempt was made in subsequent syntheses to improve on the coupling strategy and final 
steps pioneered in the first.28  
OH O O
O
baconipyrone C (8)
O
O
O
O
PMB
O O O
O
O
HO
42
O OOH
+
41
esterification
 
Figure 1.10 Baconipyrone C (8) synthetic strategy 
1.2.2.1 Paterson’s synthesis 
Paterson approached the total synthesis of baconipyrone (8) based on his earlier work 
in constructing carboxylic acid 40 (Scheme 1.1).21 Knowing the required absolute 
configuration, he began with the opposite enantiomeric seriesviii from what was used 
previously (Scheme 1.2). The steps pioneered previously were followed without deviation; 
however, several notable improvements to the efficiency of the process were made. For 
example, using the alternative Yamamura protocol24 (CCl4/PPh3) to form the Bn-protected 
pyrone (ent-34, Scheme 1.1) improved the yield from 54% to 88%. Another notable 
                                                 
viii See Scheme 1.1. The absolute configurations used in the synthesis of baconipyrone C (8) are, however, 
opposite to that shown in Scheme 1.1. Paterson started the synthesis of baconipyrone C (8) with ent-31. 
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improvement was the Sn-mediated aldol reaction25 to form ent-37: the yield of this 
transformation was improved from 59%21 to 80%28 with the same selectivity. Overall, PMB-
protected keto-acid 42 was produced in a longest linear sequence of 18ix steps in an 
astounding overall yield of 25%. 
BnO
O
Obtained in: 
3 steps, 
88% yield
ent-31
HO O
O
42
O
PMB
O O
15 steps
 
Scheme 1.2 
Attention then turned towards the synthesis of the remaining fragment, hydroxydione 
41 (Scheme 1.3).  An enantioselective aldol of 3-pentanone (43) with (E)-2-methyl-2-
pentenal (44) using previously established conditions31 gave the desired aldol adduct in 
moderate yield and enantioselectivity (57%, 85% ee). Protection as the corresponding 
tbutyldimethylsilyl ether, hydroboration,32 oxidation under Swern conditions, and 
deprotection finished the synthesis of the desired alcohol 41 over 5 steps in 32% overall 
yield.  
In the same study,28 Paterson also presented an alternative diastereoselective 
synthesis of 41, starting from (R)-ethyl lactate. The synthesis was slightly longer (9 steps) 
than the enantioselective synthesis shown in Scheme 1.3, but was very efficient (38% overall 
yield. and delivered the desired compound (41) with excellent ee, as would be expected from 
a synthesis starting from the chiral pool. 
                                                 
ix 21 steps inclusive of the 3 steps required to make ent-36. 
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Scheme 1.3 
Completion of the synthesis required what Paterson described as a challenging 
esterification step due to, what was thought to be, epimerization occurring at C-14 (Scheme 
1.4); HC-14 is  to a ketone (C-13) and a vinylagous ester (the -pyrone moiety), thus HC-14 
should be the most acidic proton and the stereocenter most sensitive to epimerization. After 
much experimentation, a modified Yamaguchi esterification protocol finally gave 73% 
combined yield of a 10:1 mixture of C-14 diastereomers.x The remaining protecting group 
was oxidatively removed and the minor diastereomer chromatographically separated to 
provide baconipyrone C (8) in 67% yield. 
                                                 
x Epimerization at C-14 was assumed based on sound reasoning, but was not rigorously proven. 
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Scheme 1.4 
From commercially-available starting material, the longest linear sequence was 20xi 
steps. Despite the length, the described synthesis was extremely efficient giving an overall 
yield of 11%. This remarkable achievement confirmed the structure proposed for 
baconipyrone C (8), as well as its absolute configuration.  
1.2.2.2 Hoveyda’s synthesis 
Hoveyda’s synthesis was the first enantioselective synthesis of the unnatural 
enantiomer of baconipyrone C (ent-8).30 The strategy employed was based on the extensive 
use of chiral metal complexes to enantioselectively access each fragment.  
The key catalytic asymmetric allylic alkylation (CAAA) step in the synthesis of the 
alcohol required diene 53, which was accessed in 22% yield over 7 steps from commercially-
available starting material (Scheme 1.5). Subjecting diene 53 to the CAAA protocol 
developed to support this synthesis, gave the desired doubly alkylated product 55 in 61% 
yield and >98% ee. Removal of the allyl protecting group,33 followed by ozonolysis gave the 
                                                 
xi Inclusive of 41, the synthesis had a total of 28 steps. 
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desired alcohol fragment (ent-41). In summary, hydroxydione ent-41 was synthesized in 10 
steps with an overall yield of 7% (>98% ee).  
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Scheme 1.5 
The synthesis of carboxylic acid ent-42 was based on the desymmetrization of 
oxabicycle 58, accessible in 4 steps from commercially available starting materials (Scheme 
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1.6). The first 2 steps in this sequence are knownxii,34 but later two steps are not reported and, 
therefore, must be estimated based on analogy.xiii,35 Desymmetrization was achieved via a 
previous established asymmetric ring-opening metathesis/cross metathesis reaction36 that was 
somewhat optimized in this synthesis to access pyran 61 in moderate yield (62%) and 
enantioselectivity (88% ee, 15:1 er). Pyran 61 was then opened by dissolving metal 
reduction. The moderate yield of this step was the result of competitive loss of the PMB 
group to form the corresponding diol. Nevertheless, 62 was a compound that could be 
elaborated into the desired compound. This would, however, require the stereoselective 
addition of another methyl group in addition to the -pyrone moiety.  
Hoveyda first tackled stereoselective addition of the required methyl group to 62. 
Consistent with the theme of this synthetic effort, he extended the carbon skeleton through a 
catalytic Si-tethered ring-closing metathesis reaction37, 38 and then performed a 
diasteroselective allylic alkylation with Me2Zn and CuCN.  
                                                 
xii Obtained in 36% overall yield. 
xiii Yadav reported the synthesis of the related Bn ether. Yields of the reduction and protection steps are 74 and 
94%, respectively.  
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Scheme 1.6 
With all the stereogenic centers now correctly installed, attention turned to towards 
formation of the -pyrone moiety (Scheme 1.7).  Protection of 65, followed by ozonolysis 
and reduction in the same pot gave diol 66. Differentiation of the two primary alcohols was 
now required to continue the synthesis. Fortunately, experimentation found that the two 
alcohols reacted at different rates with TBSOTf. By using substoichiometric amounts of 
reagent, at low temperature, and resubjecting recovered starting material to the reaction 
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conditions, desired alcohol 67 could be produced in 60% yield.xiv The exposed 1° alcohol 
was oxidized to give 68 and the stage was now set to install the -pyrone and complete the 
total synthesis. 
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Scheme 1.7   
                                                 
xiv Four runs (four individual experiments) of subjecting starting material to the reaction conditions was required 
to achieve this modest yield of the protected compound (67). 
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Hoveyda opted to use a novel method of his own design to form the -pyrone rather 
than use any of the more mild methods more recently introduced (Scheme 1.7). xv,23, 24, 39 
Following an aldol reaction of aldehyde 68 with 69 and oxidation of the aldol with DMP, 
Hoveyda found that a DBU-promoted dehydrative cyclization gave desired pyrone 71 in 
good yield. Hydrolysis of both TBS-ethers produced the enantiomer of same intermediate 
used by Paterson28 in the first total synthesis of baconipyrone C (8). Repetition of steps 
pioneered by Paterson (see Scheme 1.4) furnished the unnatural enantiomer of baconipyrone 
C (ent-8) in yields comparable to those obtained previously.28 
1.2.2.3 Yadav’s synthesis 
Yadav’s synthetic strategy, like Hoveda’s, was based on the desymmetrization of 
oxabicycle 58 to construct a key section of carboxylic acid fragment 42.29  This strategy and 
methodology had been used successfully by Yadav in synthetic studies on several natural 
products.35, 40-48 
Desymmetrization of oxabicycle 58xvi by enantioselective hydroboration and its 
elaboration into lactone 72 has not been described in the open literature; however, a closely-
related analogue (Bn vs. PMB) has been partially described (Scheme 1.8).35 It can be 
assumed that similar steps were employed; yields (and selectivities) are expected to be 
similar, but this is speculation. 
                                                 
xv Few mild methods to form -pyrones from 1,3,5-triketone (or protected derivatives) were available to 
Hoveyda at the time this work was published. More recently, additional investigations into this problem have 
been published (vide infra).  
xvi Obtained in four steps in 36% yield. 
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 Scheme 1.8 
Reduction of lactone 72xvii gave triol 73. In order to isolate C-15-OH (siphonariid 
numbering), a significant protecting-group game was engaged. Once isolated, the alcohol 
was oxidized with IBX in DMSO to give aldehyde 76 and the stage was set to install the 
remaining carbon atoms, form the -pyrone, and complete the synthesis of carboxylic acid 42 
(Figure 1.10).  
Installation of the -pyrone proceeded according to methodology developed by 
Yamamura (Scheme 1.9); the lithium dianion of 4-methyl-3,5-heptanedione (77) was reacted 
with aldehyde 76, followed by DMP oxidation to give triketone 78.23, 24 The resulting 
triketone was then subjected to PPh3/CCl4 in THF to form desired -pyrone 79. Deprotection 
                                                 
xvii Accessible in 4 steps from commercially-available material. Like Hoveyda (Section 1.2.2.2), no yields, 
selectivities, or procedures are given; overall yield is assumed (vide supra). 
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of the MOM and benzyl groups gave ent-39, the same compound first made by Paterson28 
and a key intermediate in the total synthesis of baconipyrone C (8). Oxidation, as reported by 
Paterson, gave the desired carboxylic acid in 23 steps. The overall yield to obtain carboxylic 
acid 42 was 3.0%.xviii 
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Scheme 1.9 
Yadav’s approach to hydroxydione 41 was significantly longer than both prior reports 
(Scheme 1.10). He opted for an enzymatic resolution as a means to obtain the product in 
                                                 
xviii Assuming that the 8 unreported steps are as efficient as those reported for the Bn derivative. 
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enantioenriched form. In total, hydroxydione 41 was accessed in 14 steps in 3% overall yield. 
The ee of 41 was not stated, but can be inferred from the optical rotation Yadav obtained and 
comparison to prior reports.28, 30 
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l) HFpyridine, THF  
Scheme 1.10 
1.2.2.4 Synthetic comparison and summary 
 The synthesis of baconipyrone C (8) presented by Paterson is by far the most 
efficient, has the least number of steps in the longest linear sequence, and the least number of 
steps overall (Section 1.2.2.1). Paterson’s synthesis is a clear demonstration of just how 
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powerful the methodology he has developed to efficiently construct polypropionate motifs.49 
The only weakness of Paterson’s synthesis is the use of expensive, enantiopure reagents.  
 Hoveyda’s synthetic approach was interesting from several different perspectives 
(Section 1.2.2.2). Each fragment in the synthesis relied upon an enantioselective reaction 
based on a chiral metal complex. Carboxylic acid fragment 42 relied upon the 
desymmetrization of a meso compound using an AROM/CM reaction. Hydroxydione 41 used 
an interesting catalytic asymmetric allylic alkylation (CAAA) protocol that was developed 
specifically to support the synthesis. However, to be clear, Hoveyda never synthesized 
baconipyrone C (8) because the correct enantiomer was not accessed. It is unclear why 
catalysts with the appropriate absolute configuration were not utilized in this synthetic effort. 
 Yadav’s synthesis was largely based on methodology previously shown to be 
effective in synthetic studies of several natural products (Section 1.2.2.3). However, in the 
case of this target, Yadav was forced to make significant use of protecting groups in order to 
coax his starting material into the final target. These protecting group manipulations detract 
from the key chemistry employed in this synthesis - desymmetrization of a meso compound 
by enantioselective hydroboration - and as such do not showcase the power of this 
methodology well. Further, Yadav turned to an enzymatic resolution as a means to 
enantioselectively access hydroxydione 41, rather than explore a more modern approach - 
like the desymmetrization methodology highlighted in this synthesis - to access this 
fragment.  
 Despite the innovative and powerful chemistry shown in these three syntheses of 
baconipyrone C (8), none addressed the hypothesis regarding the formation of this 
compound. Additionally, neither of the two subsequent syntheses improved on any aspect of 
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Paterson’s synthesis, except for the issue of accessing baconipyrone C (8) through 
completely enantioselective routes.  
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O
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 Paterson 2000a 
Hoveyda 
2007b, c 
Yadav 
2009d 
42 
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sequence 18 22 23 
Total number of steps 21 24 24 
Yield 25% 2.3% 3.0% 
[α]De -96.5 (c 0.4) 
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(c 0.19) 
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41 
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Total number of steps 5 10 14 
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a Ref 28. b Ref 30. c Antipodes of 41 and 42 prepared. d Ref 29. e CHCl3. f  Also 
synthesized diasteroeselectively from (R)-ethyl lactate (9 steps; 38% overall yield).  
g Not reported.  
 
Figure 1.11 Baconipyrone C (8) synthetic comparison 
1.2.3 Synthetic studies on baconipyrone A (6) 
 Baconipyrone A (6) has never been synthesized, but the cyclohexanone subunit (87) 
has been the subject of two synthetic studies.50, 51  
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Figure 1.12 Disconnection of baconipyrone A (6) 
1.2.3.1 Vogel’s synthetic study on the cyclohexanone subunit (87) 
 Vogel accessed the cyclohexanone subunit (87) of baconipyrone A (6) through a very 
concise route starting from 88 (Scheme 1.11).51 An SO2-induced oxyallylation of 88 
followed by retro-ene elimination of SO2 (the intermediate is shown as 90) gave 91 in a 
single pot.52 Transesterification of 91 with Bu3SnOMe53 presumably generated the 
corresponding Sn-enolate which underwent an efficient intramolecular aldol reaction.54 
Hydrogenolysis gave the desired cyclohexane subunit (87) of baconipyrone A (6). The 
cyclohexane subunit (87) fortuitously crystallized, which provided the means to 
unambiguously prove the structure of the compound obtained. 
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Scheme 1.11 
There is no comment in Vogel’s report on the synthesis of 87 on whether any effort 
was made to make carboxylic acid fragment ent-40 and attempt to complete the first total 
synthesis of baconipyrone A (6).  
1.2.3.2 Plumet’s synthetic study towards the cyclohexanone subunit (87) 
Plumet was actually the first to report a synthetic effort towards the synthesis of ()-
87.50 However, as unambiguously shown by Vogel in his subsequent synthesis of the 
cyclohexane subunit (87), the compound claimed to be ()-87 by Plumet was, most likely, a 
diastereomer of 87.51 Vogel showed that the last step in Plumet’s synthesis had gone awry; 
subjection of authentic 87 to the reaction conditions described by Plumet resulted in 
complete transformation to other compounds, including decomposition. The synthetic 
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sequence reported by Plumet is shown in Scheme 12, noting the failure to produce the 
desired product. 
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Scheme 1.12 
 Lastly, as Vogel pointed out, there was no discussion of structure proof in Plumet’s 
report nor was any data provided that could facilitate a retrospective analysis of the 
structure.51 
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1.2.4 Synthetic studies on siphonarin B (4) 
Shortly after completing the first total synthesis of baconipyrone C (8), Paterson and 
coworkers published an elegant synthesis of siphonarin B (4).15 This synthetic effort clearly 
showed the degree of difficulty that the construction of such natural products present.  
In an initial attempt towards siphonarin B (4), Paterson utilized key fragment ent-39, 
which had been previously used in the synthesis of baconipyrone C (8) (Scheme 1.13).28 
Protecting group manipulation exposed the 1° alcohol towards oxidation by DMP. A Sn-
mediated aldol reaction between aldehyde 102 and ketone 103, again derived from the 
previous baconipyrone C (8) synthesis, afforded aldol 104.28, 49 Hydrolysis of the triethylsilyl 
group, followed by bis-oxidation of the exposed alcohols provided triketone 105.  
The plan at this stage was to remove the silylidene protecting group of 105 and allow 
the C-7-OH to form a hemiacetal with the C-9 carbonyl. Unfortunately, the C-3-OH formed a 
hemiacetal with the C-7 carbonyl instead. Oxidative removal of the PMB group then formed 
spiroacetal 106 (C-11-OH onto C-7 hemiacetal), which resisted all attempts to undergo ring-
chain tautomerism to a form more amenable to the synthesis at hand; a revision in strategy 
was thus required. This attempt clearly shows that the protecting group strategy employed 
must work hand-in-hand with the redox strategy to create and unveil functionality at the 
correct time. 
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Scheme 1.13 
 In the second attempt, Paterson retooled ketone 110, derived from ketone 109,xix,55 
and modified acceptor aldehyde 108 (Scheme 1.14). These changes were made to 
orthogonally protect C-3 and C-5-OH (siphonariid numbering) in order to control the release 
of each hydroxyl group and thus establish some level of control over hemiacetal formation 
that thwarted the previous effort. 
                                                 
xix Available in 3 steps, 62% overall yield from (S)-methyl-3-hydroxy-2-methylpropionate 
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Scheme 1.14 
 Upon release of the DEIPS protecting group of 112 with HFpyridine, the desired 
ring-chain tautomerism of C-5-OH onto C-9 carbonyl occurred and internally protected C-5-
OH from further reaction (cf. 113). Hydrogenolysis of 113 released the benzyl group and the 
resulting hydroxyl group was oxidized under Swern conditions. The sensitive aldehyde was 
immediately subjected to the Kishi-Nozaki protocol56, 57 with vinyl iodide to give allylic 
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alcohols 114. A second Swern oxidation gave the corresponding enone, which was subjected 
to hydrogenation with palladium on carbon in order to reduce the olefin and hydrogenolyze 
the PMB group. Extended reaction time (16 hours) was required for hydrogenolysis, which 
resulted in what was described as significant, competing decomposition. However, a small 
amount of spirocyclization occurred to afford siphonarin B (4) in 8% yield over the final two 
transformations of the synthesis. 
 In total, this remarkable diastereoselective synthesis of siphonarin B (4) - reportedly 
described as a sensitive compound - was achieved in a longest linear sequence of 28 steps 
and 0.86% overall yield from commercially available starting material.xx,58 
1.3 Conclusions 
There have been several synthetic efforts over the years that have answered a limited 
number of questions about this series of related structures. The previous efforts primarily 
focused on proof of structure and determination of absolute configuration. However, even 
these aspects have not been fully addressed because two of the four structures (caloundrin B 
(10) and baconipyone A (6))xxi have never been synthesized: caloundrin B (10) has not been 
the subject of any synthetic study. 
There remain many unanswered questions in this series of potentially related 
compounds. For example, no study has addressed the formation and potential relationships 
between these molecules. Specifically, is there an acyclic precursor (cf. 14 or 15) that gives 
rise to caloundrin B (10) and siphonarin B (4) via alternative folding patterns and is this 
folding under thermodynamic control? Why is it that siphonarin B (4) has been observed 
multiple times, but caloundrin B (10) only a single time? Are the baconipyrones A (6) and C 
                                                 
xx The synthesis was described as starting from ent-31, but ent-31 is a synthetic product and is available 3 steps, 
88% overall yield from (S)-(+)-3-hydroxy-2-methylpropionate. 
xxi Conceivably routes to fragments of this compound exist, but the fragments have never been coupled. 
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(8) formed from any of the former via retro-Claisen rearrangement (cf. 8) and retro-Claisen 
rearrangement/aldol cascades (cf. 6)? Further, is baconipyrone C (8) the precursor of 
baconipyrone A (6)? If this were the case, then how is it possible that the resulting aldol 
reaction is face and group selective since no other diastereomers have been observed? 
As shown in these synthetic studies, accessing siphonariid polypropionates in 
reasonable yield is extremely challenging due to the sensitivity of these molecules towards 
even mild conditions,15, 28, 51 storage,30 and in the case of caloundrin B (10), decomposition 
during NMR studies to determine structure.9 Further, the strategy to reveal and create 
functionality has to be carefully planned and executed otherwise a synthetic approach can 
rapidly reach a dead end due to unexpected ring-chain tautomerization events15 or 
undesirable epimerization events.28 
These unresolved questions coupled with the inherent synthetic challenge present the 
possibility of an intriguing research project. 
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RESULTS AND DISCUSSION 
2.1 Research objectives 
 The objectives of this research project were to establish relationships between 
siphonarin B (4), baconipyrone A (6), baconipyrone C (8), and caloundrin B (10), ideally 
through the putative acyclic precursor (cf. 14 and 15) (Figure 2.1). With the acyclic 
precursor in hand, conditions could be investigated to attempt to control these alternative 
cyclization pathways and/or facilitate the proposed chemical transformations that would lead 
to the observed structures. Additionally, with one, or more, of these isolated structures in 
hand, conditions could be investigated to test for conversion of one isolated structure to 
another. If successful, some comment could be made about the natural product status of this 
series of compounds; a subject which has not been broached by any of the synthetic studies 
performed on this series of compounds. 
 Model studies would be used where literature precedent is weak or non-existent. 
These studies are, however, not research objectives per se, but are tools to determine how to 
progress towards answering the above research questions. 
 A secondary research objective was to showcase the power that the Thiopyran Route 
to Polypropionates (see Section 2.3) provides in rapidly assembling polypropionate structural 
motifs. The available adducts from this synthetic strategy are useful building blocks for the 
total synthesis of complex polypropionate natural products.   
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Figure 2.1 Research objectives 
2.2. Target selection and synthetic considerations 
 Of the four isolated, related structures (4, 6, 8 and 10), the target that was selected to 
become the primary focus for synthetic study was caloundrin B (10) (Figure 2.2). This 
selection was made primarily because of the structures containing contiguous carbon 
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skeletons (siphonarin B (4) and caloundrin B (10)), only caloundrin B (10) has never before 
been synthesized. This molecule also contains several unique structural features and eight 
stereogenic centers, providing significant synthetic challenge in its construction. Further, 
caloundrin B (10) is reportedly unstable,9 presenting an even higher degree of challenge. 
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Figure 2.2 Caloundrin B (10) structural features 
Any synthesis of caloundrin B (10) would require control over the relative 
configuration of the eight stereogenic centers present in the molecule, as well as control over 
the absolute configuration since these natural products exist as single enantiomers (Figure 
2.2). The Thiopyran Route to Polypropionates (Section 2.3) was envisioned to provide the 
control required for both of these aspects. 
Caloundrin B (10) contains an intriguing and unusual bis-acetal/hemiacetal ring 
system (hereafter referred to as “trioxaadamantane ring system” or “trioxaadamantane”) 
(Figure 2.2), a rare structural feature present in just one other marine polypropionate natural 
product, muamvatin (3) (Figure 1.1).6 There are very few synthetic studies on 
trioxaadamantanes and these are limited to muamvatin (3)59-62 and related systems.16 Thus, 
the caloundrin B (10) trioxaadamantane ring system would require study through a model 
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system in order to determine how to form it and gain an understanding of the conditions that 
it may be stable towards in order to develop a synthetic strategy (Section 2.4).    
In addition to studying the trioxaadamantane ring system, the synthesis also requires 
installation of a -pyrone moiety (Figure 2.2). The timing and conditions required for the 
formation of the -pyrone moiety also require study (Section 2.5).  
2.3 The Thiopyran Route to Polypropionates 
The Thiopyran Route to Polypropionates is a long-standing research theme in Prof. 
Ward’s research group (Figure 2.3).63-76 The route has been designed and optimized to 
rapidly and efficiently construct tetrapropionate synthons 118 (4 diastereomers) and 
hexapropionate synthons 119 (20 diastereomers). These synthons are useful building blocks 
for the synthesis of polypropionate natural products. Thus far, the Thiopyran Route to 
Polypropionates has been utilized in the synthesis of serricornin (123)72 and membrenone B 
(121).77  
A key aspect of any synthetic strategy, and indeed the Thiopyran Route to 
Polypropionates, is the preparation of starting materials through, ideally, simple, efficient, 
scalable, and cost-effective procedures with minimal chromatography (Figure 2.3). My 
contribution in this area included: 1) optimizing a multi-gram procedure (ca. 0.5 kilogram) to 
prepare Dieckmann product 126;74 2) development of a multi-gram procedure (ca. 100 gram) 
to prepare ketone 117 in free-flowing, white, crystalline form;74 3) and the investigation of an 
alternative oxidation protocol78 to prepare multi-gram (ca. 40 gram) quantities of aldehyde 
()-116,xxii a previously challenging endeavor under available standard laboratory 
                                                 
xxii Athanasios Karagiannis, unpublished results. Experimental conception and design under my supervision. 
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conditions.xxiii,66, 79 Following optimization, all of the aforementioned reactions no longer 
required chromatography to produce their respective products in excellent yield and purity. 
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Figure 2.3 The Thiopyran Route to Polypropionates 
                                                 
xxiii The volumes of solvent (CH2Cl2) involved to conduct a Swern reaction at this scale (>2 L) exceed available 
equipment and cooling (-78 °C) mechanisms. 
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The syntheses of polypropionate natural products, generally speaking, require single 
enantiomers to be accessed. Control over absolute configuration has been established in the 
Thiopyran Route to Polypropionates in the synthesis of the tetrapropionate synthons 11867, 68, 
70, 72 and in a specialized example of a meso hexapropionate synthon 119 via an enantiotopic 
group selective reaction (desymmetrization reaction).71 With respect to the tetrapropionate 
synthons 118, access to all four enantioenriched diastereomers has been established via 
diastereoselective aldol reactions though the use of enantioenriched aldehyde 116.67 
Alternatively, a direct aldol reaction between ()-116 and 117 that occurs with enantiotopic 
group selectivity80 and dynamic kinetic resolution81 accesses 122 in >98% ee has been 
established (Scheme 2.1).70  
The latter chemistry presented an opportunity for improvement as the yield of the 
proline-mediated version of the reaction was a modest 56% (>98% ee) and required a 
substantial amount (6 equivalents) of ketone 117 (Scheme 2.1). Considering that the direct 
aldol reaction between 117 and ()-116, mediated by proline, had been extensively optimized 
to achieve this remarkable result, one of the few avenues left to explore was the catalyst 
employed in the reaction (Scheme 2.1). Tetrazole catalyst 127 is known to be more soluble 
than proline.82-85 By employing this catalyst, the yield of the direct aldol reaction between 
117 and ()-116 was improved (86%, >98% ee).72 It was also found that by increasing the 
concentration of the reaction substantially (9 M in ()-116 vs. 1 M), that the amount of 
ketone 117 could be reduced (from 12 equivalents to 2) while maintaining a similar yield 
(75%, >98% ee) at gramxxiv scale. Conditions to isomerize aldol 122 to 128 were identified 
and optimized.72 Thus two of the four tetrapropionate synthons 118 (cf. 122 and 128) could 
                                                 
xxiv This reaction has been performed at ca. 40 gram scale in >70% isolated yield (>98% ee) with no 
chromatography; Athanasios Karagiannis, unpublished results. 
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be obtained in enantiopure form from a racemic reactant (()-116) in high yield and 
enantioselectivity. 
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Scheme 2.1 
An aldol reaction between tetrapropionate synthon 118 and aldehyde 116 produces 
the next layer of complexity in the Thiopyran Route to Polypropionates: hexapropionate 
synthons 119 (also referred to as “bisaldols”) (Figure 2.3). Now, however, there are 
twentyxxv possible diastereomers (all known).64, 73, 76, 86 My contribution to this area was 
related to deepening the understanding of the stereochemical control elements operating in 
the aldol reactions between tetrapropionate synthons 129 and 130 and aldehyde 116 (Figure 
2.4).73 The systematic study of these reactions allowed a model to be developed that 
rationalized the stereochemical outcome of these reactions. From this model, reactions were 
designed to exploit these stereochemical control elements to access single diastereomers of 
134 or 135xxvi in high yield and diastereoselectivity through the kinetic resolution of ()-
116.76 
                                                 
xxv Chiral diastereoisomers (even # of stereogenic centers, n) = 2n-2 : meso forms = 2(n-2)/2. 
xxvi Eight (8) stereoisomers are possible from an aldol reaction of tetrapropionate synthon 129 (or 130) with 
aldehyde ()-116. Protecting groups other than MOM were used in the subsequent study. 
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Figure 2.4 Model for stereoselectivity in aldol reaction of 129 and 130 with ()-116 
2.4 Trioxaadamantane ring system synthesis and isomerization: model study 
This model study has been previously published in Organic Letters.75 Much of the 
original text and tables have been included herein, with some modification for clarity and 
consistency with this thesis. The schemes and figures in the following are somewhat different 
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than in the Organic Letters publication, which was done to be consistent with the graphical 
presentation of this thesis. 
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Figure 2.5 Natural products containing a trioxaadamantane ring system 
The highly unusual trioxaadamantane ring system has been identified in only two 
siphonariid natural products: muamvatin (3)6 caloundrin B (10) (Figure 2.5).9 The difference 
between the trioxaadamantane ring systems in muamvatin (3) and caloundrin B (10) is the 
configuration of C-4. This difference is used to distinguish between the two ring systems in 
the following discussion.   
The trioxaadamantane ring system is formally derived from ring-chain tautomerism 
of a 3-hydroxy-1,5,7-trione (Scheme 2.2). Although this ring system is thermodynamically 
stable, its formation is impeded because it proceeds via the less stable of the intermediate 
hemiacetal anomers (i.e., 140/141 and 148/149 vs. 138/139 and 146/147), and these 
hemiacetals readily undergo dehydration (to 152/153) or retro-Claisen  (to 154/155) under 
acidic and basic conditions.16, 59-62 Consequently, the precursor hydroxytrione rearrangement 
(i.e., 136/137 or 144/145) must be unveiled under very mild conditions. 
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Scheme 2.2 
Synthetic studies are limited to the muamvatin (3) ring system (cf. 151), 16, 59-62 but 
despite the limited study two different approaches have been described (Scheme 2.3). The 
first approach, utilized by Hoffmann60-62 and Perkins,16 approached formation of the 
muamvatin-related trioxaadamantane ring system via the deprotection of a silyl-protected 
triketone. Treatment of these silyl-protected triketones (157 and 158) under mild conditions 
provided the desired trioxaadamantane ring system in good yield. Paterson approached the 
formation of the trioxaadamantane moiety based on trihydroxy ketone 160.59 Internal 
protection of one of the alcohols as a hemiacetal served as a means to differentiate one of the 
three alcohols present in 160. Oxidation of the exposed alcohols of 160 via a double Swern 
followed by exposure to silica gel provided the desired trioxaadamantane ring system 162 in 
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excellent yield. All of these studies underscored the mildness of the conditions required to 
generate the trioxaadamantane moiety. 
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Scheme 2.3 
It was reasoned that by exploiting a thiopyran template like 163/164, formation of 
sulfur-bridged trioxaadamantane 167 or 168 would not require such mild conditions. Acidic 
conditions could be used because dehydration of the required intermediate hemiacetal 
anomer 165/166 is disfavored by Bredt’s rule (Scheme 2.4).87, 88  
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Scheme 2.4 
2.4.1 Muamvatin’s trioxaadamantane ring system and isomerization 
To test the hypothesis outlined in Section 2.4, the preparation of known61 
trioxaadamantane ()-151 related to muamvatin (3) was attempted (Scheme 2.5). Aldol 169 
was first protected as its corresponding MOM ether 170,69, 73 which was followed by an aldol 
reaction of the enol borinate of ()-170 with propanal gave aldol adduct ()-171xxvii, 73, 76 as a 
9:1 mixture of diastereomers. Oxidation of ()-171 with IBX in DMSO followed by 
treatment of the crude reaction mixture with FeCl36H2O in refluxing acetone/MeOHxxviii, 89 
served to hydrolyze the acetal protecting groups and catalyze the formation of unusual 
trioxadithiapentacycle ()-168 in good yield. Desulfurization of ()-168 with Raney nickel 
surprisingly provided trioxaadamantane ()-143, whose structure was confirmed by X-ray 
crystallography (Figure 2.6). 
                                                 
xxvii The relative configuration shown was assumed based on precedent established in refs 73 and 76. 
xxviii MeOH was added to facilitate removal of the MOM protecting group. 
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Scheme 2.5 
The isolation of ()-143 was surprising because it is thermodynamically unstable 
relative to its epimer ()-151 due to the syn-pentane relationship between the C-8 and C-9 
methyl groups. It was expected that under the conditions for desulfurization (refluxing 
ethanol) that epimerization would have occurred spontaneously. Investigation of suitable 
isomerization conditions was required to overcome the unexpected kinetic stability of ()-
143. 
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Figure 2.6 ORTEP plot of ()-143.xxix  
Considering previous studies on this ring system (Scheme 2.3), there were several 
conditions that could be attempted: HFpyridine,60-62 silica,59 and DBU.16 In addition to 
attempting these conditions, imidazole in chloroform was also attempted based on previous 
experience with this catalyst in the isomerizations (via keto-enol tautomerization) of sensitive 
aldol adducts (Table 2.1).65, 69 
 
                                                 
xxix Thermal ellipsoids shown at 30% probability. Hydrogen atoms omitted for clarity. X-ray data is available at 
the Cambridge Crystallographic Data Center: CCDC 721137 and ref 75. 
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Table 2.1 Isomerization studies on ()-143 
 
O
O
O
HO
conditions
Table 2.1 O
O
O
HO
143 151
9 9
8 8
O
O
H
O OO
153 156
4
3
5
7
 
Entry Conditions Temp. Time Product Distribution (%)
a 
()-143 ()-151 ()-153 ()-156 
1 silica gelb rt 1 d 85 15   2 rt 5 d 35 65   
3 
HFpyridine/ 
pyridine/H2Oc 
rt 1 d 95 5   
4 rt 7 d 70 30   
5 40 °C 1 d 30 70   
6 40 °C 5 d  95 5  
7 
DBU/C6D6e 
rt 2 d 6 83  11d 
8 rt 5 d 1 81  18d 
9 rt 10 d  30  70d 
10 
Im/CDCl3f 
rt 1 d >95 <5   
11 40 °C 1 d 30 70   
12 40 °C 4 d  100g   
a By 1H NMR spectroscopy. b Absorption of a CH2Cl2 solution of ()-143 onto silica gel 60 
(a 0.25 mm PTLC plate) followed by elution after the indicated time. c Pyridine (1.2 mL), 
HFpyridine (0.4 mL), and H2O (50 L) were added to a solution of ()-143 (10-20 mg) in 
THF (2 mL). d Tentatively identified. e DBU (0.02 M; ca. 1 equiv.). f Imidazole 0.6 M. g 85% 
isolated yield on 20 mg scale. 
 
Absorption of ()-143 onto silica gel produced ()-151 very slowly (entries 1 and 2). 
Reaction of ()-143 with HFpyridine at room temperature also slowly produced ()-151; 
isomerization was accelerated at elevated temperature (40 °C), but small amounts of 
dehydrated product ()-153 were detected at longer reaction times (entry 6). Treatment of 
()-143 with DBU in C6D6 at room temperature gave ()-151 in addition to ()-156 (entries 
7-9). The formation of ()-156 presumably results from elimination of propanoic acid from 
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an initially formed retro-Claisen ester 155.xxx Alternatively, a warm (40 °C) solution of ()-
143 in CDCl3 containing imidazole (0.6 M) cleanly produced ()-151 in 85% isolated yield 
(entry 12). 
 
2.4.1.1 Structure determination of ()-143, ()-153, ()-156, and ()-168 
 The structure of ()-151 is knownxxxi, 61 and the structure of ()-143 was confirmed by 
X-ray crystallography (Figure 2.6). The structure of ()-168 was inferred on the basis of the 
X-ray crystal structure of ()-143 and by analogy to 167 – the structure of which was 
confirmed by an X-ray crystal structure (vide infra). 
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Figure 2.7 Structure determination of ()-168, ()-143, and ()-151 
The significant spectroscopic differences (in C6D6) between ()-151 and ()-143 
include: i) the small 4J coupling (W-coupling) between HC-8 and HC-9 (as revealed by 
COSY) in the latter that is absent in the former; ii) the large upfield shift for C-9 in ()-151 
(δC 36.0) compared to ()-143 (δC 44.7) due to the axial-axial interaction between H3CC-8 
and HC-9 in ()-151 (Figure 2.7). 
                                                 
xxx The retro-Claisen ester was never observed in the crude reaction mixture or by following the reaction by 1H 
NMR spectroscopy. 
xxxi Hoffman reported obtaining an X-ray crystal structure of this compound. 
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2.4.2 Caloundrin B’s trioxaadamantane ring system and isomerization 
Armed with the knowledge obtained from the production of known trioxaadamantane ()-
151, the synthesis of its 4S diastereomer 150 – the trioxaadamantane corresponding to 
caloundrin B (10) – was attempted (Scheme 2.6). Enantiopure 122, readily available from 
the organocatalyzed direct aldol reaction of 117 and ()-116 (Section 2.3),70, 72 protected as 
its triethylsilyl ether 172, was subjected to a boron-mediated aldol reaction with propanal to 
give aldol adduct 173xxxii, 73, 76 in excellent yield. Oxidation of 173 with IBX followed by 
treatment with FeCl3-impregnated silica gel90 provided trioxadithiapentacycle 167, which 
readily crystallized to provide a crystal suitable for X-ray crystallography (Figure 2.8).  
 
 
Figure 2.8 ORTEP plot of 167.xxxiii  
                                                 
xxxii The relative configuration shown was assumed based on precedent established in refs 73 and 76. 
xxxiii Thermal ellipsoids shown at 30% probability. Hydrogen atoms omitted for clarity. X-ray data is available at 
the Cambridge Crystallographic Data Center: CCDC 721136 and ref 75. 
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Scheme 2.6 
Desulfurization of 167 with Raney nickel gave the anticipated trioxaadamantane ring 
system, 142 (Scheme 2.6). The yield of this step was variable (ca. 30 – 60%) and could not 
be optimized, which could reflect a lower stability of 142 relative to ()-143 (vide infra). 
Alternatively, reaction of 167 with (CH3)3SiOTf (or Et3SiOTf) gave silyl acetal 174 in 
excellent yield, which could be readily desulfurized with Raney-nickel to afford 175. 
Attempts to hydrolyze the silyl-protecting group of 175a with TBAF in THF led to rapid 
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decomposition and employing aqueous HF in MeCN led to quantitative formation of 152 
(from 175b). Brief treatment of 175a with HFpyridine, however, cleanly gave 142 in good 
yield (80%). Interestingly, the design of this strategy to access these trioxaadamantane ring 
systems was validated by reversing the steps (i.e., desulfurization of 173, oxidation by IBX in 
DMSO, and then FeCl36H2O in acetone quantitatively gave 152). 
Applying the isomerization conditions developed for ()-143 to 142, clearly showed a 
difference in reactivity and several additional products were isolated (Table 2.2). For 
example, ()-143 was relatively stable to silica gel, but 142 (entry 1) gave a mixture of 
trioxaadamantanes 142 and 150, hemiacetal 146, dihydropyrone 152, and retro-Claisen ester 
154 products. Whereas ()-143 was isomerized to ()-151 by HFpyridine at 40 °C, only the 
dihydropyrone 152 was obtained from the trimethylsilyl ether of 142 (cf. 175a) under these 
conditions (entry 5). At room temperature, hemiacetal 138 accumulated and could be isolated 
in reasonable yield (entry 3). 
Exposure of 138 to HFpyridine produced a 5:1 mixture of 142 and 150 at low 
conversion demonstrating the reversible formation of 142 (entries 6 and 7). In contrast to ()-
143, treatment of 142 with DBU in C6D6 rapidly gave a 1:2 mixture of 150 and 154, 
respectively (entries 8 and 9), presumably via 138 (entry 13). Similar treatment of 150 also 
produced 154 although much more slowly (entries 10-12). In all cases, treatment with DBU 
led to 156 via elimination of propanoic acid from 154 (entries 9-15). Attempts to isolate 156 
met with failure presumably because of its volatility and thus 156 was tentatively identified 
by NMR spectroscopy as a mixture of 156 and the propanoic salt of DBU (see Figure 2.12). 
Imidazole catalyzed the isomerization of 142 at room temperature predominantly gave 150 
along with smaller amounts of 138 and 154 (entries 16 and 17).  
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Table 2.2 Isomerization studies on 142 
conditions
Table 2.2O
O
O
HO
O
O
O
HO
142 150
O
O
H
O
O
O
O
O
OO
138 152 154 156
O
OH
O
O
H
 
Entry SMb Conditions Temp. Time Product Distribution (%)
a 
142 150 138 152 154 156 
1 142 silica gelc rt 1 d 13 31 9 24 33  
2 175d 
HFpyridine/ 
pyridine/H2Oe 
rt 2 h 86  9 5   
3  rt 2 d 22 15 56f 7   
4  rt 5 d 4 57 30 9   
5  40 °C 4 d    >90   
6 146 rt 1 d 7 36 44 13   
7  rt 3 d 10 44 31 15   
8 142 
DBU/C6D6g 
rt 2 h 26 22 12  40  
9  rt 1 d  31   63h 6i 
10 150 rt 1 d  67  4 26 3i 
11  rt 7 d  40  7 37 15i 
12  rt 18 d  30  2 36 32i 
13 138 rt 8 h  33   67  
14 154 rt 1 d     55 45i 
15  rt 7 d      >90i 
16 142 
Im/CDCl3j 
rt 2 d 19 65 10 2 4  
17  rt 5 d  76k 10  14  
18 150 rt 5 d  >90     
19 146 rt 1 d 5 67 16  12  
a By 1H NMR spectroscopy. b Starting material. c Absorption of a CH2Cl2 solution of 142 
onto silica gel 60 (a 0.25 mm PTLC plate) followed by elution after the indicated time. d The 
trimethylsilyl ether 175a was used. e Pyridine (1.2 mL), HFpyridine (0.4 mL), and H2O (50 
L) were added to a solution of 142 (10-20 mg) in THF (2 mL). f 49% isolated yield on 40 
mg scale. g DBU (0.02 M; ca. 1 equiv.). h 47% yield on 45 mg scale. i Tentatively identified 
by NMR spectroscopy, but not isolated (vide infra). j Imidazole 0.6 M. k 77% isolated yield 
on 16 mg scale. 
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Similar results were obtained from 138, confirming the reversible formation of 142 
(entry 19). Thus, any of 138, 150, 152, 154, or 156 can be obtained as major products from 
142 depending upon the conditions selected. 
2.4.2.1 Structure determination of 138, 142, 150, 152, 154, 156, and 167 
 The structure of 167 was verified by X-ray crystallography (Figure 2.8).  
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Figure 2.9 Structure determination of 142, 150, and 167 
The structures of 142 and 150 were assumed based on analogy to ()-143 and ()-151 
(Figure 2.9). In analogy to ()-143 and ()-151, there is a small 4J coupling (W-coupling) 
between HC-8 and HC-9 (as revealed by COSY) in 142 that is absent in 150. Similarly, there 
is a large upfield shift for C-9 in 150 (δC 36.6) compared to 142 (δC 45.4). The significant 
NMR spectroscopic differences (in C6D6) between ()-151/143 and 150/142 include: i) the 
chemical shifts for C-8 in 150/142 (δC 36.5/36.9) are well upfield from those in ()-151/143 
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(δC 43.3/43.3); ii) the 3J coupling constants between HC-7 and HC-10 are much larger in 
150/142 (3.5/2.5 Hz) than in ()-151/143 (<2Hz); iii) the 1H chemical shifts (in C6D6) for 
H3CC-10 in 150/142 (δH 0.65/0.63) are well upfield from those in ()-151/143 (δH 
1.10/1.11). These differences in the NMR spectrum are consistent with the data reported for 
muamvatin (3)6 and caloundrin B (10).9 The absolute configuration of 142 is based on that of 
167. The absolute configuration of 150 is based on that of 142. 
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Figure 2.10 Structure determination of 138 
The relative configuration of 138 was determined by 1H NMR spectroscopy (Figure 
2.10). The trans diaxial relationship between the HC-5 and HC-6 was confirmed by the 10.7 
Hz coupling constant between them. The axial OH group was suggested by a positive NOE 
on HC-6 on irradiation of the OH and vice versa. This assignment was also supported by a 
small 4J coupling constant (1.6 Hz) between the OH and HC-3 (this W-coupling is consistent 
with a trans diaxial OH and HC-3). The axial position of HC-3 was suggested by the small 4J 
coupling constant (1.1 Hz) between the HC-3 and HC-5; this observation is consistent with 
that reported in related compounds.17 The relative configuration at C-1” is assumed based on 
no change from 150. It is notable that 138 was the only hemiacetal isolated and is calculated 
to be the most stable of the possible hemiacetals (i.e., 138-141 and 146-149) (see Scheme 
2.2) (vide infra). The absolute configuration is assumed based on that of 150. 
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Figure 2.11 Structure determination of 152 
The trans relative configuration for the substituents at C-2 and C-3 in 152 was 
assigned based on the large coupling constant observed between the protons at these 
positions consistent with the large J values reported for several related compounds (Figure 
2.11).91 The C-1’ diastereomer 153 is known61 and its reported NMR data are significantly 
different from 152; thus the relative configuration at C-1’ in 152 is assigned as indicated. The 
absolute configuration for 152 is assumed based on 150. 
The assigned relative configuration of 154 is confirmed by its C1 symmetry (14 
signals in the 13C NMR spectrum; the 4R,6S diastereomers (e.g., 155) are meso). The 
absolute configuration is assumed based on 150. 
Compound 156 was observed in various isomerization experiments (Table 2.1 and 
2.2) in the presence of DBU in C6D6. In a larger scale reaction, DBU (10 L, 10 mg, 0.07 
mmol) was added to a solution of 154 (8 mg, 0.03 mmol) in C6D6 (0.4 mL) at room 
temperature (Figure 2.12). The reaction was monitored by 1H NMR spectroscopy and after 
14 days, <5% of 154 remained. Attempted isolation of 156 from the reaction mixture by 
standard aqueous workup failed. However, the structure for 156 was assigned based on its 
NMR data that were easily extracted by comparison of the 13C spectra of the reaction mixture 
with that obtained from a mixture of DBU and propanoic acid (i.e., the other components in 
the reaction mixture). The presence of two ketone carbonyls (C 209.1, 200.9), two isolated 
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CH3CH2- groups, and a -(CH3)C=CHCH(CH3)- spin system were readily identified and 
confirmed by COSY, DEPT and HSQC. The (E) configuration is tentatively assigned based 
on the absence of NOE between the vinyl CH3 and vinyl H and the presence of a weak NOE 
between the vinyl CH3 and the allylic CH. The specific rotation of 156 (from 154) was not 
determined. 
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Figure 2.12 Structure determination of 156 
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2.4.3 Trioxaadamantane ring system comparison and conclusions 
Compounds 150 and ()-151 differ by a single stereocenter (C-4), yet their 
isomerization behavior is remarkably different. In an attempt to identify the reasons for these 
differences, Prof. Jonathan M. Goodmanxxxiv was contacted about the possibility of studying 
these systems computationally.xxxv Figure 2.13 illustrates the results of the computational 
experiments graphically.  
The computational studies found that the preferred conformation of 140 was the chair 
with equatorial methyl groups, and those of 141 and 149 were twist boats stabilized by H-
bonding (Figure 2.14). The more facile isomerizations of 142 compared to ()-143 (cf. 
Tables 2.1 and 2.2) and to 150 (Table 2.2, entries 9 and 10) are consistent with the 
differences in energies between these trioxaadamantanes and their hemiacetal precursors 
(140-142, 16.8 kJ/mol; 141-143, 23.8 kJ/mol; 150-148, 32 kJ/mol).xxxvi The lack of 
intermediates observed in the isomerization of ()-143 to ()-151 (Table 2.1) can be 
rationalized by considering the much smaller differences in energies between 139 and 149 
(7.3 kJ/mol) vs. 141 (13.3 kJ/mol) (i.e., transformation of 139 to 151 should be faster than 
that of 143 to 139) and the low equilibrium concentration expected for 139.xxxvii Although a 
similar analysis of 138, 140, and 148 supports a greater persistence and equilibrium 
concentration of 138 (i.e., facilitating more elimination and retro-Claisen rearrangement) 
compared to 139, it does not account for the significant accumulation of 138 on treatment of 
142 with HFpyridine.  
                                                 
xxxiv University Chemical Laboratory, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, U.K.; a 
computational chemist with significant experience computationally studying polypropionate natural products. 
xxxv All computations were made by Prof. Goodman. 
xxxvi The computed energies are for ground states. 
xxxvii Relative reaction facilities are based on Hammond’s postulate (more stable intermediates are formed 
faster). 
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Figure 2.13 B3LYP/6-31G** energies (kJ/mol) relative to 151 
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Figure 2.14 Illustrations of the preferred conformations of 140, 141, and 149, as determined 
by computational studies.   
In conclusion, the isomerization of 142 under different conditions leads selectively to 
138, 150, or 154. These compounds represent structural motifs present in siphonarin B (4), 
caloundrin B (10), and baconipyrone C (8), respectively. In principle, each compound in this 
series of natural products could be accessed via a structure analogous to 142. 
 
 
141 
140 
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2.5 -Pyrone formation model study 
 The synthesis of -pyrones can be accomplished through a variety of means and 
methods, but none of these methods are general.92 A common approach used in the synthesis 
of marine polypropionate natural products is through the dehydrative cyclization of 1,3,5-
triketones (e.g. 179, Scheme 2.7).24, 30, 39, 93 
b
a) H+ or (COCl)2, DMSO or PPh3, CCl4  b) DBU or 
O O
a
176 71
O
O
O
178
O OTIPSO
PMB
O OTBS
TBSO
R
R = H or R=
R
R
 
Scheme 2.7 
Early methods to dehydratively cyclize 1,3,5-triketones typically relied upon strong 
acid,92 which are not well suited to the synthesis of complex, potentially acid and base 
sensitive, polypropionate natural products, such as caloundrin B (10). This issue was 
recognized by several research groups and several alternative approaches have been 
disclosed, i.e.: PPh3/CCl4,23, 24 amberlyst-15 with celite-supported P2O5,39 DMSO/(COCl)2,23, 
24 bulky Brønsted acids,94, 95 base30 and thermal93 cyclization of silyl-protected triketones. 
The most popular of these methods is Yamamura’s methodology,23, 24 which has been used in 
the synthesis of several natural products.15, 24, 28, 29 However, even this method has not been 
proven general.39  
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Even rarer are examples of -pyrones accessed directly from protected 1,3,5-
triketones.30, 93, 96 An example is provided by Hoveyda30 (178  71) in his synthesis of 
baconipyrone C (8). Hoveyda’s sequence for installation of the -pyrone was later adapted by 
Jung in his synthesis of auripyrone A.93 
The -pyrone required for the synthesis at hand was envisioned coming from a 1,3,5-
triketone via Yamamura’s or a related methodology (Scheme 2.8).23, 24 We opted to form 
1,3,5-triketone 182, in protected form (cf. 181), through an aldol reaction with dithioacetal 
aldehyde 179 followed by oxidation to the protected diketone. Hydrolysis of the dithioacetal 
protecting group of 181 would provide 1,3,5-triketone 182. Known97 -pyrone 177 would 
then be accessed through established methodology.  
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Scheme 2.8 
 Dithioacetal aldehyde 179 was accessed in three steps from readily-available98 β-
keto-ester 184 (Scheme 2.8). β-Keto-ester 184 was protected as its corresponding 
dithioacetal 185 by treatment with ethanedithiol and BF3OEt2 as catalyst. Reduction of 185 
with LiAlH4 gave 186, which was oxidized in excellent yield by oxidation with IBX in 
DMSO to afford aldehyde 179. The synthesis of aldehyde 179 from 183 was accomplished 
on multi-gram scale in high yield without chromatography. 
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 Aldehyde 179 was then subjected to an LDA-mediated aldol reaction with 3-
pentanone (43) to form a complicated mixture of aldol adducts (Scheme 2.8).xxxviii An 
attempted oxidation with IBX in hot (80 °C) acetonitrile78 of this mixture of aldol adducts 
failed to provide the anticipated diketone 181. Instead, known97 -pyrone 177 was directly 
obtained in ca. 30% yield.  
 If the yield of this process could be improved, then a rapid synthetic sequence to -
pyrones could be realized. Further, this initial result indicated that it might be possible to 
annulate a pyrone onto a ketone through an aldol reaction followed by oxidation: 
conceivably, only two steps would be required for this process, a possible advantage over 
other methodologies. Further, variation of the dithioacetal aldehyde or the ketone employed 
in the reaction could provide the means to easily substitute the -pyrone ring at any position: 
there are no known general methodologies or strategies capable of this.92 
 Investigation of yield improvements through aldol 180 did not reveal any promising 
possibilities through the usual reaction optimization parameters (time, temperature, solvent, 
reagent amounts, concentration, etc.) (entry 1, Table 2.3). Considering, however, what must 
occur during the process, namely, oxidation of the aldol 180 to the corresponding diketone 
181, provided an alternative front for investigation.  
Oxidation of aldol 180 under alternative oxidation conditions (i.e., IBX in 
DMSO)xxxix,99, 100 provided diketone 181 in excellent yield. Subjecting diketone 181 to IBX 
in hot (80 °C) acetonitrile gave -pyrone 177 in much improved yield (entry 2). The reaction 
proved responsive to the amount of IBX employed in the reaction (entries 2-4). Alternative 
                                                 
xxxviii An aldol reaction between 3-pentanone (43) and aldehyde 180 can form up to 8 stereoisomers. In the 
present reaction, 4 products were obtained, but these could not be separated and were not characterized. 
xxxix IBX is soluble in DMSO. IBX-mediated oxidation in DMSO is a fairly recent discovery by Santagostino. 
 
 
70
solvents (entries 5 and 6) were unproductive or led to decomposition products that were 
unidentifiable. Interestingly, heating diketone 181 with IBX in DMSO led to decomposition 
(entry 6), but under similar conditions, without the application of heat, diketone 181 is stable 
and can be isolated in excellent yield from the oxidation of 180.xl The addition of H2O 
(entries 7 and 8), to aid hydrolysis of the ethanedithiol protecting group,101-104 significantly 
attenuated the rate of the reaction or was unproductive.  
Table 2.3 -Pyrone 177 optimization studies 
 
181
OO SS
177
O
O
 
 
Entry SMa Solvent Equiv. IBX Additive Temp. Time Yield (%)
b
1 180 MeCN Variousc - 80 °C various <30 
2 181 MeCN 1 - 80 °C 24 h 63 
3  MeCN 1.5 - 80 °C 24 h 77 
4  MeCN 2 - 80 °C 24 h 77 
5  EtOAc 2 - 80 °C 24 h NRd 
6  DMSO 2 - 80 °C 24 h decomp.e 
7  MeCN 2 H2Of 80 °C 24 h <40 
8  DMSO 2 H2Of 80 °C 4 h NRd
9 185 MeCN 2 - 80 °C 24 h <15g
10 181 MeCN 2 p-TsOH 80 °C 24 h 100h
11  MeCN 0 p-TsOH 80 °C 24 h NRd 
12  MeCN 2 CF3SO3H rt 18 h 92
a Starting material. b Yield of 177, unless stated otherwise. c Various conditions attempted 
including: solvent, reaction time, equiv. IBX, concentration. d No reaction. e No identifiable 
products obtained. f 5% (v/v). g Deprotection to 184; as judged by 1H NMR spectroscopy of 
the crude reaction mixture. h Yield by 1H NMR spectroscopy using an internal standard 
(ClCH=CCl2). 
 
                                                 
xl This reaction takes 24 h to go to completion. 
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The fate of the ethanedithiol protecting group in this reaction was unknown because 
no products attributable to ethanedithiol could be detected in the crude reaction mixture or by 
monitoring the reaction by 1H NMR spectroscopy.xli It is known that the sulphur atoms of an 
S,S-acetal protecting group can be oxidized by IBX;104 it is conceivable that a sulfinic or a 
sulfonic acid could be formed in situ and thus promote the reaction through acid catalysis. 
Interestingly, exposure of ester 185 to IBX resulted in very slow deprotection to 184 (entry 9) 
suggesting the involvement of the diketone functionality (perhaps through its enol tautomer) 
in facilitating the observed reaction. Therefore, the effect of added acid on the reaction was 
investigated. Dramatic improvement of yield was observed with the addition of p-TsOH 
(entry 10).xlii Attempts to promote the formation of -pyrone 177 with p-TsOH, in the 
absence of IBX, returned starting material (entry 11). The use of triflic acid (entry 12) with 
IBX, however, allowed the reaction to be performed at room temperature with excellent 
conversion to desired -pyrone 177.xliii  
2.5.1 -Pyrone model study conclusions  
A simple, three-step procedure to annulate a -pyrone onto a ketone was optimized to 
a high-yielding process. The scope and limitations of this method have not yet been fully 
explored. However, sufficient information was obtained through this model study to attempt 
installation of the required -pyrone of caloundrin B (10) through novel conditions. 
The use of triflic acid as a catalyst in the reaction is concerning due to its high acidity 
(pKa = 2.6 in MeCN; for comparison CH3COOH in H2O = 4.76 and in MeCN = 23.5).105  
The use of this method could, therefore, present a problem in a more complicated, and 
                                                 
xli The reaction was conducted in an NMR tube using MeCN-d3, which allowed real-time monitoring. 
xlii Trichloroethylene as an internal standard for 1H NMR spectroscopic determination of yield was validated 
through isolation of the product following determination of yield by internal standard. 
xliii Athanasios Karagiannis, unpublished results. 
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potentially sensitive, substrate. However, the original plan to access the -pyrone could still 
be explored (i.e., hydrolysis of 181 to triketone 182, followed by -pyrone formation through 
a known method24 to give 177) should this novel method fail. 
2.6 Retrosynthetic analysis 
 Based on the model studies performed (Sections 2.4 and 2.5) and the known 
instability of the trioxaadamantane ring system, it was clear that the sensitive 
trioxaadamantane would have to be installed late in the synthesis of caloundrin B (10) 
(Figure 2.15). Thus, working backwards, the synthesis would be geared towards production 
of trioxadithiapentacycle 187.   
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Figure 2.15 Retrosynthetic analysis of caloundrin B (10) 
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Disconnection of the C-3”,7’ bond in 187, leads to 188 - a protected version of 122, 
which is available from the Thiopyran Route to Polypropionates in enantiopure form 
(Scheme 2.1) - and aldehyde 189. A significant advantage of this disconnection is that the 
reaction to couple these two fragments together does not require any stereoselectivity.xliv 
 The -pyrone aldehyde 189 was seen as being accessed via the chemistry developed 
in the model study described in Section 2.5, leading to dithioacetal aldehyde 179 and ketone 
190 available70 in enantioenriched form from the Thiopyran Route to Polypropionates.  
 The protecting group strategy is critical to the success of this synthesis. Not only must 
the P1 protecting group (cf. 189) be orthogonal to protecting groups P2 (cf. 188) and P3 (cf. 
189), P1 must also survive the conditions required to form the trioxadithiapentacycle (cf. 187) 
and be removable under mild conditions that will not interfere with the sensitive 
trioxaadamantane ring system. P2 (cf. 188) must be removable under the aforementioned 
conditions in order to form the trioxadithiapentacycle.xlv The final protecting group, P3 (cf. 
189), must be robust enough to survive through the synthesis of aldehyde 189 and the steps 
that lead up to the formation of 187. An ideal situation would be P3’s concomitant removal 
during the reaction to form trioxadithiapentacycle 187 (see Section 2.4).  
2.7 Synthesis of key aldehyde 
2.7.1 -Pyrone formation 
 As discussed previously (Section 2.6), the synthesis of -pyrone containing aldehyde 
189 requires the enantioselective synthesis of known70 ketone 190 (Scheme 2.10). Few 
changes were made to the reactions to obtain ketone 190 with the exception of the 
preparation of dial 196 (Scheme 2.9). Oxidation of diols 194 and 195 under the previously 
                                                 
xliv The aldol reaction between 188 and 189 would form an alcohol at C-7’ (cf. 187) which, upon oxidation, both 
the C-7’ and C-3” stereocenters will be destroyed (C-7’) and/or exist as an epimeric/enol mixture (C-3”). 
xlv C-1” of 187 initiates trioxaadamantane formation by forming a hemiacetal with the C-7’ carbonyl. 
 
 
74
established Swern conditions70 presented a significant problem in regards to scale-up due to 
low solubility of trans-diol 194. Due to these issues, reaction scale is limited using available 
laboratory equipment. Investigation into an alternative oxidation protocol for 194 to 196 was 
warranted to support this synthesis. 
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Scheme 2.9 
 Oxidation of a ca. 1.5:1 mixture of diols 194 and 195 with IBX in hot (80 °C) 
acetonitrile78 produced desired dialdehyde 196 as an inseparable mixture of meso/dl forms 
and lactone 197 (Scheme 2.9). Lactone 197 could be separated from dialdehyde 196, but its 
production reduces the yield of dialdehyde 196. Upon considering this dilemma, it was 
realized that lactone 197 would only be produced from oxidation of cis-diol 195.xlvi In this 
particular sequence, only diesters 192 and 193 are separable; therefore, 192 and 193 were 
                                                 
xlvi The production of lactone 197 requires production of a hemiacetal precursor, which can undergo further 
oxidation to form the lactone. 
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separated and carried through separately. Oxidation of 194 and 195 under different 
conditions maximized the overall yield of dialdehyde 196. 
 The enantioselective aldol reaction between dialdehyde 196 (mixture of meso and d/l 
forms) and 117 to enantioselectively produce hemiacetal 190 had undergone rigorous 
screening of reaction parameters when the reaction was first developed (Scheme 2.10). In 
analogy to the improvements made to the enantioselective direct aldol between 117 and ()-
116 (Scheme 2.1), tetrazole catalyst 127 was attempted. Unfortunately, none of the attempts 
or conditions investigated appeared promising; therefore, the reaction was scaled (ca. 8 
grams of dialdehyde 196) to a level appropriate to support this synthesis. 
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Scheme 2.10 
 At this stage, hemiacetal 190 had to be set up to receive dithioacetal aldehyde 179. 
Protection of hemiacetal 190 by reaction with pivoyl chloride produced 198 as a 1:1 mixture 
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of anomers that could not be separated and was carried forward as a mixture. The sulfur 
atoms in 198 were no longer required and were removed by reaction with Raney nickel in 
refluxing THF.xlvii These conditions resulted in the production (ca. 10%) of reduction 
products (via hydrogenation of the ketone), which were dealt with by treatment of the crude 
reaction mixture with IBX in DMSO. The resulting anomers of 199 (1:1) could be separated, 
but were typically carried forward as a mixture in subsequent reactions. 
 The structure of each anomer of 199 was inferred based upon the assumption that no 
isomerization occurred during pivoylation or the reaction with Raney nickel (the structure of 
190 is secure).70 The two different anomers were distinguished on the basis of NOE. The 
conformation of -199 shown in Figure 2.16 was established based on the small (<1 Hz) 
4JHH (W-coupling) between HC-6 and HC-10 (as revealed by COSY): this coupling was 
absent in -199. The axial position of the pivaloate in -199 was established based on a 
positive NOE on HC-6 and HC-9 on irradiation of the tBu group of the pivaloate and vice 
versa. Further, C-6-methyl exhibited a positive NOE upon irradiation of HC-7 and vice versa, 
which is consistent with the conformation shown in Figure 2.16. The absolute configuration 
of 199 is based on 190. By default, the configuration of the pivaloate in -199 was 
established.  
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Figure 2.16 Structure elucidation of -199 
                                                 
xlvii Desulfurization in alcoholic solvent led to significant reduction products and side products which were not 
isolated or characterized. 
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 An unselective LDA-mediated aldol reaction between 199 and dithioacetal aldehyde 
179 produced a complicated mixture of aldol adducts 200 that were not separable, but, as 
previously discussed (Section 2.6), selectivity was unimportant relative to a high yielding 
process (Scheme 2.11).  
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Scheme 2.11 
 As a first step toward formation of the -pyrone (see Section 2.5), β-diketone 201 was 
subjected to IBX in hot (80 °C) MeCN to test if this adduct would form the desired -pyrone 
as a mixture of anomers 203 (Scheme 2.11). Instead of generating the expected products 203, 
pyrone-dihydropyrone 202 was produced in low yield (ca. 30%). In addition to the formation 
of the expected -pyrone moiety, the C-4” carbonyl was revealed and the pivaloate was 
eliminated across C-5”,6”. A mechanism is proposed in Figure 2.17, based on the known104 
sulfur oxidation of S,S-acetals by IBX. 
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Figure 2.17 Proposed mechanism for the formation of pyrone-dihydropyrone 202 
 Generation of pyrone-dihydropyrone 202 provided a mixed blessing in that a step 
could be saved due to the hydrolysis of the ethylene ketal that occurred during the reaction. 
Additionally, the C-4” carbonyl was isolated and conditions could be investigated to reduce it 
with the correct configuration followed by protection. However, the stereocenter at C-5” had 
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been lost; the C-5”,6” double bond would have to be regio- and stereoselectively hydrated to 
reestablish the aldehyde functionality at C-6” and concomitantly reset the C-5” stereocenter.  
 The source of the additional transformations (acetal deprotection and pivaloate 
elimination) was of interest and was thus investigated. Exposure of 199 (1:1 mixture of 
anomers), as a model substrate, to IBX in hot (80 °C) MeCN for 24 hours returned starting 
material (entry 1, Table 2.4). Exposure of the recovered starting material to IBAxlviii in hot 
(80 °C) MeCN for 24 hrs also returned starting material (entry 2). Exposure of 199 to 2-
iodobenzoic acid (IB) also returned starting material (entry 3). Thus IBX and its reduction 
products were not responsible for the additional reaction chemistry observed in the formation 
of pyrone-dihydropyrone 202 (Scheme 2.11). Exposure once again to IBX in hot (80 °C) 
MeCN along with the addition of a controlled amount of ethanedithiol (entry 4), produced 
dihydropyrone 208 as the sole product in the reaction crude (56% yield, unoptimized). 
Further, dihydropyrone 208 could be produced by brief exposure of 199 (1:1 mixture of 
anomers) to 1M HCl in THF. This confirmed the prior hypothesis (Section 2.5) that an acid 
(perhaps a sulfinic or a sulfonic acid) was produced during the course of the reaction to form 
the -pyrone. The acid produced in the reaction catalyzed acetal deprotection and elimination 
of the pivaloate. Unfortunately, despite several attempts, the acidic compound(s) responsible 
could not be observedxlix or isolated from the reaction mixture. 
 
 
 
 
                                                 
xlviii Obtained from the IBX oxidation of isopropanol (of solvent) in hot (80°C) MeCN for several days. 
xlix Monitoring the reaction by 1H NMR spectroscopy over time in MeCN-d3 and analysis of the crude reaction 
mixture. 
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Table 2.4 Dehydration and deprotection of 199 
O O
199
O
O
OPiv
O O
208
O
 
Entry Starting Material Reagent 1 Reagent 2 Product 
1 
199 
IBX - 199 
2 IBA - 199 
3 IB - 199 
4 IBX (CH2SH)2 208 
5 1M HCl - 208 
 
 At this stage, it was worthwhile to attempt optimization of the initial poor yield of 
pyrone-dihydropyrone 202 because this adduct afforded several positive attributes, as 
discussed previously. Despite repeated attempts (entries 1-3, Table 2.5), the yield could not 
be improved to the levels seen previously with IBX alone in the model substrate (cf. Section 
2.5, Table 2.3). Addition of p-TSOH at elevated temperature improved yield somewhat 
(entry 4), but isomerizationl was also detected. At lower temperature, isomerization was 
attenuated and the desired compound was isolated in slightly improved yield (entries 5 and 
6). Addition of CF3SO3H under previously optimized conditions improved yield significantly 
(entry 7) in a small-scale reaction. Upon scale up (same stoichiometry, concentration, etc.), 
the reaction still performed well (entry 8), but not to the same level as the small-scale 
reaction. The reasons for this disparity are unclear.   
 
                                                 
l Isomerization presumably occurred at C-3’ (of 202) to lead to the more stable pseudo-equatorial diastereomer; 
however, this was not rigorously established since the minor diastereomer could not be separated from the 
desired product (202). 
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Table 2.5 Pyrone-dihydropyrone 202 optimization studies 
 
O O
201
O
O
OPiv
SSO O
202
O
O
O
 
 
Entry Starting Material 
Equiv. 
IBX Additive Temp. Time Yield (%) 
1 
201 
2 - 80 °C 24 h 41 
2 2 - 80 °C 48 h 41 
3 2a - 80 °C 36 h 48 
4 2 p-TsOH 80 °C 24 h 60b
5 2 p-TsOH rt 48 h 57
6 2 p-TsOH rt 72 h 63
7c 2 CF3SO3H rt 16 h 81
8d 2 CF3SO3H rt 17 h 71
a IBX added portion-wise. b Accompanied with ca. 20% isomerization. c117 mg scale. d 2.41 
g scale. 
 
 This improvement of the yield of pyrone-dihydropyrone 202 could make this 
approach viable synthetically, provided the C-5”,6” double bond could be hydrated with 
reasonable selectivity when resetting the C-5” stereocenter.  
2.7.2 Hydration of pyrone-dihydropyrone 202 
 Prior to attempting any experiments to hydrate pyrone-dihydropyrone 202, reduction 
of the C-4” carbonyl was attempted (Scheme 2.12). Inspired by Danishefsky,106-109 reduction 
under Luche conditions110-112 provided an extremely selective reaction (>20:1). At this stage, 
the selectivity shown in alcohol 209 was assumed based upon the well-documented113 
delivery of the hydride to a pseudo-axial position in the product. Protection of C-4”-OH of 
209 as its corresponding acetate 211 and benzyl ether 210 provided substrates for attempted 
hydration of the C-5”,6” double bond. 
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Scheme 2.12 
 It is well known that such systems (cf. 209 - 211) are prone to Ferrier 
rearrangement.114 Danishefsky exploited this facility towards Ferrier rearrangement as a 
multi-step solution to hydrate similar dihydropyrans obtained by his LACDAC (Lewis-acid 
catalyzed diene-aldehyde cyclocondensation) chemistry.106-109, 115-119 This series of 
transformations, however well precedented, would significantly increase the number of steps 
in the synthesis at hand. A direct method to hydrate the C-5”,6” double bond and 
concomitantly reset the C-5” stereocenter would be highly advantageous, but such a method 
appears to be unprecedented in C-5” substituted dihydropyrans.   
 There are a number of methodologies that have been developed over the years 
to hydrate C-5” unsubstituted dihydropyrans based on Lewis acids,120-122 transition metal 
complexes,123 electrophilic iodine,124 acidic resin,125 Brønsted acids,126-128 triphenylphosphine 
hydrobromide,126, 129, 130 and hydroxymercuration/demercuration.131-133 Of these methods, 
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triphenylphosphine hydrobromide (PPh3HBr) had been used beyond model studies134, 135 
and hydroxymercuration/demercuration is a well-established approach to olefin and enol 
ether hydration.136 Both methods looked promising from this perspective and were thus 
attempted concurrently. 
E+
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O
O
AcO  O
H
R
OAc
H
E+
R =
'favoured' approach
'disfavoured' approach  
Figure 2.18 Electrophile addition to dihydropyran 211 
It was expected that reagent addition would occur from the top face because the 
bottom face is more sterically hindered (due to the C-3” pseudo-axial methyl), based on 
conformational analysis of the dihydropyran (Figure 2.18). Regioselectivity would be 
‘controlled’ through the oxygen atom of the dihydropyran ring and its ability to stabilize the 
resulting carbocation.  
Treatment of 211 (Scheme 2.13) with PPh3HBr and methanol in CH2Cl2 gave 
Ferrier product 212 and a small amount of starting material (ca. 10%) detected in the crude 
reaction mixture. The configuration of the methoxy group was suggested by a positive NOE 
on HC-2” upon irradiation of the methoxy group and vice versa.  
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Scheme 2.13   
In parallel, hydroxymercuration/demercuration of benzyl-dihydropyran 210 was 
attempted (Scheme 2.14). The initial reaction resulted in the production of two fully-reduced 
compounds in low yield with structures proposed to be 213 and 214. 
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Scheme 2.14 
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 At this stage, it was unknown which of the two compounds produced, 213 or 214, 
corresponded to the required configuration at C-6’. Further, none of the structures in this 
synthetic sequence (198  213 and 214) had been rigorously established. Fortunately, an 
analogue of these two compounds (cf. ent-39, Scheme 1.9) had been used in the three 
previous syntheses of baconipyrone C (8): the difference between the two unknown 
compounds and the known baconipyrone C intermediate, PMB-diol ent-39, was the aromatic 
group of the C-5’ ether (4-methoxyphenyl vs. phenyl). 
 Comparison of the 1H NMR spectra of Bn-diols 213 and 214 with the data reported 
by Hovedya30 for 39 showed a close match (Table 2.6) to Bn-diol 213. The major difference 
in the spectra for 39 and Bn-diol 213 was the methyl singlet at 3.78 ppm for 39 and the 
signals in the aromatic region of the spectrum – essentially differences attributable to 
differences in the aromatic moiety of the respective protecting groups. Bn-diol 214 showed a 
significant number of differences in its 1H NMR spectra compared with that of 39, not 
inclusive of differences attributable to the protecting group. Thus, tentative assignments were 
made based on 1H NMR spectroscopy. This tentative assignment was confirmed by 
comparison of the 13C NMR spectra (Table 2.7). 
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Table 2.6 1H NMR (CDCl3) comparison of 213, 214 and 39 
39a, b 213 214 
Hc multiplicity (J’s in Hz) Hd 
multiplicity 
(J’s in Hz) Hd 
multiplicity 
(J’s in Hz) 
7.23 d (8.8) 
7.33-7.26 m 7.35-7.26 m 
6.83 d (8.8) 
4.61 q (10.6) 4.72-4.66 m 4.67 d (11) 
4.21 d (9.7) 4.22 br d (10) 4.63 d (11) 
3.81-3.68 m 3.84-3.77 m 4.22 br d (10) 
3.78 s 3.75-3.68 m 3.70-3.61 m 
3.55 dd (3.7, 8.1) 3.59 dd (4, 7.5) 3.11 dq (10, 7) 
3.14-3.06 m 3.14-3.05 m 
2.65-2.48 m 
2.60 dddd (15.0, 7.7, 7.7, 7.7) 2.64-2.51 m 
2.58 dddd (15.0, 7.7, 7.7, 7.7) 
2.19 br m 2.22 br s 
2.09-1.95 m 2.09-1.99 m 2.11-1.98 m 
1.99 s 1.98 s 1.98 s 
1.91 s 1.90 s 1.91 s 
1.19 t (7.7) 1.17 t (7.5) 1.14 t (7.5) 
1.14 d (7.1) 1.14 d (7) 1.11 d (7) 
1.09 d (7.1)e 1.10 d (7) 1.03 d (7) 
1.04 d (7.1) 1.07 d (7) 1.02 d (7) 
a Ref 30. b Ref 28., 300 MHz in ref 29. c 400 MHz, 7.26 ppm as reference. d 500 MHz, 7.26 
ppm as reference. e Reported as a triplet (t), but is clearly a doublet (d) in the provided 
supporting information. 
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Table 2.7 13C NMR (CDCl3) comparison of 213, 214 and 39 
39a, b 213 214 
Cc, d Ce, f Cg Ce, f C g 
179.9 180.0 0.1 180.0 0.1 
164.7 164.8 0.1 164.9 0.2 
164.1 164.1 0 164.3 0.2 
159.7h 128.8 h - 128.7h - 
129.8 h 128.3 h - 128.0 h - 
129.7 h 128.0 h - 127.9 h - 
119.5 119.6 0.1 119.7 0.2 
118.0i 118.0 0 118.1 0.1 
114.1 h - - - - 
88.3 88.2 0.1 83.8 0.5 
76.3 76.6 0.3 75.6 0.7 
72.0 72.1 0.1 72.4 0.4 
65.5 65.3 0.2 66.2 0.7 
55.4h - - - - 
38.9 39.1 0.2 39.5 0.6 
38.0 38.0 0 38.5 0.5 
35.4 35.6 0.2 36.6 1.2 
24.9 25.0 0.1 25.0 0.1 
15.2 15.2 0 14.8 0.4 
14.6 14.7 0.1 12.0 2.6 
11.4 11.4 0 11.4 0 
11.1 11.0 0.1 10.2 0.9 
9.8 9.9 0.1 9.9 0.01 
9.7 9.7 0 9.7 0 
a Ref 30. b Ref 28, 75 MHz in ref 29. c 100 MHz, C in ppm. d 77.16 ppm selected as 
reference. e125 MHz, C in ppm.  f 77.23 ppm selected as reference. g Difference between 
39 and the applicable adduct. h 13C resonances belonging to the protecting group  not 
applicable. i Reported as a 118.9 ppm, but the attached peak-picked spectra provided in the 
supporting information clearly shows this signal is at 118.0 ppm. 
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 As shown in Table 2.7, comparable 13C signals for 213 are only 0.1-0.3 ppm different 
from known compound 39. The 13C signals for C-6' epimer 214 are as high as 2.6 ppm 
different from known compound 39. Based on this analysis, the tentative assignment based 
on the 1H NMR spectroscopy is far more secure, but not absolute. Additional work to secure 
the structures of these compounds is required (vide infra).     
 With the desired transformation of 210 to 213 (and minor compound 214) now 
known to occur using hydroxymercuration/demercuration, the initial low yield and selectivity 
observed would have to be investigated to establish this approach as a synthetic possibility. 
Table 2.8 Hydration of 210 
O
210
O
O OH
213
O
O
BnO
Bn
O
HO
OH
214
O
O
Bn
O
HO+
 
Entry SMa THF: H2O 
Equiv. 
Hg(OAc)2 
Additive Reaction Time 
Conversion 
(%) 
Selectivity 
(213:214) 
1 
210 
10:1 2 - 40 h 48b 1.7:1 
2 8:1 1.5 - 48 hc 80 2:1 
3 2:1 2 - 1 h 60 1:1 
4 1:1 2 - 1 h 95 1:1 
5 1:1 1 Na2CO3 1.5 h >95 3:1 
6 1:1 1 Na2CO3 10 min 9 3:1 
7 1:1 1 Na2CO3 30 min 95 2.9:1 
8 1:1 1 Na2CO3 1 h >95 3:1 
9 2:1 1.1 Na2CO3 2 h >95d 3.5:1 
a Starting Material. b Isolated yield of 213 (33%), 214 (15%), and 210 (52%). c 16 h at 2-8 °C 
then 24 h at rt. d Isolated yield of 213 (62%) and 214 (16%).  
 
Initially, the hydroxymercuration/demurcuration reaction produced low levels of 
conversion and marginal selectivity in favour of the desired Bn-diol 213 (Table 2.8). It was 
found that reactivity could be improved through adjustment of solvent composition (entries 
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1-4), seemingly at the expense of selectivity. This could be the result of reaction reversibility 
and other equilibrium processes, which according to Brown, are well known in 
hydromercuration/demercuration reactions.137 These competitive reactions can be suppressed 
through the addition of base to the reaction, just prior to the radical138 demercuration step, but 
the time between addition of base and NaBH4 must be carefully controlled to obtain 
reproducible results.137 Attempting this modification (entry 5) by addition of aq. Na2CO3 
improved conversion substantially with reasonable selectivity in favour of the desired 
compound. Based on this result, the amount of time required before base was added to the 
reaction was investigated to determine if conversion and selectivity changed as a function of 
time. As shown in entries 6-8, the reaction progresses over the course of an hour with no 
change in selectivity; selectivity may be a result of the radical mechanism138 operating in the 
demercuration step when using NaBH4. Other research groups have found that sodium 
amalgam (Na/Hg) reduces organomercurials with complete retention of configuration.139 
This modification was attempted without success. 
 Attempting the established conditions in subsequent reactions, showed no change in 
selectivity, but, conversion was not always consistently high.li Solvent composition and 
reaction time before addition of base were adjusted (entry 9, Table 2.8) to attain 
reproducibility. 
 Attempts were made to make the hydroxymercuration/demercuration reaction and the 
subsequent reduction of the hemiacetalslii into a one-pot reaction. Unfortunately, some of the 
constituents of the reaction mixture were not stable to the conditions and decomposition 
occurred: presumably, extended exposure to base was responsible for the decomposition 
                                                 
li Conversion in subsequent experiments under these conditions ranged from 90->95%. 
lii Reduction of the hemiacetals is slow. After 3 h, only 50-60% reduction had occurred (by 1H NMR 
spectroscopy): complete reduction was consistently observed after 16 h. 
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products. Therefore, the reaction of 210 to 213 and 214 was conducted as a two-pot process: 
work-up between demercuration and hemiacetal reduction.  
2.7.3 Formal synthesis of baconipyrone C (8) 
 With a method to deliver Bn-diol 213 in reasonable yield, a simple change of the 
protecting group from Bn to PMB could deliver PMB-diol ent-39 used in three previous 
syntheses of baconipyrone C (8) (Scheme 2.15). Obtaining ent-39 through the same reaction 
sequence that produced Bn-diol 213 (substitution of BnBr for PMBCl) would secure the 
structure 213 by analogy and all previous compounds leading to 213 from 190. However, to 
claim a formal synthesis of baconipyrone C (8), a synthetic route to hydroxydione 41 would 
also be required.  
O
209
O
O
OH
ent-39
O
O
PMB
O
HO
2 steps
S
OO OH
S
O
122
OH
41
O O
steps
HO
 
Scheme 2.15 
 The PMB series of compounds was accessed as anticipated with only minor 
modification to the established procedures for the Bn series of compounds (210, 213, and 
214) (Scheme 2.16). In general, the yields obtained were slightly lower than the Bn series, 
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but the reaction selectivity in the hydroxymercuration/demercuration step was the same.liii 
Comparison of the 1H and 13C NMR of the two PMB diols (ent-39 and 216) obtained from 
the hydroxymercuration/demercuration of 215 showed an excellent match to the previously 
reported data.29, 30 Comparison of the optical rotation for ent-39,liv [α]D -15 (c 0.45, CHCl3) to 
literature values [α]D -9.9 (c 0.91, CHCl3) for ent-3929 and [α]D +8.4 (c 0.15, CHCl3) for 39,30 
confirmed that the required absolute configuration was accessed. 
O
215
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O
OH
ent-39 (51%)
O
O
a) KHMDS, PMBCl, HMPA, tBuOH b) i. Hg(OAc)2 in THF/H2O ii. NaBH4
PMBO
PMB
O
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216 (17%)
O
O
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O
HO +
a
74%
O
209
O
O
HO
b
68%
(combined
yield)
3:1
 
Scheme 2.16  
 The synthesis of hydroxydione 41 was seen coming directly from the Thiopyran 
Route to Polypropionates (Section 2.3), specifically through aldol diastereomer 122 that can 
be obtained in excellent yield (86%) and enantioselectivity (>98% ee) from 116 and 117 
                                                 
liii Reactions performed with 215 were attempted a limited number of times; i.e., not optimized to the same 
degree as the reaction with 210. 
liv The adduct produced in this synthesis. 
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(Scheme 2.1). From 122, all that is required to obtain 41 is desulfurization and deprotection 
of the ethylene acetal (Scheme 2.17).  
 Towards this end, aldol 122 was subjected to Raney nickel in refluxing THF,lv, 140 
which smoothly desulfurized (Scheme 2.17). At the end of the reaction, the reaction mixture 
was cooled and aq. HCl was added to destroy the Raney nickel. The aqueous acid also served 
to deprotect the ethylene acetal. Thus 41 was obtained from 122 in a one-pot process in 
excellent yield (79%). The NMR data matched previously reported data.28-30 
 
S
OO OH
S
O
122
OH
41
O O
a
one pot
79%
a) i) Raney nickel ii) aq. HCl  
Scheme 2.17 
 Comparison of the three previous routes to the two key intermediates previously used 
in the synthesis of baconipyrone C (8) to this work are shown in Table 2.9.  
As shown in Table 2.9, the synthetic route to both 41 and ent-39 compare favorably 
to Paterson’s synthesis. While fewer steps are required in this synthesis to construct ent-39, 
Paterson’s synthesis is over three times as efficient, a truly amazing feat. The same is not true 
for 41, despite one extra step, the yield of 41 in this synthesis is nearly twice that of 
Paterson’s and was produced with much higher ee than what Paterson achieved. Both the 
Hoveydalvi and Yadav syntheses are longer and less efficient than the current work 
                                                 
lv It is known that the use of alcoholic solvent increases the ability of Raney nickel to reduce other functionality 
by increasing available H2 through hydrogenolysis of the solvent to its corresponding carbonyl compound. 
lvi For clarity, Hoveyda never synthesized baconipyrone C (8). 
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Table 2.9 Key baconipyrone C (8) intermediates synthesis comparison 
 This  Work 
Paterson 
2000a 
Hoveyda 
2007b, c 
Yadav 
2009d 
ent-39 
Longest linear 
sequence 14 16 20 21 
Total number of 
steps 18 19 22 22 
Yield 7.3% 26% 2.3% 3.8% 
[α]De -15  (c 0.45) NR
f +8.4  
(c 0.15) 
-9.9  
(c 0.91) 
41 
Longest linear 
sequence 6 5 10 14 
Total number of 
steps 7 5 10 14 
Yield 45% 32% 7% 3.3% 
ee >98% 85%g >98% NRf 
[α]De -20  (c 1.1) 
-16.4  
(c 1.1) 
+12  
(c 1.0) 
-15.6  
(c 2.0) 
a Ref 28. b Ref 30. c Antipodes of ent-39 and 41 prepared. d Ref 29. e CHCl3. f  Not reported. g 
Also synthesized diasteroeselectively from (R)-ethyl lactate (9 steps; 38% overall yield).  
  
2.7.4 Aldehyde 218 synthesis  
In Paterson’s 1st attempted synthesis of siphonarin B (4) (Scheme 1.13), PMB-diol 
ent-39 could be bis-silylated by treatment with Et3SiOTf and 2,6-lutidine and then the 1° 
triethylsilyl ether was selectively deprotected; both reactions occurred in excellent yield.15 
The same sequence was attempted with Bn-diol 213 (Scheme 2.18). Despite the similarity 
between ent-39 and 213, the C-3'-OH of 213 could not be silylated.lvii This observation was 
capitalized upon through a one-pot reaction scheme by transient protection of the C-7’-OH 
(of 213): C-7’-OH was silylated with Et3SiOTf, followed by methoxymethylation of the C-
                                                 
lvii Repeated attempts employing extended reaction times (>24 h) and excess reagents (>5 equivalents in both 
Et3SiOTf and 2,6-lutidine) were met without success. In all cases, only the C-7’-OH of 213 would silylate.  
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3’-OH. After TLC indicated complete reaction, MeOHlviii and TBAF were added, cleanly 
removing the triethylsilyl group and delivering 217 in excellent yield.  
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Scheme 2.18 
Oxidation of the C-7’-OH to the corresponding aldehyde (218) was accomplished 
with IBX in DMSO in quantitative yield without need for chromatography (Scheme 2.19). 
IBX in hot (80 °C) MeCN (cf. Scheme 2.9, oxidation of diol 194 to dialdehyde 196) was 
attempted with a C-3’-acetate derivative (Scheme 2.20). This resulted in elimination and 
isomerization products.lix Acetate derivative 221 was prepared as an alternative to aldehyde 
218 and to investigate conditions to produce aldehyde 221 without competing isomerization 
and elimination pathways. Aldehyde 221 was not explored further other than to establish 
appropriate oxidation conditions for 217. 
 
 
 
 
 
                                                 
lviii Added as a sacrificial alcohol to prevent possible MOMylation of the C-7’-OH after removal of the silyl 
protecting group. 
lix Elimination was speculated to occur across the C-2,3 bond and isomerization at C-2 through tautomerism, but 
this could not be proven because all three compounds were inseparable from each other. 
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Scheme 2.19 
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Scheme 2.20 
 
 
 
96
2.8 Total synthesis of siphonarin B (4) and baconipyrones A (6) and C (8)  
2.8.1 Carbon skeleton completion: total synthesis of the putative common precursor 
With 222lx and aldehyde 218 in hand, an aldol reaction to couple these reactants could 
be attempted. Aldol reactions between 222 (and its diastereomers) (see Figure 2.4) and chiral 
aldehydes have been extensively studied in the Ward group in order to determine and exploit 
the stereocontrol elements present in these reactions.64, 73, 76 Based on these studies, the 
configurations at C-3 (of 222) and C-2 and C-3 (of 218) provide guidance as to the selection 
of an aldol mediator to efficiently couple these two reactants (Figure 2.19). 
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S
OO O
S
O
222
trans-
selective
Felkin-
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+
aldol mediator required to be:
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3
O
 
Figure 2.19 Considerations for the required aldol coupling of 222 and 218 
The aldol reactions of 222 (and its diastereomers) are unerringly trans selective (C-3 
and C-5 of 222) with aldehyde 116. This is a result of pseudo-axial delivery of the 
electrophile for stereoelectronic reasons: conformational analysis places the existing C-3 
ligand (of 222) in a pseudo-equatorial position thus necessitating a trans relationship of the 
existing ligand at C-3 and the newly installed ligand. Further, the anti relative configuration 
of the -methyl and β-OBn substituents of aldehyde 218 are expected to reinforce Felkin 
                                                 
lx Methoxymethylation of 122 produced 222. Compound 188 (P2 = MOM, Figure 2.15) is the generic version of 
222. 
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selective addition to the carbonyl.141 These strong diastereoface selectivities require an aldol 
mediator with either no selectivity preference or one that favours syn relative aldol topicity.   
The aldol mediators investigated with 222 (and its diastereomers) that show either no 
selectivity or are syn selective are based on titanium(IV). Ward et al. have shown that the 
transmetalation of Li enolates of 222 (and its diastereomers) with Ti(OiPr)4 produces 
Ti(OiPr4)Li “ate” enolates that react with syn relative aldol topicity selectively with one 
enantiomer of ()-116 (Figure 2.4) to produce single compounds (i.e., 134).lxi,76 
Titanium(IV) enolates of 222 based on TiCl4 or TiCl3OiPr have also been shown to 
efficiently couple 222 and 116.73 These reactions occur without significant preference of 
relative aldol topicity. In general, the latter reaction format is faster and is a simpler 
procedure to execute than the former.  
Based on the above analysis, TiCl4 was selected as the mediator for the aldol reaction 
between 222 and 218 (Scheme 2.21). Gratifyingly, this reaction gave a 79% yield of 
essentially one diastereomer (>20:1, as judged by 1H NMR spectroscopy), clearly showing 
the effectiveness of the selected conditions. 
                                                 
lxi Such reactions are kinetic resolutions of ()-116. 
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Scheme 2.21 
The structure of aldol adduct 223 was assumed to have the configuration shown 
(Scheme 2.21), based on the model in Figure 2.4. The relative configurations of C-3” and C-
7’ were not rigorously proven: all stereocenters present in 222 and 218 were assumed to be 
unchanged from starting material.  
 The relative configurations of C-3” and C-7’ of 223 are not critical to the success or 
failure of this synthetic effort because C-7’-OH will be oxidized and the C-3” stereocenter in 
resulting C-4”,7’ β-diketone will be susceptible to keto-enol tautomerism. 
2.8.2 Attempted trioxadithiapentacycle formation 
 With aldol adduct 223 in hand, the oxidation of C-7’-OH to the corresponding C-
4”,7’ β-diketone was attempted (Scheme 2.22). The resulting oxidized compounds proved to 
be a complicated mixture of keto (2 diastereomers) and enol forms and was taken forward as 
a crude product, as previously described in the model study (Section 2.4) 
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Scheme 2.22 
 Despite numerous attempts using various conditions, nothing corresponding to 
trioxadithiapentacycle 224 could be isolated from the attempted reactions (Scheme 2.22). 
Indeed, no pure compounds could be identified and, although deprotection of acetal groups 
was occurring, the precise course of the reaction could not be determined. Unfortunately, the 
synthetic strategy outlined in Section 2.6 had failed. 
2.8.3 Alternative avenues of investigation 
 Despite the failures encountered in the attempted formation of desired 
trioxadithiapentacycle 224, aldol adduct 223 still offered some potential towards addressing 
the objectives of this research project. Additionally, it was hoped that exploration with this 
adduct may offer some insight into reasons for the failure to form trioxadithiapentacycle 224, 
which had so readily formed in the earlier model study (Section 2.4).   
As a first attempt, aldol adduct 223 was subjected to FeCl36H2O, which gave a 
mixture of desired deprotected compound 225 and retro-aldol adduct 226 (Scheme 2.23).lxii 
Unfortunately, desired deprotected compound 225 was only isolated in ca. 80% purity (too 
                                                 
lxii In this particular case, the resulting hemiacetal, obtained as a result of a retro-aldol reaction, was trapped as a 
methoxy acetal. 
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impure to characterize) and was produced in similar yield to retro-aldol adduct 226 (39% 
isolated yield).  
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Scheme 2.23 
Retro-aldol adduct 226 was obtained as a pure compound (Scheme 2.23). The 
structure was assumed to have undergone no isomerization events. The configuration of the 
methoxy group was suggested by a positive NOE on HC-4’’ and HC-2’’ on irradiation of the 
methoxy group and vice versa. A positive NOE on HC-2’’ on irradiation of HC-4’’ and vice 
versa was also observed. 
Noting the propensity of aldol adduct 223 towards retro-aldol and anticipating the 
need for a desulfurization reaction soon in the reaction sequence, an adjustment was made in 
the order of steps. Desulfurization of 223 followed by deprotection of the three acetal groups 
with FeCl36H2O in acetone/MeOH (5% v/v), cleanly furnishing 227 in 87% yield (Scheme 
2.24) over two steps without detectable retro-aldol 226 (Scheme 2.23).    
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Scheme 2.24 
In order to effectively utilize 227, the C-5, C-9, and C-13 alcohols require 
differentiation before oxidation of C-9 and C-13 alcohols could be attempted. Fortunately, C-
13-OH was previously shown to be unreactive towards Et3SiOTf in a related compound (cf. 
C-3’-OH in diol 213, Scheme 2.19). It was hoped that this lack of reactivity would translate 
to 227, leaving two alcohols to differentiate, C-5 and C-9. Considering the C-5 and C-9 
alcohols have considerable differences in their surrounding environments, it was speculated 
that these two alcohols should have different reactivities. Depending on their relative 
reactivities, two potential strategies could be investigated: 1) the C-5-OH (of 227) could be 
selectively protected; or, 2) the bis-protected compound (cf. 229, Scheme 2.24) could be 
selectively hydrolyzed (i.e., if C-9-OH of 229 would be more reactive towards silylation, it 
should also be more reactive towards selective hydrolysis).    
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Treatment of 227 with Et3SiOTf produced a 5:1 mixture of 228 and the C-9 
triethylsilyl ether, as well as 229 and some recovered starting material (Scheme 2.24). The 
mono-silylated compounds were not separable from each other; therefore, the reaction was 
typically run to nearly equal ratios of 228 and 229 to avoid complication of carrying the 
minor C-9 triethylsilyl ether forward. Bis-silylated derivative 229 could be efficient recycled 
to starting material 227. 
The position of the silyl-protecting group of 228 was determined by NOE (Figure 
2.20). A positive NOE was detected on HC-5 upon irradiation of the methylene (-H2C-) 
group of the silyl-protecting group and vice versa. No NOE was detected on HC-9 upon 
irradiation of the methylene (-H2C-) grouplxiii of the silyl-protecting group and vice-versa. 
 
OH
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Bn
OO OHO
9
11 13 2'
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5
O
73
Si
H H
HH
NOE  
 
Figure 2.20 NOE results for 228 
Obtaining compound 228 provided an avenue for further investigation because C-5-
OH was differentially protected from C-9 and C-13-OH. Where the previous strategy had 
failed (Section 2.8.2), a new possibility emerged that could address the objectives of this 
research project (Section 2.1). 
 
                                                 
lxiii The methylene H’s of the silyl group are interchangeable. Figure 2.19 is drawn arbitrarily. 
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2.8.4 Synthesis and isomerization of the putative common precursor  
Oxidation of 228 with IBX in DMSO gave the corresponding tetraone 230 in good 
yield (Scheme 2.25). Hydrogenolysis of the benzyl group with Raney nickel gave a 
complicated mixture of compounds that was not characterized, but was immediately 
subjected to HFpyridine to hydrolyze the triethylsilyl group. Interestingly, a mixture of 
hemiacetals (ca. 80% of the reaction mixture; identified by the signals at ca. H 6.19, 6.35, 
6.39, and 6.46 ppm and acetal carbons C 104.4, 104.6, and 104.7) was produced with a very 
small amount of enol, β-diketone tautomers (2 diastereomers; C-8 signals at C 61.9 and 61.1) 
content and a trace amount of siphonarin B (4) (ca. 2% of the reaction mixture).lxiv This 
mixture of hemiacetals was speculated to be the elusive putative common precursor 14/15 of 
the siphonariid polypropionates (4, 6, 8, and 10). If this were the case, this would be the first 
enantioselective synthesis of putative acyclic precursor 14/15, but to claim this, the mixture 
of hemiacetals would have to be isomerized to one, or more, of the known compounds (4, 6, 
8, and 10) (vide infra). 
                                                 
lxiv Diagnostic signal at 5.12 ppm (1H NMR spectrum; CDCl3). 
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Scheme 2.25lxv 
Putative common precursor 14/15 exists primarily as a mixture of hemiacetals 231 – 
234 (Figure 2.21). This mixture of hemiacetals bears a strong resemblance to the impurities 
present in the 1H NMR spectroscopy of natural siphonarin B (4), provided by Garson and 
reported in Paterson’s total synthesis of siphonarin B (4).15 It is proposed that of the four 
observed hemiacetals, two (i.e., 231 and 233) arise from addition of the C-5-OH group onto 
C-9 carbonyl and two (i.e., 232 and 234) arise from addition of the C-11-OH group on the C-
7 carbonyl. The relationships between 231 and 232 and between 233 and 234 are very close; 
i.e., they have identical configuration around the ring with only subtle differences in the 
substituents at C-9 and C-5 (in 231/233) versus those at C-7 and C-11 (in 232/234). It is 
important to note that an additional four hemiacetals are possible (8 total) from the two 
                                                 
lxv Atom numbering in the intermediates leading up to the natural products was performed according to IUPAC. 
Atom numbering of the natural products was performed according to the numbering scheme applied by the 
scientists responsible for isolation and structure determination.  
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different cyclization pathways (C-5-OH  C-9 carbonyl and C-11-OH  C-7 carbonyl) that 
have the opposite configuration at the acetal carbon (i.e., C-9 in 213/233 and C-7 in 
232/234). However, the additional four hemiacetals (two from each cyclization pathway) do 
not benefit from anomeric stabilization (i.e., the hemiacetal OH group is in an equatorial 
orientation) and were discounted as possible contributors to the observed equilibrium. This 
hypothesis is consistent with the experimental and computation results from the model study 
(Section 2.4). 
The hemiacetals 231 - 234 were remarkably stable to silica gel chromatography. 
Further support of their stability was provided by allowing the mixture to stand at room 
temperature (in the dark) in CDCl3; the mixture of hemiacetals slowly produced siphonarin B 
(4) (ca. 9% of the reaction mixture after 28 days) with very little change in the hemiacetal 
ratio. None of the other known siphonariid polypropionates (6, 8, and 10) were detected. 
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Figure 2.21 1H NMR spectrum of the putative common precursor 
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Turning towards the earlier model study (Section 2.4) for guidance on how to 
proceed in isomerizing 14/15 into one or more of the isolated polypropionate structures (4, 6, 
8, and 10), the first condition attempted was imidazole in CDCl3 (Scheme 2.26).75 Based on 
the previous work, this condition was viewed as having the best chance to form caloundrin B 
(10) (Section 2.4).  
Exposure of 14/15 (primarily as a mixture of hemiacetals 231 – 234) to imidazole in 
CDCl3 produced siphonarin B (4) as the only identifiable natural product in 70% isolated 
yield after 1 day along with some remaining 14/15. This experiment conclusively showed 
that the putative common precursor 14/15 had been synthesized, as had been previously 
speculated, and concluded the first enantioselective total synthesis of siphonarin B (4).  
Subjecting purified siphonarin B (4) to imidazole in CDCl3 for 2 days, returned 
siphonarin B (4) and 14/15. The 14/15 obtained from this experiment existed as a different 
ratio of hemiacetals than that obtained from triethylsilyl hydrolysis of 230 (see Figure 2.21). 
This experiment showed that, under these conditions, the formation of siphonarin B (4) is 
reversible. Caloundrin B (10) was not observed as a product of any of the isomerization 
experiments with imidazole in CDCl3. 
a
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Scheme 2.26 
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 The NMR data of natural and synthetic siphonarin B (4) are compared in Tables 2.10 
and 2.11.  
Table 2.10. 1H NMR (CDCl3) comparison of natural and synthetic siphonarin B (4) 
naturala  synthetic 
H multiplicity (J’s in Hz) assignment
a H multiplicity (J’s in Hz) 
5.14 s HO 5.12 s 
3.88 br d (10.5) HC-5 3.91 d (10.5) 
3.81 br s HC-11 3.81 br s 
3.28 q (7) HC-14 3.27 q (7) 
3.11 br s HO 3.08 br s 
2.79 q (7) H2C-20 2.77 q (7.5) 
2.66 q (6.5) HC-8 2.66 q (7) 
2.61 br q (7) HC-4 2.61 q (6.5) 
2.48 dq (18.5, 7) HC-2 2.48 dq (18.5, 7) 
2.28 dq (10.5, 6.5) HC-6 2.32-2.18 2H m 
2.25 dq (18.5,7) HC-2   
2.04 dq (2.5, 7) HC-12 2.05 dq (2.5, 7) 
2.00 s H3CC-18 1.97 s 
1.98 s H3CC-16 1.96 s 
1.83 dq (2, 7) HC-10 1.86 dq (2, 7) 
1.25 d (7) H3CC-12 1.25 d (7) 
1.21 d (7) H3CC-10 1.21 d (7) 
1.20 t (7) H3CC-20 1.21 t (7) 
1.18 d(7) H3CC-14 1.19 d (7) 
1.07 d (7) H3CC-4 1.07 d (7) 
1.07 d (6.5) H3CC-8 1.07 d (6.5) 
0.94 t (7) H3CC-2 0.94 t (7) 
0.76 d (6.5) H3CC-6 0.77 d (6.5) 
a  Data and assignments according to ref 8. 
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Table 2.11. 13C NMR (CDCl3) comparison of natural and synthetic siphonarin B (4) 
naturala  synthetic   naturala  synthetic 
C assignmentb 
(carbon #) 
Cc   C assignmentb 
(carbon #)
Cc 
213.3 C-3 213.5   38.7 C-12 38.9 
206.4 C-7 206.7   38.4 C-10 38.6 
179.8 C-17 180.1   35.6 C-2 35.9 
165.5 C-19 165.7   24.7 C-20 24.9 
161.6 C-15 161.8   13.0 CH3C-10 13.2 
121.6 C-16 121.8   12.6 CH3C-12 12.8 
117.2 C-18 117.5   11.9 CH3C-14 12.1 
105.1 C-9 105.4   11.4 CH3C-20 11.6 
103.1 C-13 103.4   10.9 CH3C-16 11.1 
74.6 C-5 74.82   9.4 CH3C-18 9.6 
74.6 C-11 74.80   9.3 CH3C-6 9.5 
50.0 C-8 50.2   8.6 CH3C-8 8.8 
46.0 C-4 46.2   8.2 CH3C-4 8.4 
45.3 C-6 45.5   7.4 CH3C-2 7.6 
42.4 C-14 42.7      
a Ref 8. b Assignments from ref 9. cChemical shifts for synthetic material are consistently 
0.2-0.3 ppm higher than those reported for the natural product presumably due to a 
different reference standard; C CDCl3 = 77.23 was used for this study.  
 
The specific rotations of natural ([]D +13 (c 0.14, CHCl3)) and syntheticlxvi, 15 ([]D +12 (c 
0.1, CHCl3)) compare favorably. 
 Of the four hemiacetals 231 – 234 originally present in 14/15, only two hemiacetals 
were present in any appreciable amount (H 6.39 and 6.19) following isomerization with 
                                                 
lxvi Paterson obtained ([]D +10.5 (c 0.12, CHCl3)) for his synthetic sample. 
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imidazole. These hemiacetals are hypothesized to be 231 and 232, considering Figure 2.21. 
This conclusion is further rationalized based on the results of the trioxaadamantane model 
study (Section 2.4): 231 is assumed to be the most stable hemiacetal from 14 (8S, C-5-OH  
C-9 carbonyl) and 232 is the most stable from 15 (8R, C-11-OH  C-7 carbonyl). No 
definitive structure proof was attempted.  
 Continuing with investigation of the conditions identified in the earlier model study 
(Section 2.4), exposure of 14/15 to DBU in benzene-d6 rapidly induced a retro-Claisen 
rearrangement (Scheme 2.27). However, significant C-14 epimerization occurred during the 
course of the reaction to give a 1.4:1 ratio of baconipyrone C (8): 14-epi-baconipyrone C 
(235). Baconipyrone C (8) was isolated from this reaction mixture in 50% yield providing the 
first total synthesis of 8 via the proposed retro-Claisen rearrangement from the contiguous 
carbon skeleton. 14-epi-baconipyrone C (235) was isolated from the crude reaction mixture 
in 30% yield for a combined yield of 80%.   
The isomerization of baconipyrone C (8) to 14-epi-baconipyrone C (235) was verified 
by exposing baconipyrone C (8) to DBU in benzene-d6 (Scheme 2.27). Rapid epimerization 
occurred to give a 1.3:1 ratio of 8 and 235, respectively, within 45 minutes. Interestingly, the 
C-14 epimer 235 isolated from these experiments did not match the NMR data, specific 
rotation, and Rf (same mobile and stationary phases as reported previously) of a compound 
that was tentatively assigned as 14-epi-baconipyrone C (235) in a previous study.lxvii, 28, 142 
                                                 
lxvii Data for the putative 14-epi-baconipyrone C (actually C-10 epimer 236) was provided by Prof. Paterson in a 
private communication. See also Chen, D. Y-K. Ph.D. Thesis, University of Cambridge, Cambridge, U.K., 
2002. 
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Scheme 2.27 
Comparison of the 13C NMR data (CDCl3) for all three compounds (baconipyrone C (8), 
the 14-epi-baconipyrone C (235) isolated from this study, and the putative 14-epi-
baconipyrone C (236)lxviii isolated by Paterson28) led to the hypothesis that 10-epi-
baconipyrone C (236) had been formed in all three syntheses based on the esterification 
approach.lxix, 28-30   
                                                 
lxviii Likely the C-10 epimer (vide infra). 
lxix It is possible that C-10 epimerization occurred via enolization of the activated ester and/or ketene formation. 
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Table 2.12. 13C NMR (CDCl3) comparison of baconipyrone C (8), 
14-epi-baconipyrone C (235), and 10-epi-baconipyrone C (236) 
assignmenta 
8 14-epi-baconipyrone C (235) 
10-epi-baconipyrone C 
(236) 
Cb Cb C Cc C 
C-7 or C-3 212.1 212.3 0.2 213.5 1.4 
C-3 or C-7 211.1 211.7 0.6 211.7 0.6 
C-13 210.7 210.4 0.3 210.4 0.3 
C-17 179.9 179.9 0 179.9 0 
C-9 174.3 173.8 0.5 173.4 1.1 
C-19 164.8 165.0 0.2 164.7 0.1 
C-15 160.8 160.0 0.8 161.0 0.2 
C-16 120.6 120.4 0.2 120.4 0.2 
C-18 118.5 118.4 0.1 118.3 0.2 
C-11 77.8 76.6 0.2 74.9 2.9 
C-5 74.0 74.1 0.1 73.5 0.5 
C-14 51.2 48.7 2.5 51.3 0.1 
C-12 48.8 47.8 1.0 47.0 1.8 
C-4 or C-6 47.5 47.6 0.1 45.7 1.8 
C-6 or C-4 46.0 46.1 0.1 45.6 0.4 
C-10 41.1 42.4 1.3 41.7 0.6 
C-2 or C-8 35.1 
35.5 0.4 
35.6 0.5 
35.4 0.3 
C-20 24.7 25.0 0.3 24.7 0 
CH3C-10 15.0 15.1 0.1 13.5 1.5 
CH3C-12 14.1 14.9 0.8 13.3 0.8 
CH3C-4 or CH3C-6 13.8 13.7 0.1 12.7 0.9 
CH3C-14 13.1 13.5 0.4 11.4 1.7 
CH3C-20 11.3 11.5 0.2 9.9 1.4 
CH3C-16 9.9 10.0 0.1 9.5 0.4 
CH3C-6 or CH3C-4 9.6 10.0 0.4 9.2 0.4 
CH3C-18 9.5 9.7 0.2 8.0 1.5 
CH3C-8 or CH3C-2 7.7 7.9 0.2 7.6 0.1 
CH3C-2 or CH3C-8 7.2 7.7 0.5 7.3 0.1 
a Assignments made via COSY, HSQC and HMBC. Although two different sets of signals 
can be assigned for two different CH3CH2C(O)CH(Me) - fragments, the fragments cannot be 
assigned (e.g. C-4 vs. C-6). Assignments only apply to 8 and 235. b Reference standard: C 
CDCl3 = 77.23. c Reference standard: C CDCl3 = 77.0.  
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 The assignment of 235 is supported in two ways. The most acidic proton in 
baconipyrone C (8) is expected to be HC-14 (vinylogous β-ketoester): brief treatment of 8 
with base (DBU) produced 235 as the only product. The 13C NMR of 8 and 235 are very 
similar with C only 0.8-1.2 ppm for C-10, C-11, C-12, and the largest difference (2.5 ppm) 
for C-14. However, 236 is quite different from that of 8 with 7 carbons having C>1.5 and 
there are significant differences in the chemical shifts for the methyl signals. Unfortunately, 
the hypothesis that the latter is actually the C-10 epimer 236 cannot be confirmed because 
assignments for the 13C data are not available. 
Considering the conditions explored in the earlier model study (Section 2.4), lengthy 
exposure of 14/15 to HFpyridine remained as a possible route to caloundrin B (10). 
Exposure of 14/15 for 16 hrs HFpyridine gave a small amount (20% isolated) of siphonarin 
B (4) and recovered starting hemiacetals (60% isolated). Resubjecting the hemiacetals for a 
longer period of time under identical conditions was unproductive and led to unidentifiable 
compounds. 
2.4.8.1 Conclusions on the synthesis and isomerization of the putative common 
precursor 14/15  
 The enantioselective total synthesis of putative common precursor 14/15 was 
achieved in 18 steps in 3.1% overall yield (20 total steps). The putative common precursor 
14/15 exists mainly as a mixture of four hemiacetals, speculated to be hemiacetals 231 - 234 
(Figure 2.21). The hemiacetals 231 - 234 proved to be remarkably stable to silica gel 
chromatography and did not spontaneously form any of the polypropionate structures 
isolated from siphonariid extracts (i.e., 4, 6, 8, and 10) upon standing (28 days in CDCl3). 
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The isomerization conditions identified in the model study (Section 2.4) were attempted with 
the putative common precursor 14/15.  
Imidazole in chloroform readily isomerized 14/15 to provide siphonarin B (4) 
(Scheme 2.26). This work was the first enantioselective synthesis of siphonarin B (4).  
Interestingly, these conditions were effective in the model study to provide trioxaadamantane 
ring system 150 (see Section 2.4), but the presence of caloundrin B (10) was not detected in 
the reaction mixture.  
HFpyridine, a reagent proven favourable in the model system (Section 2.4) to 
produce the truncated structure of siphonarin B (4) (cf. 138, Scheme 2.2), was not as 
productive or clean when applied to 14/15. 
Exposure of 14/15 to DBU in benzene-d6 readily induced retro-Claisen 
rearrangement. Baconipyrone C (8) was obtained was obtain in 50% yield (final step). This is 
first total synthesis of baconipyrone C (8) via the proposed “biomimetic” route and the first 
synthesis to explore a route other than that based on esterification. Unfortunately, these 
conditions also readily epimerized baconipyrone C (8) to provide 14-epi-baconipyrone C 
(235). Baconipyrone A (6) was not detected; i.e., no retro-Claisen rearrangement/aldol 
cascade occurred under these conditions. 
Caloundrin B (10) was never observed in any of these isomerization experiments. 
Other conditions, or an alternative strategy, would have to be investigated to access the 
elusive caloundrin B (10). 
2.8.5 Investigation of alternative conditions 
An early experiment to determine the correct order of deprotection of tetraone 230 to 
access putative common precursor 14/15 (Scheme 2.25), found that triethylsilyl hydrolysis 
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followed by attempted hydrogenolysis of the Bn group with a very small amount of Raney 
nickel in refluxing EtOH gave what appeared to be a mixture of Bn-protected retro-Claisen 
rearrangement products by 1H NMR spectroscopy.lxx It was hypothesized that exposure of 
14/15 to a solid phase might induce retro-Claisen rearrangement under more controlled 
conditionslxxi. Silica gel and aluminum oxide are known to induce retro-Claisen 
rearrangement in related systems during chromatography.14, 15  
Subjecting 14/15 to neutral aluminum oxide in refluxing ethanollxxii gave a 3: 5: 7: 10 
mixture of baconipyrone A (6), siphonarin B (4), baconipyrone C (8), and retro-Claisen ester 
237 (Scheme 2.28).  Ester 237 arises from the alternative hemiacetal formed from C-11-OH 
addition onto the C-7 carbonyl. Interestingly, ester 237 from the alternative hemiacetal was 
the dominant compound (40%) in the reaction mixture. Also, for the first time, baconipyrone 
A (6) was detected.  
The observation of 237 confirmed the hypothesis (Section 2.8.4) that the alternative 
addition of C-11-OH onto C-7 carbonyl to form hemiacetals 232 and 234 (Figure 2.21) was 
occurring. Under these conditions, isomerization to the alternative hemiacetals arising from 
C-5-OH onto C-9 carbonyl is slow relative to retro-Claisen rearrangement.  
 
                                                 
lxx Essentially, hydrogenolysis of the benzyl group had failed; diagnostic ester peaks were observed in the 1H 
NMR (ca. 5.0 – 5.5 ppm) spectrum of the crude reaction mixture. The products of this reaction were not 
characterized. 
lxxi Reactions employing Raney nickel with this substrate were capricious. 
lxxii A control experiment of 14/15 in refluxing ethanol returned unaltered starting material. 
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Scheme 2.28 
The structure of 237 was determined by two dimensional NMR spectroscopy: COSY, 
HSQC, and HMBC (Figure 2.22). Eight isolated spin systems were determined by COSY. 
One bond connectivity (H to C) was established by HSQC. Three of the spin systems 
corresponded to the -pyrone methyl (x2) and ethyl group signals. There were two additional 
isolated ethyl groups, two spin systems each containing a proton correlated to a carbinol 
signal (C 76.1 and 73.1 ppm) (as determined by HSQC), and an isolated proton at 4.03 ppm. 
The isolated proton, HC-1’, was identified by its diagnostic 1H NMR chemical shift and 
multiplicity (HC-1’: quartet, 4.03 ppm). H3CC-1’ (as determined by COSY) showed an 
HMBC correlation to C-3’ and C-2”. The HC-4’ to HC-6’ spin system (as determined by 
COSY) showed an HMBC correlation from H3CC-4’ to C-3’. The isolated ethyl signals were 
distinguished on the basis of HMBC correlation from H3CC-9’ to C-7’; an HMBC 
correlation from H3CC-6’ to C-7’ was also detected. HC-2 was differentiated from HC-4 on 
the basis of HMBC correlations from their respective methyl groups: H3CC-2 to C-1 (C 
174.3) and H3CC-4 to C-5 (C 215.4). The remaining ethyl group showed an HMBC 
correlation from H3C-7 to C-5. It is assumed that no isomerization events occurred. 
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Figure 2.22 Structure determination of 237 
Exposure of siphonarin B (4) to aluminum oxide in refluxing ethanol gave recovered 
starting material (siphonarin B (4)), baconipyrone C (8), and baconipyrone A (6) in a ratio of 
2.3: 3: 1 (Scheme 2.29). Retro-Claisen ester 237 was not detected in the 1H NMR spectrum 
(CDCl3) of the crude reaction mixture. Under these conditions, isomerization to the 
alternative C-11-OH addition onto C-7 carbonyl is slow relative to the retro-Claisen reaction.  
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O
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O
siphonarin B (4)
2.3 (4): 3 (8): 1 (6)
 
 
Scheme 2.29 
 With this latter experiment in mind and armed with the following knowledge:  
1) No C-14 epimerization occurred in the reactions of siphonarin B (4) and 14/15 
with aluminum oxide.  
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2) Paterson found no cyclization of the C-9 hemiacetal onto the C-13 carbonyl in any 
of the PMB derivatives leading up to the culmination of his total synthesis of 
siphonarin B (4) (cf. Scheme 1.14) (i.e., no C-11 PMB-protected siphonarin B was 
formed).  
3) The alternative C-11-OH addition onto C-7 carbonyl cannot occur with C-11-OH 
blocked as its corresponding benzyl ether.  
Therefore, leaving the benzyl group intact prior during the retro-Claisen rearrangement 
reaction could provide a means to access baconipyrone C (8) without epimerization that had 
been so extensive when 14/15 was subjected to DBU (Scheme 2.27). 
a
a) HFpyridine, pyridine, THF, H2O (cat.) b) basic aluminum oxide, EtOH,  c) H2, Pd/C, EtOH
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 The triethylsilyl ether protecting group was hydrolyzed by brief treatment with 
HFpyridine (Scheme 2.30). Gratifyingly, subjecting 238 to basic aluminum oxidelxxiii in 
refluxing EtOH gave a 1:4 mixture of products that were speculated to be the Bn-protected 
derivatives of baconipyrones A (6) and C (8), 242 and 243, respectively (Figure 2.23).lxxiv 
Treating this mixture with palladium on carbon (10%) under an atmosphere of H2 slowly (ca. 
16 hours)lxxv,15 hydrogenolyzed the benzyl ether protecting groups to give baconipyrones A 
(6) and C (8) in excellent isolated yield (88% combined yield over two steps). There was no 
evidence of 14-epi-baconipyrone C (235), 237, or siphonarin B (4) in the 1H NMR spectrum 
of the crude reaction mixture.  
The selectivity of this transformation can be rationalized by the transition state model 
proposed by Vogel to explain a related aldol reaction (see 241, Figure 2.23).51 In the reaction 
of 238 with aluminum oxide, group selectivity between C-3 and C-7 carbonyls is achieved as 
a result of the retro-Claisen rearrangement (cf. 239  240). Ketonization of enol(ate) 240 
provides 242, whereas intramolecular attack of enol(ate) 240 onto C-3 carbonyl, via 241, 
results in 243. This type of retro-Claisen rearrangement/aldol cascade reaction appears to be 
unprecedented. 
                                                 
lxxiii Neutral aluminum oxide proved ineffective in this case.  
lxxiv Characteristic signals (dd’s) above 5 ppm (1H NMR spectrum (CDCl3)). No attempt was made to separate 
or characterize the individual compounds, presumed to be benzyl-protected precursors of 6 and 8. 
lxxv Paterson also observed slow hydrogenolysis of a similar PMB ether under these conditions. 
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Figure 2.23 Proposed retro-Claisen rearrangement and retro-Claisen rearrangement/aldol 
cascade pathways 
A comparison of NMR data for natural and synthetic baconipyrones A (6) and C (8) 
are shown in Tables 2.13, 2.14, 2.15, and 2.16. The specific rotations of natural ([α]D -82.0 
(c 0.47, CHCl3)) and synthetic ([α]D -96 (c 0.13, CHCl3)) baconipyrone A (6) compare 
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favorably as do those for naturallxxvi, 4, 28: [α]D -82 (c 0.16, MeOH) and syntheticlxxvii, 28-30: 
[]D -81 (c 0.1, MeOH) baconipyrone C (8). 
                                                 
lxxvi Initially reported by Faulkner as [α]D -19 (c 0.90, MeOH), but revised by Paterson in a subsequent report. 
lxxvi Paterson: [α]D -73.3 (c  0.77, MeOH); Yadav : [α]D -70.20 (c 0.4, MeOH); Hoveyda: [α]D +11.8 (c 0.09, 
MeOH). 
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Table 2.13. 1H NMR (CDCl3) comparison of natural and synthetic baconipyrone C (8) 
natural a  synthetic 
H multiplicity (J’s in Hz) assignment 
a,b H multiplicity (J’s in Hz) 
5.46 dd (9.0, 3.5) HC-5 5.47 dd (3.5, 9) 
4.16 q (6.9) HC-14 4.15 q (7) 
3.54 ddd (7.2, 9.0, 10.5) HC-11 3.55 ddd (3, 9, 10) 
3.64 c d (10.5) HO 3.38 d (10) 
2.86 dq (9.0, 7.2) HC-12 2.89-2.79 3H m 
2.83 m HC-4   
2.83 m HC-6   
2.76 dq (18.1, 7.2) HC-8 2.75 dq (18, 7) 
2.56 dq (18.3, 7.2) HC-2 2.60-2.45 4H m 
2.56 q (7.6) H2C-20   
2.55 dq (2.7, 7.2) HC-10   
2.39 dq (18.1, 7.2) HC-8 2.44-2.29 2H m 
2.34 dq (18.3, 7.2) HC-2   
2.03 d s H3CC-16 2.09 s 
1.93 s H3CC-18 1.93 s 
1.38 d (6.9) H3CC-14 1.38 d (7) 
1.22 d (7.2) H3CC-10 1.22 d (7) 
1.16 t (7.6) H3CC-20 1.16 t (7.5) 
1.09 d (7.2) H3CC-12 e 1.09 d (7) 
1.02 d (6.9) H3CC-6 1.02 d (7) 
1.01 t (7.2) H3CC-8 1.01 t (7.5) 
0.91 t (7.2) H3CC-2 0.91 t (7) 
0.85 d (6.8) H3CC-4 e 0.86 d (7) 
a Data and assignments according to ref 4. b Although two different sets of signals can 
be assigned for two different CH3CH2C(O)CH(Me)- fragments, the assignment of the 
individual fragments (e.g., C-4 vs. C-6) should be considered as arbitrary. c Other 
workers have reported this signal at 3.38 and 3.39 ppm.28, 29 d Other workers have 
reported this signal at 2.09 ppm.28, 29 e Assignments are reversed compared to ref 4. The 
methyls at C-4 (or C-6)b and C-12 were assigned by HMBC through their correlations 
to C-5 and C-11, respectively. 
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Table 2.14. Comparison of 13C NMR spectra of natural and synthetic baconipyrone C (8) 
natural a  synthetic   natural a  synthetic 
C assignment b C c   C assignment b C c 
211.9 C-7 or C-3 212.1   41.1 C-10 41.3 
210.9 C-3 or C-7 211.1   
35.1d 
C-2 or C-8 35.32 
210.4 C-13 210.7   C-2 or C-8 35.28 
179.7 C-17 179.9   24.7 C-20 24.9 
174.0 C-9 174.3   15.0 CH3C-10 15.3 
164.7 C-19 164.8   14.1 CH3C-12 14.4 
160.6 C-15 160.8   13.8 CH3C-4 or CH3C-6 13.7 
120.4 C-16 120.6   13.1 CH3C-14 13.4 
118.2 C-18 118.5   11.3 CH3C-20 11.5 
77.5 C-11 77.8   9.9 CH3C-16 10.1 
73.7 C-5 74.0   9.6 CH3C-6 or CH3C-4 9.9 
50.9 C-14 51.2   9.5 CH3C-18 9.7 
48.6 C-12 48.8   7.7 CH3C-8 or CH3C-2 7.9 
47.2 C-4 or C-6 47.5   7.2 CH3C-2 or CH3C-8 7.5 
45.7 C-6 or C-4 46.0      
a Data from ref 4. b Assignments made via COSY, HSQC and HMBC. Although two 
different sets of signals can be assigned for two different CH3CH2C(O)CH(Me) - fragments, 
the fragments cannot be assigned (e.g. C-4 vs. C-6). cChemical shifts for synthetic material 
are consistently 0.2-0.3 ppm higher than those reported for the natural product presumably 
due to a different reference standard; we used C CDCl3 = 77.23. d Two (2) overlapping 
signals.  
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Table 2.15. 1H NMR (CDCl3) comparison of natural and synthetic baconipyrone A (6) 
natural a  synthetic 
H multiplicity (J’s in Hz) 
assignment a 
 H 
multiplicity 
(J’s in Hz) 
5.05 dd (4.7, 6.3) HC-5 5.00 dd (4.5, 6.5) 
4.09 q (6.9) HC-14 4.04 q (7) 
3.68 ddd (3.4, 8.6, 9.6) HC-11 3.62 ddd (3.5, 8.5, 9.5) 
3.43 d (9.6) HOC-11 3.35 d (9.5) 
3.00 dq (4.7, 7.2) HC-6 2.96 (dq (4.5, 7) 
2.84 dq (8.6, 6.9) HC-12 2.79 (dq (8.5, 7) 
2.65 dq (3.4, 7.2) HC-10 2.64 dq (3.5, 7) 
2.60 q (6.8) HC-8 
2.62-2.51 m 
2.60 m H2C-20 
2.13 dq (6.3, 6.9) HC-4 2.13 dq (6.5, 7) 
2.05 s H3CC-16 2.05 s 
1.95 s H3CC-18 1.95 s 
1.66 dq (14, 7.5) HC-2 1.66 dq (14.5, 7) 
1.54 dq (14, 7.5) HC-2 1.52 dq (14.5, 7) 
1.38 d (6.9) H3CC-14 1.38 d (7) 
1.29 d (7.2) H3CC-10 1.29 d (7) 
1.16 t (7.5) H3CC-20 1.16 t (7.5) 
1.07 d (6.8) H3CC-8 1.07 d (7) 
1.06 d (6.9) H3CC-4 1.06 d (7) 
1.00 d (7.2) H3CC-6 1.00 d (7) 
0.91 d (6.9) H3CC-12 0.90 d (7) 
0.86 t (7.5) H3C-1 0.86 t (7.5) 
a  Data and assignments according to ref 4.  
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Table 2.16. 13C NMR (CDCl3) comparison of natural and synthetic baconipyrone A (6) 
natural a  synthetic  natural a  synthetic
C assignment b C c  C assignment b C c 
221.4 d,e C-7 211.5  41.4 C-10 41.6 
210.2 C-13 210.5  37.8 C-4 38.0 
179.6 C-17 179.8  30.1 C-2 30.5 
174.7 C-9 175.0  24.7 C-20 24.9 
164.8 C-19 165.0  15.1 CH3C-10 15.4 
160.3 C-15 160.5  14.2 CH3C-12 14.5 
120.3 C-16 120.5  12.9 CH3C-14 13.2 
118.4 C-18 118.7  11.9 CH3C-4 or CH3C-6 12.1 
77.3 C-5 or C-11 77.5  11.5 CH3C-6 or CH3C-4 11.8 
77.1 C-11 or C-5 77.4  11.3 CH3C-20 11.5 
77.0 d,f C-3 76.6  9.9 CH3C-16 10.2 
51.1 C-14 51.4  9.5 CH3C-18 9.8 
48.1 C-12 48.3  8.8 C-1 9.0 
46.2 C-8 46.4  7.3 CH3C-8 7.6 
44.7 C-6 44.8     
a Ref 4. b Assignments made via HSQC and HMBC. cChemical shifts for synthetic material 
are consistently 0.2-0.3 ppm higher than those reported for the natural product presumably 
due to a different reference standard; we used C CDCl3=77.23. d With the exception of the 
signals due to the -pyrone moiety, the chemical shifts reported for baconipyrone A (6) are 
within 0.1 ppm for those for baconipyrone B (7). e This value is much too high and must be 
an error (211.2 in baconipyrone B (7)). f This signal (76.1 in baconipyrone B (7)) would be 
obscured by solvent; the value from this study was obtained from a DEPT experiment. 
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Scheme 2.31 
 Several control experiments were performed to determine the origin of baconipyrone 
A (6) and its relationship to baconipyrone C (8) (Scheme 2.31). Exposure of baconipyrone C 
(8) to neutral alumina oxide (conditions that had induced retro-Claisen rearrangement in 
siphonarin B (4), Scheme 2.29), returned baconipyrone C (8) with no sign of epimerization 
(cf. 235, Scheme 2.27) and no baconipyrone A (6). Repeating with basic aluminum oxide 
gave a 3:1 ratio of baconipyrone C (8) to C-14 epimer 235,lxxviii again with no detectable 
baconipyone A (6). These control experiments suggest that the sequence of events leading to 
baconipyrone A (6) from the acyclic precursor or either of the contiguous carbon skeleton 
structures (4 and possibly 10) does not proceed through baconipyrone C (8). Subjection of 
baconipyrone A (6) to neutral alumina oxide in refluxing ethanol returned starting material, 
                                                 
lxxviii Epimerization under these conditions and not during the transformation of 234 to 6 and 8 suggests that the 
C-11-OH may be facilitating HC-14 epimerization, perhaps through hydrogen bonding.  
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indicating that the reaction leading to 6 is not reversible under these conditions. No attempt 
was made to use basic aluminum oxide due to the high likelihood of inducing HC-14 
epimerization, as demonstrated by baconipyrone C (8) producing 235 under these conditions.  
2.8.5.1 Conclusion of the investigations into alternative conditions 
Exposure of putative common precursor 14/15 to aluminum oxide in refluxing 
ethanol for 1 hour produced ester 237, a compound never isolated from siphonariid extracts 
(Scheme 2.28).  Ester 237 was not observed when siphonarin B (4) was exposed to the same 
conditions, but these conditions produced baconipyones A (6) and C (8) in addition to 
recovered starting material (siphonarin B (4)) (Scheme 2.29). This implies that 14/15 is not 
present in any appreciable amount when retro-Claisen rearrangement occurred in the 
isolation experiments on siphonariid mollusks. Either isomerization to siphonarin B (4) 
preceded retro-Claisen rearrangement or 14/15 is not a biosynthetic product. 
The investigation of alternative conditions led to the total synthesis of baconipyrones 
A (6) and C (8) in excellent combined yield without competing C-14 epimerization (Scheme 
2.30). This was the first total synthesis of baconipyrone A (6). Interestingly, under the 
conditions examined, the processes leading to baconipyones A (6) and C (8) are irreversible 
implying that baconipyrone C (8) is not a precursor to baconipyrone A (6).     
2.9 Conclusions 
In summary, the siphonariid polypropionates: siphonarin B (4), baconipyrone A (6), 
and baconipyrone C (8) were synthesized from their putative common precursor 14/15 
(existing mainly as hemiacetals 231 - 234). This work constitutes the first enantioselective 
synthesis of siphonarin B (4), baconipyrone A (6), and the putative common precursor 14/15. 
The synthesis of baconipyrones A (6) and C (8) were achieved "biomimetically" via the 
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proposed retro-Claisen rearrangement (8) and an unprecedented retro-Claisen 
rearrangement/aldol cascade (6). This work is the first total synthesis of baconipyrone C (8) 
via a route other than the "classical" route based on esterification. 
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Figure 2.24 Synthetic summary 
The synthesis of 14/15 proceeded in a longest linear sequence of 18 steps in 3.1% 
overall yield (20 total steps) by convergent aldol coupling of simple achiral, meso, or racemic 
precursors. Enantioselective organocatalyzed direct aldol reactions proceeding with dynamic 
kinetic resolution generated five of the seven stereocenters in the putative acyclic precursor 
(C-4, 5, 6, 12, 14; dr >20:1). The remaining two stereocenters result from carbonyl reduction 
(C-11; dr >20:1) and an unusual enol ether oxymercuration/demercuration (C-10; dr 3.5:1).  
Evidence was provided showing that both baconipyrones A (6) and C (8) can be 
derived from siphonarin B (4) and, as such, the baconipyrones are likely artifacts of isolation. 
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Under the conditions examined, baconipyrone A (6) could not be generated from 
baconipyrone C (8) and vice-versa indicating that the processes at work are irreversible and 
that baconipyrone C (8) is not a precursor of baconipyrone A (6). Despite all the experiments 
performed and paying keen attention to the products of each reaction, caloundrin B (10) was 
never detected.  
Interestingly, experiments have shown that the common precursor 14/15 (existing as 
hemiacetals 231 - 234) under the same conditions that produced the baconipyrones A (6) and 
C (8) from siphonarin B (4) also produced ester 237 from retro-Claisen rearrangement of an 
alternative hemiacetal (C-11-OH addition onto C-7 carbonyl). This sequence of events 
occurred with equal facility to the events that produced the known compounds, baconipyrone 
A (6) and C (8). Ester 237 has never been observed in any isolation experiment. Based on 
this, it seems unlikely that hemiacetals 231 - 234 are the precursors of baconipyrone A (6) 
and C (8) unless equilibration to siphonarin B (4) occurred before retro-Claisen 
rearrangement. Considering that siphonarin B (4) has always been co-isolated with every 
compound in this series, siphonarin B (4) is more likely a biosynthetic product as opposed to 
14/15. This is further supported by the remarkable stability that 14/15 exhibits. 
Caloundrin B (10) is the 'missing link' in this work: it was never observed despite 
careful analysis. This fact challenges the hypothesis that caloundrin B (10) is an artifact of 
isolation because 10 should be present at a level that represents its relative stability. It is 
possible that caloundrin B (10) is a biosynthetic product, which isomerizes to more stable 
ring-chain tautomers (4) and/or rearranges to baconipyrones A (6) and C (8). 
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2.10 Suggestions for future research 
 The missing piece of this puzzle is caloundrin B (10). With this compound in hand, it 
would have been possible to more clearly determine which of these compounds are artifacts 
of isolation and what might be the real biosynthetic product.  
Considering the failure to form the pentacyclic ring system in the elaborated structure 
(cf. 223  224, Section 2.82), it would be worthwhile to test whether a more truncated 
system would form the required ring system, but still have functionality to use a handle to 
install more of the structure (Figure 2.25).  
In a preliminary experiment, pentacyclic compound 245 was formed from 172 and 
isobutyraldehyde (244) (unoptimized and uncharacterized, but the NMR spectra of this 
compound were consistent to 167, Section 2.4) through the previously established synthetic 
sequence described in Section 2.4. Based on this result, it seems likely that the increased 
steric hindrance (or the presence of a branched chain) present in 223 (or 224), versus 245, 
may not be the culprit in the observed failure. 
It is suggested to continue this line of research and test whether 172 and ent-31 will 
form the corresponding pentacyclic compound 246 (Figure 2.25). A positive result from this 
reaction would provide a substrate that could be synthetically viable. A negative result could 
implicate the benzyl protecting group as the source of the problem. If the benzyl group is the 
source of the problem, a change of this protecting group might solve the observed failure 
(i.e., appropriate selection of P in 247).  
Either way, there are still several avenues of investigation left to explore that could 
lead to a first total synthesis of caloundrin B (10), an unusual and intriguing compound. 
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Figure 2.25 Proposed continuation of this research 
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EXPERIMENTAL 
3.1 General methods 
Anhydrous solvents were distilled under argon atmosphere as follows: 
Tetrahydrofuran (THF) from benzophenone sodium ketyl; diethyl ether from benzophenone 
sodium ketyl; CH2Cl2 from CaH2; MeOH from Mg(OMe)2. All experiments involving air- 
and/or moisture sensitive compounds were conducted in an oven dried round-bottom flask 
capped with a rubber septum, and attached via a needle and connecting tubing to an argon 
manifold equipped with mercury bubbler (ca. 5 mm positive pressure of argon). Low 
temperature baths were: ice/water (0 °C) and CO2(s)/acetone (-78 °C). Unless otherwise 
noted, reaction temperatures refer to that of the bath.  
Preparative TLC (PTLC) was carried out on glass plates (20×20 cm) pre-coated (0.25 
mm) with silica gel 60 F254. Materials were detected by visualization under an ultraviolet 
lamp (254 nm) and/or by treating a 1 cm vertical strip removed from the plate with a solution 
of phosphomolybdic acid (5%) containing a trace of ceric sulfate in aq sulfuric acid (5% v/v), 
or with basic KMnO4 [KMnO4 (1.5 g), K2CO3 (10 g), 10% aq. NaOH (1.25 mL), in H2O 
(200 ml)], followed by charring on a hot plate. TLC was carried out on glass plates (1×3 cm) 
pre-coated (0.25 mm) with silica gel 60 F254 and was visualized in the same manner as that 
described for PTLC. 
Concentration refers to removal of volatiles with a rotary evaporator under vacuum 
supplied by a water aspirator. Evacuation at ca. 0.5 torr with a vacuum pump generally 
followed rotary evaporation.  
Flash column chromatography (FCC) was performed according to Still et al.143 with 
Merck Silica Gel 60 (40-63 μm). All mixed solvent eluents are reported as v/v solutions. 
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Unless otherwise noted, all reported compounds were homogeneous by thin layer 
chromatography (TLC) and by 1H NMR spectroscopy.  
3.2 Spectral data 
High resolution mass spectra (HRMS) and low resolution mass spectra (LRMS) were 
obtained on a VG 70E double focusing high resolution spectrometer; only partial data are 
reported. EI ionization was accomplished at 70 eV and CI at 50 eV with ammonia as the 
reagent gas; only partial data are reported. Alternatively, HRMS was obtained on an LC-
MS/MS time-of-flight high resolution spectrometer with electrospray ionization (ESI) from 
acetonitrile solution. 
IR spectra were recorded on a Fourier transform interferometer using a diffuse 
reflectance cell (DRIFT) or by Thin Film; only diagnostic and/or intense peaks are reported. 
Unless otherwise noted all experiments used DRIFT.  
  Unless otherwise noted, NMR spectra were measured in CDCl3 solution at 500 MHz 
for 1H and 125 MHz for 13C. Signals due to the solvent (13C NMR spectroscopy) or residual 
protonated solvent (1H NMR spectroscopy) served as the internal standard: CDCl3 (7.26 δH, 
77.23 δC); C6D6 (7.16 δH, 128.39 δC). The 1H NMR chemical shifts and coupling constants 
were determined assuming first-order behavior. Multiplicity is indicated by one or more of 
the following: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), br (broad), ap 
(apparent); the list of couplings constants (J) corresponds to the order of the multiplicity 
assignment. Couplings constants (J) are reported to the nearest 0.5 Hz (digital resolution ca. 
0.2 Hz/pt) or the nearest 0.1 Hz (digital resolution ca. 0.03 Hz/pt). The 1H NMR assignments 
were made based on chemical shift and multiplicity and were confirmed, where necessary, by 
homonuclear decoupling and/or two-dimensional correlation experiments (gCOSY, gHSQC, 
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gHMBC).144 The 13C NMR assignments were made on the basis of chemical shift and 
multiplicity (as determined by 13C-DEPT or gHSQC) and were confirmed, where necessary, 
by two-dimensional 1H/13C correlation experiments (gHSQC and/or gHMBC).144 The 
multiplicity of 13C NMR signals refers to the number of attached H's (i.e., s = C, d = CH, t = 
CH2, q = CH3).  
Specific rotations ([α]D) are the average of 5 determinations at ambient temperature 
using a 1 mL, 10 dm cell; the units are 10-1 deg cm2 g-1, the concentrations (c) are reported in 
g/100 mL, and the values are rounded to reflect the accuracy of the measured concentrations 
(the major source of error). 
3.3 Materials  
 
The following compounds and reagents were prepared as described previously: 
124,lxxix, 66 125,lxxx, 66 127,85 169,66 170,69 184,98 190,lxxxi, 70 191,70 192 and 193,lxxxii, 70 194 and 
195,70 196,lxxxiii, 70, IBX,145 W-2 Raney nickel,146 and FeCl3-impregnated silica gel.90 Et3N 
and iPr2NEt (DIPEA) were distilled from KOH under argon and were stored over KOH. 
TiCl4 and iPr2NH were distilled under argon atmosphere from CaH2. All other reagents were 
commercially available and unless otherwise noted, were used as received. 
3.4 Computational procedures 
Computation procedures were carried out by Prof. Goodman (see Section 2.4). 
Conformation searches were carried out using the MMFF force field147 as implemented in 
Batchmin148 until all low energy structures had been found at least four times. The lowest 
energy structures were then reminimized at the B3LYP/6-31G** level149-152 using Jaguar.148 
                                                 
lxxix Routinely performed at ca. 100 g scale. 
lxxx Rountinely performed at 100-200 g scale. 
lxxxi Reaction scaled to ca. 8 g of 196. 
lxxxii Reaction scaled to ca. 20 g. 
lxxxiii Known procedure applied to 195. See below for a revised procedure to oxidize 194 to 196. 
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In cases where the lowest energy MMFF conformations had similar energies, all the low 
energy structures were reminimized with B3LYP/6-31G**. Except for 141 and 149, in all 
cases the lowest energy MMFF structure corresponded to the lowest energy B3LYP/6-31G** 
structure; for 141 and 149, the preferred conformations were chairs (with the C-8 methyl 
group equatorial) according to MMFF, but were twist boats according to B3LYP/6-31G**.  
3.5 Experimental Procedures and Spectral Data for Compounds 
Spectral data and experimental procedures are presented in order by compound 
number with the exception of the natural products: these are presented last by compound 
number (i.e., 4, 6, 8). 
 
2-((2S,3S,4S,5R,6R)-3,7-Dihydroxy-5-((4-methoxybenzyl)oxy)-4,6-dimethylheptan-2-yl)-
6-ethyl-3,5-dimethyl-4H-pyran-4-one (ent-39) 
 
OH
ent-39
O
O
PMB
O
HO
6' 4'
3'
2'
2 3
5
6
5'7'
 
 
This procedure was not optimized. A solution of Hg(OAc)2 (12 mg, 0.038 mmol) in water 
(1.5 mL) was added to a stirred solution of 215 (15 mg, 0.035 mmol) in THF (1.5 mL) at rt. 
The resulting yellow suspension was stirred at this temperature for 2 h and then a solution of 
Na2CO3 (20 mg, 0.19 mmol) in water (2 mL) was added in one portion. After 10 min, a 
solution of NaBH4 (32 mg, 0.84 mmol) in water (2 mL) was added. After 1 min, the reaction 
was diluted with a 1:1 mixture of brine and water and extracted with CH2Cl2. The combined 
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organic layers were dried over Na2SO4, concentrated, and the residue taken up in ethanol (2 
mL), and then NaBH4 (12 mg, 0.32 mmol) was added to the stirred solution at rt. After ca. 48 
h, the mixture was diluted with water and extracted with CH2Cl2. The combined organic 
layers were dried over Na2SO4, concentrated, and fractionated by FCC (100% ethyl acetate, 
two elutions) to give 216 (3 mg; ca. 90% pure, ca.17%) and the known28-30 titled compound 
(8 mg, 51%)([α]D -15 (c 0.45, CHCl3)).  
 
IR νmax: 3430, 1652, 1609, 1588 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.23 (2H, ap d, J = 8.5 Hz, ArH), 6.84 (2H, ap d, J = 8.5 Hz, 
ArH), 4.63 (1H, d, J = 10.5 Hz, H2CAr), 4.59 (1H, d, J = 10.5 Hz, H2CAr), 4.21 (1H, br d, J 
= 9.5 Hz, HC-3'), 3.83-3.74 (1H, m, HC-7'), 3.78 (3H, s, H3CO), 3.71 (1H, dd, J = 5, 10.5 
Hz, HC-7'), 3.55 (1H, dd, J = 3.5, 8 Hz, HC-5'), 3.14-3.06 (2H, m, HO, HC-1), 2.61 (1H, dq, 
J = 15, 7.5 Hz, H2C-C-6), 2.58 (1H, dq, J = 15, 7.5 Hz, H2C-C-6), 2.09-1.94 (2H, m, HC-4', 
HC-6'), 1.99 (3H, s, H3CC-3), 1.92 (3H, s, H3CC-5), 1.18 (3H, t, J = 7.5 Hz, H3CCH2), 1.15 
(3H, d, J = 7 Hz, H3CC-4'), 1.09 (3H, d, J = 7 Hz, H3C-1'), 1.04 (3H, d, J = 7 Hz, H3CC-6'). 
13C NMR (125 MHz, CDCl3) δ: 180.0 (s, C-4), 164.8 (s, C-2), 164.2 (s, C-6), 159.8 (s, Ar), 
129.9 (s, Ar), 129.8 (d ×2, Ar), 119.6 (s, C-3), 118.1 (s, C-5), 114.2 (d ×2, Ar), 88.4 (d, C-5'), 
76.4 (t, CH2Ar), 72.1 (d, C-3'), 65.6 (t, C-7'), 55.5 (q, CH3O), 39.0 (d, C-2'), 38.0 (d, C-6'), 
35.5 (d, C-4'), 25.0 (t, CH2C-6), 15.3 (q, CH3C-6'), 14.7 (q, C-1'), 11.5 (q, CH3CH2), 11.2 (q, 
CH3C-4'), 9.9 (q, CH3C-3 or CH3C-5), 9.7 (q, CH3C-3 or CH3C-5). 
LRMS: m/z (relative intensity) 446 ([M]+, 1), 310 (7), 209 (13), 180 (36), 121 (100) (EI). 
HRMS: m/z calcd for C26H38O6 446.2668, found 446.2672 (EI). 
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(4S,6S)-5-Hydroxy-4,6-dimethylnonane-3,7-dione (41) 
 
OH
41
O O
 
 
 
Raney nickel (W2; 1 mL settled volume) was washed with THF (x3) and transferred to a 
solution of 122 (50 mg, 0.16 mmol) in THF (8 mL) and the resulting suspension was heated 
under reflux with vigorous stirring. After 5 h, the reaction mixture was allowed to cool to rt 
and aqueous HCl (1 M; 4 mL) was added. Concentrated HCl (12 M) was added dropwise (ca. 
1 drop/min; CAUTION: H2 evolution) until effervescence ceased (ca. 1 hr; pH<1). After 40 
h, the mixture was diluted with ethyl acetate and washed sequentially with sat. NaHCO3 and 
brine. The aqueous layers were back extracted with ethyl acetate. The combined organic 
layers were dried over Na2SO4, concentrated, and fractionated by PTLC (20% acetone in 
hexanes; 2 elutions) to give the known28-30 titled compound (26 mg, 79%) ([α]D -20 (c 1.1, 
CHCl3)). 
 
IR νmax: 3498, 1709 cm-1. 
1H NMR (500 MHz, CDCl3): δ 4.02 (1H, ddd, J = 3.5, 4.5, 8 Hz), 3.22 (1H, d, J = 4.5 Hz), 
2.73-2.62 (2H, m), 2.61-2.42 (4H, m), 1.15 (3H, d, J = 7 Hz), 1.05 (3H, t, J = 7 Hz), 1.04 
(3H, d, J = 7 Hz), 104 (3H, t, J = 7 Hz). 
13C NMR (125 MHz, CDCl3): δ 216.0 (s), 215.9 (s), 73.2 (d), 47.7 (d), 47.6 (d), 36.6 (t), 35.1 
(t), 14.2 (q), 10.3 (q), 7.9 (q), 7.6 (q). 
LRMS: m/z (relative intensity) 218 ([M+18]+, 100), 210 (77), 183 (27), 101 (6) (CI, NH3). 
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HRMS: m/z calcd for C11H20O3 200.1412 (218.1756 for M+NH4), found 218.1754 (CI, 
NH3). 
 
1,4-Dioxa-8-thiaspiro[4.5]decane-6-carboxaldehyde (116)lxxxiv  
 
S
OO O
116  
IBX (71.9 g, 0.257 mol, 1.2 equiv), was added to a stirred solution of 12466 (40.6 g, 0.214 
mol) in acetonitrile (800 mL). The heterogeneous mixture was heated to 80 °C (oil bath 
temperature) and stirred at this temperature for 2 h. The reaction mixture was cooled in an ice 
bath for 1 h and then passed through a sintered glass funnel. The solid was washed with ethyl 
acetate (2 x 150 mL) and the combined filtrate and washings were concentrated to give an 
orange oil that was passed through a column of basic alumina (120 g; column diameter, 5.5 
cm) eluting with ethyl acetate in hexane (1:1, 1200 mL). Concentration gave the titled 
compound as a pale yellow oil (33.3 g, 83%) that was homogeneous by 1H NMR. The solids 
(62.5 g; mainly 2-iodosobenzoic acid by 1H NMR in DMSO-d6) were reoxidized to IBX 
(58.3 g, 81% yield based on initial amount of IBX used) with oxone (1 equiv) according to 
Santagostino’s procedure.lxxxv, 145 
 
IR max: 2840, 2737, 1721cm-1.  
                                                 
lxxxiv Athanasios Karagiannis, unpublished results: under my direction. 
lxxxv There is an error in Santagostino’s procedure to prepare IBX. They state that they used 1.3 equivalents of 
oxone; however, by calculation they used 1.45 equivalents. In my experience, using 1.3 equivalents of 
oxone did not cleanly produce IBX. 
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1H NMR (300 MHz, CDCl3):  9.85 (1H, s), 4.07-3.94 (4H, m), 2.96 (1H, dd, J = 9.5, 13.5 
Hz), 2.86 (1H, br d, J = 13.5 Hz), 2.81-2.72 (2H, m), 2.64 (1H, m), 2.08 (1H, ddd, J = 3, 6, 
13.5 Hz), 1.89 (1H, ddd, J = 3.5, 10, 13.5 Hz).  
13C NMR (75 MHz, CDCl3):   201.3 (d), 107.8 (s), 64.9 (t), 64.7 (t), 56.6 (d), 36.2 (t), 26.7 
(t), 26.4 (t). 
HRMS: m/z calcd for C8H12O3S 188.0507, found 188.0512 (EI). Anal. Calcd for C8H12O3S: 
C,51.04; H, 6.43. Found: C, 51.20; H, 6.58. 
 
Tetrahydro-4H-thiopyran-4-one (117)  
 
S
O
117  
 
Keto ester 126 (100 g, 0.57 mol) was added via a dropping funnel over 3–5 min to a well-
stirred solution of 10% aq H2SO4 (1 L) heated under reflux. After ca. 1 h, the reaction was 
complete by TLC analysis (30% EtOAc in hexane) and the mixture was cooled to 40 °C with 
the aid of an ice bath. The aqueous layer was decanted from a yellow oil that separated and 
settled. The yellow oil was washed with H2O (500 mL) at 40 °C and the combined aqueous 
layers were extracted with CH2Cl2 (3 × 200 mL) with each extract passed through a column 
of basic Al2O3 (Brockmann I, ca. 150 mesh; 200 g). The column was finally eluted with 
CH2Cl2 (600 mL) and the combined eluates were concentrated and then reconcentrated from 
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hexane to give the titled compound as a white, freely flowing, crystalline solid (52 g, 78%); 
mp 59–60 °C. 
 
IR max: 1704 cm–1. 
1H NMR (500 MHz, CDCl3):  2.99–2.94 (m, 4H), 2.72–2.68 (m, 4H). 
13C NMR (125 MHz, CDCl3):   210.0, 44.7, 30.6. 
HRMS: m/z calcd for C5H8OS: 116.0296; found: 116.0293 (EI). 
 
(3S)-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(hydroxy)-methyl]tetrahydro-4H-
thiopyran-4-one (122)  
 
S
OO
S
OOH
122  
 
A solution of ketone 117 (1.25 g, 10.8 mmol), aldehyde 117 (1.01 g, 5.37 mmol), catalyst 
127 (145 mg, 1.04 mmol), water (0.10 mL, 0.10 g, 5.6 mmol), and DMSO (0.6 mL) was 
stirred at room temperature. After 8 days, the brownish semisolid reaction mixture was taken 
up in ethyl acetate and washed with water. The organic layer was dried over Na2SO4, 
concentrated, and fractionated by FCC (5-10% ethyl acetate in CH2Cl2) to give 122 as a 
white solid (1.22 g, 75%): []D -48, c 1.0, CHCl3 (lit.70 for 122 of >98% ee: []D -47, c 1.0, 
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CHCl3). The catalyst could be recovered in >80% yield by concentrating the water layers and 
precipitating the residue from hot MeOH on addition of benzene.lxxxvi 
 
IR max: 3488, 3409, 1711 cm-1.  
1H NMR (300 MHz, CDCl3):   4.50 (1H, dd, J = 4.5, 6.5 Hz, HC-1), 4.05-3.92 (4H, m), 
3.08-2.58 (12H, m), 2.12 (1H, ddd, J = 4.5, 4.5, 9 Hz), 2.03 (1H, ddd, J = 3.5, 6.5, 13.5 Hz), 
1.74 (1H, ddd, J = 4, 9.5, 13.5 Hz).  
13C NMR (75 MHz, CDCl3):   211.5 (s), 109.3 (s), 69.3 (d), 64.4 (t), 64.3 (t), 55.5 (d), 47.0 
(d), 44.4 (t), 35.5 (t), 34.3 (t), 31.4 (t), 27.4 (t), 26.5 (t).  
HRMS: m/z calcd for C13H20O4S2 304.0803, found 304.0801. Anal. Calcd for C13H20O4S2: C, 
51.29; H, 6.62. Found: C, 51.59; H, 6.55. 
 
Methyl Tetrahydro-4-oxo-2H-thiopyran-3-carboxylate (126)  
 
 
S
126
OCH3
OO
 
 
Anhydrous MeOH (41 mL, 32 g, 1.0 mol) was added via a dropping funnel over 30 min to a 
stirred suspension of Na metal (21.7 g, 0.95 mol; Na metal was cut into pieces weighing ca. 
50–100 mg (3–5 mm per side). The rate of Na consumption depends on the size of pieces; 
with larger pieces, more time is required to reach 90% conversion.) in THF (300 mL) at 0 °C 
                                                 
lxxxvi Prepared on ca. 40 gram scale by the same procedure in 70% yield (no chromatography). Athanasios 
Karagiannis, unpublished results: under my direction. 
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(ice bath) under argon (Caution! H2 evolution). The ice bath was removed and stirring 
continued at rt for 15–20 h, at which point most of the Na was consumed (ca. 90%; more 
time may be required if the Na pieces are larger than specified) leaving a grayish-white 
mixture of NaOMe in THF. The mixture was cooled in an ice bath and the diester 115 (150 g, 
0.728 mol) was added via a dropping funnel over 1 h (the dropping funnel was rinsed with 15 
mL of THF). The ice bath was removed and the mixture, initially a thick slurry, became a 
homogeneous amber solution (a few specks of Na metal may be present). After stirring for 3 
h at rt, the reaction was complete by TLC analysis (30% EtOAc in hexane). The mixture was 
transferred to a beaker equipped with a mechanical stirrer and cooled in an ice bath. Aq 
H2SO4 (0.475 mol; prepared by adding 47.5 g of 98% H2SO4 to ca. 45 g of ice) was added 
slowly with stirring maintaining the temperature below 20 °C; the final pH was 6–7. To the 
resulting creamy yellow mixture, CH2Cl2 (400 mL) was added after which the Na2SO4 
hydrate precipitated as granules that readily settle, leaving a pale yellow solution; 
occasionally, a small amount of H2O (2–10 mL) must be added to achieve the desired 
consistency. Na2SO4 (20 g) and solid NaHCO3 (21 g) were added with stirring and after 30 
min, the supernatant was filtered through cotton wool and the residue was washed with 
CH2Cl2 (200 mL). The combined filtrate and washings were concentrated to give the titled 
compound as a pale yellow oil (stench!); yield: 124.5 g (98%); >95% purity by NMR. The 
oil solidified (keto form) on standing for several days at 5 °C. 
 
IR max:  3100 (br), 1745, 1720, 1658, 1617 cm–1. 
1H NMR (500 MHz, CDCl3):   (for the enol tautomer) = 12.5 (s, 1H), 3.79 (s, 3 H), 3.36 (s, 
2 H), 2.80 (app t, J = 5.5 Hz, 2 H), 2.60 (app t, J = 5.5 Hz, 2 H);  (for the keto tautomer) = 
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3.80 (s, 3 H), 3.70 (dd, J = 4, 8.5 Hz, 1 H), 3.31 (dd, J = 8.5, 14 Hz, 1 H), 3.06 (dd, J = 4, 14 
Hz, 1 H), 2.99–2.94 (m, 2 H), 2.91–2.85 (m, 1 H), 2.77–2.72 (m, 1 H). 
13C NMR (125 MHz, CDCl3):   (for the enol tautomer) = 172.0, 169.3, 97.4, 51.9, 30.9, 
24.6, 23.4;  (for the keto tautomer) = 203.7, 172.6, 58.7, 52.7, 43.7, 32.6, 30.5.  
HRMS: m/z calcd for C7H10O3S: 174.0351; found: 174.0348 (EI).  
 
(2R,3S,5S,6S)-2-Ethyl-2,3,5,6-tetrahydro-2-hydroxy-3,5-dimethyl-6-[(1S)-1-methyl-2-
oxobutyl]-4H-pyran-4-one (138) 
 
 
O
138
O
O
H OH
6 2
35
1'1"3"
 
 
Pyridine (1.2 mL, 1.2 g, 15 mmol), HFpyridine (0.4 mL), and water (0.050 mL, 2.8 mmol) 
were added to a stirred solution of 175a (50 mg, 0.15 mmol) in THF (2 mL). After 2 days, 
the mixture was diluted with ethyl acetate, washed with 2% aqueous citric acid (×3), 
NaHCO3 and brine, dried over Na2SO4, concentrated, and fractionated by FCC (40% diethyl 
ether in hexane) to give a 14:1 mixture of 150 and 142, respectively (13 mg, 33%), and the 
titled compound (19 mg, 49%): [α]D +24 (c 1.1, C6H6). 
 
IR max:  3475, 1711 cm-1. 
1H NMR (600 MHz, C6D6):   4.26 (1H, dd, J = 2.6, 10.7 Hz, HC-6), 2.32 (variable) (1H, d, 
J = 1.6 Hz, HO), 2.19 (1H, dq, J = 18, 7.1 Hz, HC-3''), 2.16 (1H, dq, J = 2.6, 7.0 Hz, HC-1''), 
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2.10 (1H, dqd, J = 1.1, 1.6, 6.7 Hz, HC-3), 2.06 (1H, dq, J = 18, 7.1 Hz, HC-3''), 1.98 (1H, 
ddq, J = 1.1, 10.7, 6.6 Hz, HC-5), 1.40 (1H, dq, J = 13.9, 7.4 Hz, HC-1'), 1.28 (3H, dq, J = 
13.9, 7.4 Hz, HC-1'), 1.07 (3H, d, J = 6.7 Hz, H3CC-3), 1.03 (3H, t, J =7.1 Hz, H3C-4''), 1.02 
(3H, d, J = 7.0 Hz, H3CC-1''), 0.70 (1H, t, J = 7.4 Hz, H3C-2'). 
13C NMR (125 MHz, C6D6):   209.5 (s, C-2''), 206.9 (s, C-4), 102.8 (s, C-2), 75.3 (d, C-6), 
50.9 (d, HC-3), 48.2 (d, HC-7), 46.6 (d, HC-5), 33.4 (t, C-3''), 33.1 (t, C-1'), 9.7 (q, CH3C-5), 
9.2 (q, CH3C-3), 8.5 (q, C-4'' or CH3C-1''), 8.4 (q, C-4'' or CH3C-1''), 7.8 (q, C-2'). 
LRMS: m/z (relative intensity) 274 ([M+18]+, 49), 257 ([M+1]+, 7), 239 (34), 200 (51), 183 
(100), 160 (26), 143 (25), 74 (22) (CI, NH3). 
HRMS: m/z calcd for C14H24O4 256.1675 (274.2018 for M+NH4), found 274.2009 (CI, 
NH3). 
 
(1R,3R,5R,7R,8S,9S,10S)-3,5-Diethyl-8,9,10-trimethyl-2,4,6-trioxatricyclo [3.3.1.13,7] 
decan-1-ol (142) 
 
O
O
O
HO
142
10
3 5
91
7
8
 
 
From 167: A suspension of Raney nickel (W2; 2 mL settled volume) in EtOH (4 mL) was 
added to 167 (17 mg, 0.054 mmol) and the mixture was heated under reflux with vigorous 
stirring. After 45 min, the mixture was decanted and the solid suspended in ethanol and 
heated under reflux with rapid stirring for several min. This washing procedure was repeated 
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once with EtOH, once with CH2Cl2/acetone (1:1), and once with ethyl acetate. The combined 
organic layers were filter through Celite® and concentrated. The residue was fractionated by 
PTLC (33% diethyl ether in hexane) to give the titled compound (8 mg, 60%).  
 
From 175a: Pyridine (1.2 mL), HFpyridine (0.4 mL), and water (2.8 mmol, 50 mL) were 
sequentially added to a stirred solution of 175a (50 mg, 0.15 mmol) in THF (2 mL) at 
ambient temperature. After 2 h, the mixture was diluted with ethyl acetate, washed 
sequentially with 2% aqueous citric acid (×3), NaHCO3 and brine, dried over Na2SO4, 
concentrated, and fractionated by FCC (40% diethyl ether in hexane) to give 138 (3 mg, 8%) 
and the titled compound (ca. 95% pure by 1H NMR; 31 mg, 80%): ([α]D +11 (c 1.0, C6H6). 
 
IR max:  3407 cm-1.  
1H NMR (500 MHz, C6D6): δ 3.68 (1H, br d, J = 2.5 Hz, HC-7), 2.23 (1H, br s, HO), 2.07 
(1H, dq, J = 3.5, 7 Hz, HC-10), 1.91 (1H, br q, J = 7.5 Hz, HC-8), 1.85-1.77 (2H, m, HC-9, 
HCC-5), 1.70 (1H, dq, J = 15, 7.5 Hz, HCC-3), 1.57 (1H, dq, J = 7.5, 15 Hz, HCC-5), 1.54 
(1H, dq, J = 7.5, 15 Hz, HCC-3), 1.12 (3H, d, J = 7.5 Hz, H3CC-8), 1.05 (3H, t, J = 7.5 Hz, 
H3CCC-5), 1.02 (3H, t, J = 7.5 Hz, H3CCC-3), 0.97 (3H, d, J = 7.5 Hz, H3CC-9), 0.63 (3H, 
d, J = 7 Hz, H3CC-10).  
13C NMR (125 MHz, C6D6): δ 103.2 (s, C-3), 102.3 (s, C-5), 98.9 (s, C-1), 79.3 (d, C-7), 
45.4 (d, C-9), 37.9 (d, C-10), 35.9 (d, C-8), 30.4 (t, CH2C-5), 30.2 (t, CH2C-3), 14.8 (q, 
CH3C-8), 13.0 (q, CH3C-10), 11.2 (q, CH3C-9), 7.1 (q, CH3CC-5), 6.9 (q, CH3CC-3).  
LRMS: m/z (relative intensity) 256 ([M]+, 4), 182 (11), 153 (13), 125 (18), 113 (38), 96 (14), 
86 (15), 69 (12), 57 (100) (EI).  
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HRMS: m/z calcd for C14H24O4 256.1675, found 256.1667 (EI). 
 
(1R,3R,5R,7R,8S,9S,10R)-rel-3,5-Diethyl-8,9,10-trimethyl-2,4,6 trioxatricyclo[3.3.1.13,7] 
decan-1-ol (143) 
 
O
O
O
HO
143
10
3 5
91
7
8
 
 
A suspension of W2 Raney nickel (5 mL settled volume) in ethanol (10 mL) was added to 
(±)-168 (98 mg, 0.31 mmol) and the mixture was heated under reflux with vigorous stirring. 
After 45 min, the mixture was decanted and the solid suspended in ethanol and heated under 
reflux with rapid stirring for several min. This washing procedure was repeated twice with 
EtOH and once with ethyl acetate. The combined organic layers were filtered through 
Celite® and concentrated to give the titled compound (67 mg, 85%) that was homogeneous 
by 1H NMR. A crystal suitable for X-ray crystallography was obtained from a petroleum 
ether solution. 
 
IR νmax: 3383 cm-1. 
1H NMR (500 MHz, CDCl3): δ 3.83 (1H, br s, HC-7), 2.90 (1H, br s, HO), 1.95 (1H, br q, J 
= 7 Hz, HC-8), 1.92 (1H, br q, J = 7.5 Hz, HC-9), 1.74-1.47 (5H, m, HC-10, H2C ×2), 1.19 
(3H, d, J = 7.5 Hz, H3CC-8), 1.11 (3H, d, J = 7 Hz, H3CC-10), 1.06 (3H, d, J = 7.5 Hz, 
H3CC-9), 0.96 (3H, t, J = 7.5 Hz, H3C), 0.89 (3H, t, J = 7.5 Hz, H3C).  
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13C NMR (125 MHz, CDCl3): δ 102.8 (s, C-3), 102.0 (s, C-5), 98.8 (s, C-1), 79.6 (d, C-7), 
44.7 (d, C-9), 43.3 (d, C-8), 38.1 (d, C-10), 29.85 (t, CH2), 29.79 (t, CH2), 14.5 (q, CH3C-8), 
13.9 (q, CH3C-10), 10.8 (q, CH3C-9), 6.4 (q, CH3CH2C-5), 6.1 (q, CH3CH2C-3).  
LRMS: m/z (relative intensity) 256 ([M]+, 1), 126 (10), 125 (11), 113 (28), 96 (10), 86 (13), 
69 (10), 57 (100) (EI). 
HRMS: m/z calcd for C14H24O4 256.1675, found 256.1672 (EI). 
 
(1R,3R,5R,7R,8S,9R,10S)-3,5-Diethyl-8,9,10-trimethyl-2,4,6-trioxatricyclo[3.3.1.13,7] 
decan-1-ol (150) 
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Pyridine (1.2 mL), HFpyridine (0.4 mL), and water (50 mL) were sequentially added to a 
stirred solution of 175a (20 mg, 0.061 mmol) in THF (2 mL) at ambient temperature. After 2 
h, the mixture was diluted with ethyl acetate, washed with 2% aqueous citric acid (×3), 
NaHCO3 and brine, dried over Na2SO4, and concentrated. The residue (crude 142) was taken 
up in chloroform (2 mL) and imidazole (75 mg, 1.1 mmol) was added. After 5 d, the mixture 
was diluted with ethyl acetate, washed sequentially with 1% aqueous citric acid (×3), 
NaHCO3 and brine, dried over Na2SO4, concentrated, and fractionated by PTLC (40% ethyl 
acetate in hexane) to give the titled compound (12 mg, 77%): [α]D +34(c 1.0,C6H6). 
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IR νmax: 3428 cm-1.  
1H NMR (500 MHz, C6D6): δ 3.62 (1H, br d, J = 2.5 Hz, HC-7), 2.06-1.98 (2H, m, HO, HC-
10), 1.92 (1H, br q, J = 6.5 Hz, HC-9), 1.79 (1H, dq, J = 14, 7.5 Hz, HCC-5), 1.77 (1H, br q, 
J = 6.5 Hz, HC-8), 1.69 (1H, dq, J = 14, 7.5 Hz, HCC-3), 1.59-1.47 (2H, m, HCC-3, HCC-5), 
1.06 (3H, d, J = 7.5 Hz, H3CC-8), 1.04 (3H, t, J = 8 Hz, H3CCC-3), 1.00 (3H, t, J = 7.5 Hz, 
H3CCC-5), 0.96 (3H, d, J = 6.5 Hz, H3CC-9), 0.65 (3H, d, J = 7 Hz, H3CC-10).  
13C NMR (125 MHz, C6D6): δ 103.1 (s, C-3), 102.5 (s, C-5), 97.9 (s, C-1), 78.6 (d, C-7), 
37.8 (d, C-10), 36.6 (d, C-9), 36.5 (d, C-8), 30.6 (t, CH2C-5), 30.2 (t, CH2C-3), 13.7 (q, 
CH3C-8), 12.8 (q, CH3C-10), 7.7 (q, CH3C-9), 6.80 (q, CH3CH2), 6.75 (q, CH3CH2).  
LRMS: m/z (relative intensity) 256 ([M]+, 4), 182 (17), 126 (22), 125 (25), 113 (65), 96 
(30), 86 (25), 69 (20), 57 (100) (EI).  
HRMS: m/z calcd for C14H24O4 256.1675, found 256.1683 (EI). 
 
(1R,3R,5R,7R,8S,9R,10R)-rel-3,5-Diethyl-8,9,10-trimethyl-2,4,6-trioxatricyclo[3.3.1.13,7] 
decan-1-ol (151) 
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A solution of 143 (20 mg, 0.31 mmol) and imidazole (15 mg, 0.22 mmol) in CDCl3 (0.4 mL) 
was heated to 40 °C (oil bath temperature). After 4 days (isomerization was complete by 1H 
NMR), the mixture was diluted with ethyl acetate, washed with 1% aqueous citric acid (×3), 
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NaHCO3, and brine, dried over Na2SO4, concentrated, and fractionated by PTLC (40% ethyl 
acetate in hexane) to give the knownlxxxvii,61 titled compound (17 mg, 85%). 
 
IR νmax: 3417 cm-1.  
1H NMR (500 MHz, CDCl3): δ 3.78 (1H, br s, HC-7), 2.56 (1H, br s, HO), 1.97 (1H, q, J = 
6.5 Hz, HC-9), 1.91 (1H, br q, J = 7 Hz, HC-8), 1.73-1.49 (5H, m, HC-10, H2C ×2), 1.15 
(3H, d, J = 7 Hz, H3CC-8), 1.10 (3H, d, J = 7 Hz, H3CC-10), 0.98 (3H, d, J = 6.5 Hz, H3CC-
9), 0.96 (3H, t, J = 7.5 Hz, H3C), 0.94 (3H, t, J = 7.5 Hz, H3C). 
13C NMR (125 MHz, CDCl3): δ 102.6 (s, C-3), 102.2 (s, C-5), 97.7 (s, C-1), 78.9 (d, C-7), 
43.3 (d, C-8), 37.7 (d, C-10), 36.0 (d, C-9), 30.1 (t, CH2), 30.0 (t, CH2), 13.8 (q, CH3C-10), 
13.5 (q, CH3C-8), 7.3 (q, CH3C-9), 6.3 (q, CH3CH2C-5), 6.1 (q, CH3CH2C-3). 
LRMS: m/z (relative intensity) 256 ([M]+, 2), 182 (8), 153 (6), 126 (13), 113 (35), 86 (14), 
57 (100) (EI). 
HRMS: m/z calcd for C14H24O4 256.1675, found 256.1675 (EI). 
 
 
 
 
 
 
 
                                                 
lxxxvii Only a few specific 1H NMR resonances are reported for 151 (data obtained at 300 MHz); our data 
(obtained at 500 MHz) is within 0.02-0.04 ppm. Our 13C NMR chemical shifts are consistently 0.2-0.4 ppm 
higher than those reported, presumably due to a different assignment of the reference frequency (we used 
δC=77.23 for CDCl3). 
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(2S,3S)-6-Ethyl-2,3-dihydro-3,5-dimethyl-2-[(1S)-1-methyl-2-oxobutyl]-4H-pyran-4-one 
(152) 
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Aqueous HF (2 wt.%; 0.4 mL) was added to a stirred solution of 175b (21 mg, 0.057 mmol) 
in MeCN (2 mL). After 2 h, the mixture was diluted with ethyl acetate, washed with 
NaHCO3 and brine, dried over Na2SO4, concentrated, and fractionated by PTLC (10% 
diethyl ether in CH2Cl2) to give the titled compound (12 mg, 99%): [α]D -90 (c 0.6, CHCl3). 
 
IR νmax: 1715, 1663, 1616 cm-1. 
1H NMR (500 MHz, CDCl3): δ 4.42 (1H, dd, J = 4, 11.5 Hz, HC-2), 2.77 (1H, dq, J = 4, 7 
Hz, HC-1'), 2.53 (2H, ap q, J = 7 Hz, H2C-3'), 2.39 (1H, dq, J = 11.5, 7 Hz, HC-3), 2.36-2.22 
(2H, m, H2C-1''), 1.71 (3H, s, H3CC-5), 1.21 (3H, d, J = 7 Hz, H3CC-1'), 1.11 (3H, d, J = 7 
Hz, H3CC-3), 1.07 (3H, t, J = 7 Hz, H3C-4'), 1.06 (3H, t, J = 7.5 Hz, H3C-2'').  
13C NMR (125 MHz, CDCl3): δ 211.3 (s, C-2'), 194.9 (s, C-4), 172.4 (s, C-6), 108.5 (s, C-5), 
82.8 (d, C-2), 47.6 (d, C-1'), 41.1 (d, C-3), 34.4 (t, C-3'), 25.6 (t, C-1''), 11.2 (q, CH3C-3), 
11.0 (q, C-4'), 9.8 (q, CH3C-1'), 9.4 (q, CH3C-5), 8.0 (q, C-2'').  
LRMS: m/z (relative intensity) 238 ([M]+, 8), 181 (7), 153 (27), 125 (11), 113 (73), 83 (7), 
57 (100) (EI). 
HRMS: m/z calcd for C14H22O3 238.1569, found 238.1577 (EI). 
 
 
 
 
151
(4S,6S)-4,6-Dimethyl-3,7-dioxonon-5-yl Propanoate (154) 
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Pyridine (1.2 mL), HFpyridine (0.4 mL), and water (0.050 mL) were added to a stirred 
solution of 175a (55 mg, 0.17 mmol) in THF (2 mL). After 2 h, the mixture was diluted with 
ethyl acetate, washed sequentially with 2% aqueous citric acid (×3), NaHCO3 and brine, 
dried over Na2SO4, and concentrated. The resulting crude 142 was taken up in benzene (4 
mL) and DBU (0.010 mL, 10 mg, 0.066 mmol) was added. After 24 h, the mixture was 
diluted with ethyl acetate, washed sequentially with 1% aqueous citric acid (x3), NaHCO3 
and brine, dried over Na2SO4, concentrated, and fractionated by PTLC (10% diethyl ether in 
CH2Cl2) to give 150 (13 mg, 32%) and the titled compound (20 mg, 47%): [α]D +67 (c 1.0, 
CHCl3). 
 
IR νmax: 1742, 1715, 1180 cm-1. 
1H NMR (500 MHz, C6D6): δ 5.64 (1H, dd, J = 5, 8 Hz, HC-5'), 2.65 (1H, dq, J = 8, 7 Hz, 
HC-4'), 2.57 (1H, dq, J = 7, 18 Hz, HC-2' ), 2.44 (1H, dq, J = 5, 7 Hz, HC6' ), 2.19-2.04 (2H, 
m, H2C-8'), 2.03-1.90 (3H, m, H2C-2, HC-2'), 1.06 (3H, t, J = 7 Hz, H3C-1'), 0.95 (3H, t, J = 
7 Hz, H3C-9'), 0.90 (3H, d, J = 7 Hz, H3CC-6' ), 0.89 (3H, t, J = 7.5 Hz, H3C-3), 0.74 (3H, d, 
J = 7 Hz, H3CC-4'). 
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13C NMR (125 MHz, C6D6): δ 210.7 (s, C-3' or C-7'), 210.4 (s, C-3' or C-7'), 173.0 (s, C-1), 
74.6 (d, C-5'), 48.3 (d, C-4'), 46.8 (d, C-6'), 35.6 (t, C-8'), 35.2 (t, C-2'), 27.9 (t, C-2), 13.2 (q, 
CH3C-4'), 11.1 (q, CH3C-6'), 9.6 (q, C-3), 8.3 (q, C-1' or C-9'), 8.1 (q, C-1' or C-9'). 
LRMS: m/z (relative intensity) 274 ([M+18]+, 92), 257 ([M+1]+, 20), 200 (30), 183 (100), 
165 (14), 126 (10), 57 (8) (CI, NH3). 
HRMS: m/z calcd for C14H24O4 256.1675 (274.2018 for M+NH4), found 274.2012 (CI, 
NH3). 
 
(4E)-4,6-Dimethylnon-4-en-3,7-dione (156) 
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This compound was observed in various isomerization experiments of 138, 142, 143, and 
150, and 154 in the presence of DBU in C6D6. In a larger scale reaction, DBU (10 μL, 10 mg, 
0.07 mmol) was added to a solution of 154 (8 mg, 0.03 mmol) in C6D6 (0.4 mL) at room 
temperature. The reaction was monitored by NMR and after 14 days, <5% of 154 remained. 
Attempted isolation of the titled compound from the reaction mixture by standard aqueous 
workup failed. 
 
1H NMR (500 MHz, C6D6): δ 6.26 (1H, qd, J = 1, 10 Hz, HC-5), 3.09 (1H, dq, J = 10, 7 Hz, 
HC-6), 2.19 (2H, ap q, J = 7.5 Hz, H2C-2), 1.99-1.87 (2H, m, H2C-8), 1.73 (3H, d, J = 1 Hz, 
H3CC-3), 0.99 (3H, t, J = 7.5 Hz, H3C-1), 0.96 (3H, d, J = 7 Hz, H3CC-5), 0.91 (3H, t, J = 7 
Hz, H3C-9).  
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13C NMR (125 MHz, C6D6): δ 209.1 (s, C-3), 200.9 (s, C-7), 139.6 (d, C-5), 138.5 (s, C-4), 
46.9 (s, C-6), 34.9 (t, C-8), 30.7 (t, C-2), 16.6 (q, C-11), 12.2 (q, C-10), 9.0 (q, C-1), 8.2 (q, 
C-9). 
 
(4S,4aR,5aR,9aS,10R,10aS,12R)-12-Ethyloctahydro-5a,4,10-(epoxymethenoxy)-
1H,4aH,5aH bisthiopyrano [4,3-b:3',4'-e]pyran-4a-ol (167) 
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IBX (660 mg, 2.4 mmol) was added to a stirred solution of 173 (290 mg, 0.61 mmol) in 
DMSO (20 mL) at ambient temperature. After 5 h, the mixture was diluted with ethyl acetate 
and washed with water (×3) and brine. The organic phase was dried over Na2SO4 and 
concentrated. The residue was taken up in acetone (15 mL) and FeCl3-impregnated silica gel 
(60-200 mesh, ca.7% FeCl3;90 760 mg) was added. The resulting yellowish suspension was 
heated under reflux with stirring for 30 min. The mixture was filtered through a small silica 
gel pad eluting with 50% ethyl acetate. The combined filtrate and washings were 
concentrated and fractionated by FCC (15% diethyl ether in CH2Cl2) to give the titled 
compound (128 mg, 66%): [α]D +14 (c 1, CHCl3). A crystal suitable for X-ray 
crystallography was obtained from CH2Cl2/hexane. 
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IR νmax: 3385 cm-1. 
1H NMR (500 MHz, CDCl3): δ 4.29 (1H, br d, J = 3.5 Hz, HC-1'), 3.57 (1H, dd, J = 3.5, 14 
Hz, HC-2), 3.55 (1H, dd, J = 3, 14 Hz, HC-6), 2.98 (1H, ddd, J = 2.5, 13.5, 13.5 Hz, HC-6'), 
2.83 (1H, dd, J = 13, 13 Hz, HC-2'), 2.59-2.53 (2H, m, HC-2, HC-6), 2.47-2.40 (2H, m, HC 
3', HC-6'), 2.25 (1H, ddd, J = 2.5, 3, 13 Hz, HC-2'), 2.14 (1H, br s, HC-3), 2.04 (1H, ddd, J = 
2.5, 3, 14 Hz, HC-5'), 2.01 (1H, br s, HC-5), 1.89 (1H, ddd, J = 4, 13.5, 14 Hz, HC-5'), 1.83 
(1H, dq, J = 14.5, 7.5 Hz, HC-2''), 1.65 (1H, dq, J = 14.5, 7.5 Hz, HC-2''), 0.98 (3H, t, J = 7.5 
Hz, H3C-3''). 
13C NMR (125 MHz, CDCl3): δ 102.1 (s, C-4' or C-1''), 99.2 (s, C-4' or C-1''), 95.0 (s, C-4), 
76.9 (d, C-1'), 45.1 (d, C-3'), 43.1 (d, C-5), 37.6 (t, C-5'), 35.8 (d, C-3), 29.7 (t, C-2''), 29.0 (t, 
C-2), 27.5 (t, C-2'), 25.2 (t, C-6'), 24.8 (t, C-6), 6.4 (q, C-3''). 
LRMS: m/z (relative intensity) 316 ([M]+, 100), 298 (10), 241 (18), 209 (21), 171 (7), 152 
(30), 126 (35), 99 (45), 67 (61) (EI). 
HRMS: m/z calcd for C14H20O4S2 316.0803, found 316.0792 (EI). 
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(4S,4aR,5aR,9aR,10R,10aS,12R)-12-Ethyloctahydro-5a,4,10-(epoxymethenoxy)-
1H,4aH,5aH-bisthiopyrano[4,3-b:3',4'-e]pyran-4a-ol (168) 
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IBX (1.0 g, 3.6 mmol) was added to a stirred solution of (±)-171 (270 mg, 0.67 mmol) in 
DMSO (20 mL) at ambient temperature. After 6 h, the mixture was diluted with ethyl acetate 
and washed with water (×3) and brine. The organic phase was dried over Na2SO4 and 
concentrated. The residue was taken up in acetone (20 mL) and MeOH (1 mL) and 
FeCl36H2O (200 mg, 0.74 mmol) was added. The resulting yellowish solution was heated 
under reflux for 1 h and then diluted with water and extracted with CH2Cl2. The combined 
organic layers were washed with water, dried over Na2SO4, concentrated, and filtered 
through a small silica gel pad eluting with 50% ethyl acetate in hexane to give the titled 
compound (157 mg, 75%) as a yellowish solid. 
 
IR νmax: 3390 cm-1. 
1H NMR (500 MHz, CDCl3): δ 4.25 (1H, br s, HC-1'), 3.55 (1H, dd, J = 2.5, 13 Hz, HC-2), 
3.43 (1H, dd, J = 2, 13.5 Hz, HC-6), 3.28 (1H, dd, J = 12.5, 13 Hz, HC-2'), 2.97 (1H, ddd, J 
= 2, 13, 13.5 Hz, HC-6'), 2.81 (1H, br s, HO), 2.63-2.55 (2H, m, HC-2, HC-6), 2.45-2.33 
(2H, m, HC-2', HC-6'), 2.09 (1H, br s, HC-3), 2.07 (1H, ddd, J = 3, 3, 13.5 Hz, HC-5'), 1.98 
(1H, br s, HC-5), 1.90 (1H, dq, J = 14, 7.5 Hz, HC-2''), 1.84 (1H, dd, J = 2.5, 12.5 Hz, HC-
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3'), 1.82 (1H, ddd, J = 4, 13, 13.5 Hz, HC-5'), 1.64 (1H, dq, J = 14, 7.5 Hz, HC-2''), 1.05 (3H, 
t, J = 7.5 Hz, H3C-3''). 
13C NMR (125 MHz, CDCl3): δ 101.8 (s, C-4' or C-1''), 98.5 (s, C-4' or C-1''), 94.3 (s, C-4), 
77.5 (d, C-1'), 44.6 (d, C-3'), 43.3 (d, C-5), 41.6 (d, C-3), 38.4 (t, C-5'), 30.0 (t, C-2''), 29.3 (t, 
C-2), 28.3 (t, C-2'), 24.9 (t, C-6'), 24.8 (t, C-6), 6.4 (t, C-3''). 
LRMS: m/z (relative intensity) 316 ([M]+, 81), 242 (28), 209 (20), 153 (31), 126 (35), 99 
(39), 67 (71), 57 (100) (EI). 
HRMS: m/z calcd for C14H20O4S2 316.0803, found 316.0801 (EI). 
 
(3S,5S)-rel-3-[(R)-(6R)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(methoxymethoxy)methyl]- 5-
[(S)-1-hydroxypropyl]tetrahydro-4H-thiopyran-4-one (171) 
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A solution of (±)-170 (400 mg, 1.15 mmol) in CH2Cl2 (3 mL) was added dropwise via 
syringe to a stirred solution of triethylamine (0.48 mL, 0.35 g, 3.5 mmol) and 
chlorodicyclohexylborane (1 M in hexanes; 2.3 mL, 2.3 mmol) in CH2Cl2 (15 mL) at 0 °C 
under argon. After 20 min, the mixture was cooled to –78 °C and a solution of propanal (0.8 
mL, 0.6 g, 0.01 mol) in CH2Cl2 (3 mL) was slowly added via syringe. After 1 h, MeOH (4 
mL), pH 7 phosphate buffer (pH 7; 6 mL), and 30% aqueous H2O2 (6 mL) were sequentially 
added. The reaction mixture was transferred to a 0 °C bath and vigorously stirred for 10 min. 
 
 
157
Saturated aqueous Na2SO3 was slowly added (CAUTION: effervescence) and then the 
mixture was then extracted with CH2Cl2. The combined organic layers were dried over 
Na2SO4, concentrated, and fractionated by FCC (40% ethyl acetate in hexane and then 50% 
ether in CH2Cl2) to give a 9:1 mixture of the titled compound and an unidentified 
diastereomer (368 mg, 79%). 
 
IR νmax: 3513, 1701 cm-1. 
1H NMR (500 MHz, CDCl3): δ 4.71-4.68 (2H, m, HC-1', OCHO), 4.65 (1H, d, J = 6.5 Hz, 
OCHO), 4.12-4.01 (4H, m, H2CO ×2), 3.71-3.65 (1H, m, HC-1''), 3.38 (3H, s, H3CO), 3.20 
(1H, ddd, J = 2.5, 4.5, 14 Hz, HC-2), 3.06-3.00 (2H, m, HO, HC-3), 2.97 (1H, ddd, J = 4, 
4.5, 8.5 Hz, HC-5), 2.93-2.72 (6H, m, HC-2, H2C-6, H2C-7', HC-9'), 2.53-2.47 (2H, m, HC 
6', HC-9'), 2.13 (1H, ddd, J = 3, 4, 13.5 Hz, HC-10'), 1.74 (1H, ddd, J = 3.5, 13.5, 13.5 Hz, 
HC-10'), 1..58 (1H, ddq, J = 3.5, 14.5, 7.5 Hz, HC-2''), 1.50 (1H, ddq, J = 7, 14.5, 7.5 Hz, 
HC-2''), 0.99 (3H, t, J = 7.5 Hz, H3C-3''). 
13C NMR (125 MHz, CDCl3): δ 213.2 (s, C-4), 108.4 (s, C-5'), 96.9 (t, OCH2O), 76.2 (d, C-
1'), 73.4 (d, C-1''), 64.7 (t, CH2O), 64.2 (t, CH2O), 56.7 (q, CH3O), 54.9 (d, C-5), 54.7 (d, C-
3), 50.8 (d, C-6'), 36.6 (t, C-10'), 33.4 (t ×2, C-2, C-6), 28.3 (t, C-7'), 27.1 (t, C-2''), 26.9 (t, 
C-9'), 10.1 (q, C-3''). 
LRMS: m/z (relative intensity) 406 ([M]+, 0.4), 343 (3), 282 (11), 159 (14), 157 (11), 132 
(40), 99 (100), 86 (11) (EI). 
HRMS: m/z calcd for C18H30O6S2 406.1484, found 406.1480 (EI). 
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(3S)-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(triethylsilyloxy)methyl]tetrahydro-
4H-thiopyran-4-one (172)lxxxviii 
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Pyridine (0.17 mL, 0.17 g, 2.1 mmol) and Et3SiOTf (0.42 mL, 0.70 g, 1.8 mmol) were 
sequentially added to a stirred solution of 122 (>98% ee; 500 mg, 1.64 mmol) in CH2Cl2 (16 
mL) at 0 °C under Ar. After 15 min, the mixture was diluted with ethyl acetate and washed 
sequentially with saturated aqueous NaHCO3 and brine. The organic layer was dried over 
Na2SO4, concentrated, and fractionated by FCC (20-30% ethyl acetate in hexane) to afford 
the titled compound as a colorless oil (662 mg, 96%): [α]D -60 (c 1.2, CHCl3). 
 
IR νmax: 1700 cm-1. 
1H NMR (500 MHz, CDCl3): δ 4.88 (1H, br d, J = 5 Hz, HC-1'), 3.95-3.82 (4H, m, H2CO 
×2), 3.11 (1H, dd, J = 11, 13 Hz, HC-2), 2.96-2.86 (3H, m, HC-2, HC-6, HC-7''), 2.84-2.70 
(4H, m, HC-3, HC-5, HC-6, HC-7''), 2.69-2.54 (3H, m, HC-5, H2C-9''), 2.13-2.03 (2H, m, 
HC-6'', HC-10''), 1.60 (1H, ap ddd, J = 3.5, 8, 13 Hz, HC-10'), 0.95 (9H, t, J = 8 Hz, H3C×3), 
0.63 (6H, ap q, J = 8 Hz, H2CSi ×3). 
                                                 
lxxxviii Characterization by Fabiola Becerril-Jimenez. 
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13C NMR (500 MHz, CDCl3): δ 206.5 (s, C-4), 109.3 (s, C-5''), 68.5 (d, C-1'), 64.5 (t, 
CH2O), 63.7 (t, CH2O), 60.2 (d, C-3), 47.7 (d, C-6''), 43.0 (t, C-5), 34.5 (t, C-10'), 29.6 (t, C-
6), 29.2 (t, C-2), 27.8 (t, C-7''), 26.9 (t, C-9''), 7.2 (q ×3, CH3), 5.3 (t ×3, CH2Si). 
LRMS: m/z (relative intensity) 419 ([M+1]+, 46), 389 (31), 303 (27), 287 (59), 229 (100), 
225 (19), 132 (28), 99 (64) (CI, NH3). 
HRMS: m/z calcd for C19H34O4S2Si 418.1668 (389.1277 for M-C2H5), found 389.1276 (EI). 
 
(3S,5S)-3-[(R)-(6S)-1,4-Dioxa-8-thiaspiro[4.5]dec-6-yl(triethylsilyloxy)methyl]-5-[(S)-1- 
hydroxypropyl]tetrahydro-4H-thiopyran-4-one (173) 
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A solution of 172 (763 mg, 1.8 mmol) in CH2Cl2 (2 mL) was added dropwise via syringe to a 
stirred solution of triethylamine (0.76 mL, 0.56 g, 5.5 mmol) and chlorodicyclohexylborane 
(1 M in hexanes; 3.7 mL, 3.7 mmol) in CH2Cl2 (15 mL) at 0 °C under Ar. After 20 min, the 
mixture was cooled to –78 °C and a solution of propanal (1.0 mL, 0.80 g, 14 mmol) in 
CH2Cl2 (1 mL) was slowly added via syringe. After 1 h, MeOH (4 mL), pH 7 phosphate 
buffer (pH 7; 10 ml), and 30% aqueous H2O2 (10 mL) were sequentially added. The reaction 
mixture was transferred to a 0 °C bath and vigorously stirred for 10 min. Saturated aqueous 
Na2SO3 was slowly added (CAUTION: effervescence) and then the mixture was then 
extracted with CH2Cl2. The combined organic layers were dried over Na2SO4, concentrated, 
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and fractionated by FCC (8% Et2O in CH2Cl2) to afford the titled compound (813 mg, 94%): 
[α]D -90 (c 1.0, CHCl3). 
 
IR νmax: 3513, 1699 cm-1. 
1H NMR (500 MHz, CDCl3): δ 4.74 (1H, br d, J = 4.5 Hz, HC-1'), 3.99-3.86 (4H, m, H2CO 
×2), 3.83-3.77 (1H, m, HC-1''), 3.21 (1H, dd, J = 11, 13 Hz, HC-2), 3.18 (1H, d, J = 3.5 Hz, 
HO), 3.00 (1H, dd, J = 5, 12 Hz, HC-6), 2.89-2.76 (5H, m, HC-2, HC-3, HC-5, H2C-7'), 
2.73-2.61 (2H, m, HC-6. H2C-9'), 2.11 (1H, ap ddd, J = 3.5, 7, 7.5 Hz, HC-6'), 2.08-2.01 
(1H, m, HC-10'), 1.65-1.55 (2H, m, HC-2'', HC-10'), 1.50 (1H, ddq, J = 7, 7.5, 15 Hz, HC 
2''), 0.99 (3H, t, J = 7.5 Hz, H3C-3''), 0.97 (9H, t, J = 8 Hz, H3CCSi ×3), 0.66 (6H, ap q, J = 8 
Hz, H2CSi ×3). 
13C NMR (125 MHz, CDCl3): δ 211.5 (s, C-4), 109.1 (s, C-5'), 73.3 (d, C-1''), 69.4 (d, C-1'), 
64.6 (t, CH2O), 63.9 (t, CH2O), 60.7 (d, C-3), 53.0 (d, C-5), 47.9 (d, C-6'), 34.5 (t, C-10'), 
29.5 (t, C-7'), 27.4 (t, C-6), 27.1 (t, C-2''), 26.9 (t, C-9'), 26.2 (t, C-2), 9.9 (t, C-3''), 7.2 (t ×3, 
CH2Si), 5.3 (q ×3, CH3CSi). 
LRMS: m/z (relative intensity) 477 ([M+1]+, 24), 419 (99), 389 (36), 345 (62), 287 (100), 
229 (86), 132 (38), 99 (46) (CI, NH3). 
HRMS: m/z calcd for C22H40O5S2Si 476.2086 (477.2165 for M+H), found 477.2183 (CI, 
NH3). 
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(4S,4aS,5aR,9aS,10R,10aS,12R)-12-Ethyloctahydro-5a,4,10-(epoxymethenoxy)-4a-
trimethylsilyoxy-1H,4aH,5aH-bisthiopyrano[4,3-b:3',4'-e]pyran (174a) 
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2,6-Lutidine (0.50 mL, 0.46 g, 4.3 mmol) and Me3SiOTf (0.20 mL, 0.25 g, 1.1 mmol) were 
added to a stirred solution of 167 (271 mg, 0.86 mmol) in CH2Cl2 (10 mL) at room 
temperature under Ar. After 1 h, the mixture was diluted with ethyl acetate, washed 
sequentially with 1% (w/v) aqueous citric acid monohydrate (×3), sat. NaHCO3 and brine, 
dried over Na2SO4, concentrated, and fractionated by FCC (20% ethyl acetate in hexane) to 
give the titled compound as a clear oil (309 mg, 93%): [α]D +18 (c 1, C6H6). 
 
IR νmax: 2924, 1248, 1149, 1083, 883, 851 cm-1. 
1H NMR (500 MHz, C6D6): δ 3.79 (1H, br d, J = 3.5 Hz, HC-1'), 3.41 (1H, dd, J = 3.5, 13.5 
Hz, HC-2), 3.37 (1H, dd, J = 3, 14 Hz, HC-6), 2.87 (1H, ddd, J = 3, 13.5, 13.5 Hz, HC-6'), 
2.51 (1H, dd, J = 12.5, 13 Hz, HC-2'), 2.32 (1H, ddd, J = 3.5, 3.5, 12.5 Hz, HC-3'), 2.25 (1H, 
ddd, J = 2, 3, 14 Hz, HC-6), 2.08 (1H, ddd, J = 2, 2, 13.5 Hz, HC-2), 2.02 (1H, dddd, J = 2.5, 
3.5, 3.5, 13.5 Hz, HC-6'), 1.94 (1H, ddd, J = 3, 3.5, 13.5 Hz, HC-5'), 1.92-1.82 (3H, m, HC-
2'', HC-5, HC-5'), 1.63 (1H, ddd, J = 2.5, 3, 13 Hz, HC-2'), 1.62-1.59 (1H, m, HC-3), 1.54 
(1H, dq, J = 15, 7.5 Hz, HC-2''), 1.00 (3H, t, J = 7.5 Hz, H3C-3''), 0.20 (9H, s, H3CSi ×3). 
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13C NMR (125 MHz, C6D6): δ 102.7 (s, C-4' or C-1''), 99.6 (s, C-4' or C-1''), 97.5 (s, C-4), 
76.9 (d, C-1'), 45.9 (d, C-3'), 44.4 (d, C-5), 38.4 (t, C-5'), 37.3 (d, C-3), 30.3 (t, C-2''), 29.4 (t, 
C-2), 27.8 (t, C-2'), 25.6 (t, C-6'), 25.3 (t, C-6), 6.9 (t, C-3''), 2.6 (q ×3, CH3Si). 
LRMS: m/z (relative intensity): 388 ([M]+, 71), 314 (10), 286 (15), 225 (23), 198 (42), 155 
(31), 73 (100) (EI). 
HRMS: m/z calcd for C17H28O4S2Si 388.1198, found 388.1198 (EI). 
 
(4S,4aS,5aR,9aS,10R,10aS,12R)-12-Ethyloctahydro-5a,4,10-(epoxymethenoxy)-4a-
triethylsilyoxy-1H,4aH,5aH-bisthiopyrano[4,3-b:3',4'-e]pyran (174b) 
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2,6-Lutidine (0.11 mL, 0.10 g, 0.93 mmol) and (CH3CH2)3OTf (0.10 mL,0.12 g, 0.45 mmol) 
were sequentially added to a stirred solution of 167 (59 mg, 0.19 mmol) in CH2Cl2 (5 mL) at 
room temperature under Ar. After 2 h, the mixture was diluted with ethyl acetate, washed 
sequentially with 1% (w/v) aqueous citric acid (×3), sat. NaHCO3 and brine, dried over 
Na2SO4, concentrated, and fractionated by FCC (15% ethyl acetate in hexane) to give the 
titled compound as a clear oil (78 mg, 97%): [α]D +1.0 (c 1.1, CHCl3). 
 
 IR νmax: 2952, 2925, 1267, 1150, 1082, 896, 768 cm-1. 
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1H NMR (500 MHz, CDCl3): δ 4.25 (1H, br d, J = 3 Hz, HC-1'), 3.54 (1H, dd, J = 3.5, 13.5 
Hz, HC-2), 3.41 (1H, dd, J = 3, 14 Hz, HC-6), 2.96 (1H, ddd, J = 2.5, 13.5, 13.5 Hz, HC-6'), 
2.99 (1H, dd, J = 12.5, 13 Hz, HC-2'), 2.53-2.44 (3H, m, HC-2, HC-6, HC-6'), 2.40 (1H, ddd, 
J = 3.5, 3.5, 12.5 Hz, HC-3'), 2.24 (1H, ddd, J = 3, 3, 13 Hz, HC-2'), 2.06-2.00 (2H, m, HC-
3, HC-5'), 1.94 (1H, br s, HC-5), 1.88 (1H, ddd, J = 4, 13.5, 13.5 Hz, HC-5'), 1.80 (1H, dq, 
J = 15, 7.5 Hz, HC-2"), 1.61 (1H, dq, J = 15, 7.5 Hz, HC-2"), 0.99 (9H, t, J = 8 Hz, H3C ×3), 
0.96 (3H, t, J = 7.5 Hz, H3C-3"), 0.71-0.65 (6H, m, H2CSi ×3). 
13C NMR (125 MHz, CDCl3): δ 102.2 (s, C-4' or C-1"), 99.1 (s, C-4' or C-1"), 96.3 (s, C-4), 
77.0 (d, C-1'), 45.3 (d, C-3'), 43.8 (d, C-5), 37.7 (t, C-5'), 37.0 (d, C-3), 29.8 (t, C-2"), 29.1 (t, 
C-2), 27.7 (t, C-2'), 25.4 (t, C-6'), 24.9 (t, C-6), 7.3 (q ×3, CH3), 6.8 (t ×3, CH2Si), 6.4 (q, C-
3"). 
LRMS: m/z (relative intensity) 430 ([M]+, 77), 327 (47), 240 (31), 225 (63), 155 (38), 115 
(46), 87 (59), 67 (100) (EI). 
HRMS: m/z calcd for C20H34O4S2Si 430.1668, found 430.1665 (EI). 
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(1R,3R,5R,7R,8S,9S,10S)-3,5-Diethyl-8,9,10-trimethyl-2,4,6-trioxatricyclo [3.3.1.13,7] 
dec-1-yloxy(trimethyl)silane (175a) 
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From 142: Triethylamine (0.10 mL, 73 mg, 0.73 mmol), 2,6-lutidine (0.50 mL, 0.46 g, 4.3 
mmol) and Me3SiCl (0.050 mL, 43 mg, 0.40 mmol) were sequentially added to a stirred 
solution of 142 (8 mg, 0.03 mmol) in CH2Cl2 (1 mL) at ambient temperature. After 3 d, the 
mixture was concentrated and the resulting residue was suspended in hexane and filtered 
through Celite®. The combined filtrate and hexane washings were concentrated and 
fractionated by PTLC (20% ethyl acetate in hexane) to give the titled compound (6 mg, 
59%).  
 
From 174a: A suspension of Raney nickel (W2; 12 mL settled volume) in ethanol (20 mL) 
was added to 174a (309 mg, 0.8 mmol) and the mixture was heated under reflux with 
vigorous stirring. After 45 min, the mixture was decanted and the solid suspended in ethanol 
and heated under reflux with rapid stirring for several min. This washing procedure was 
repeated twice with EtOH and once with ethyl acetate. The combined organic layers were 
filter through Celite® and concentrated to give the titled compound (231 mg, 88%) that was 
homogeneous by 1H NMR: [α]D -9 (c 0.5, C6H6). 
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IR νmax: 2792, 2940, 2883, 1465, 1455, 1380, 1352, 1328 cm-1. 
1H NMR (500 MHz, C6D6): δ 3.70 (1H, br d, J = 3.5 Hz, HC-7), 2.09-2.03 (2H, m, HC-9, 
HC-10), 2.00 (1H, br q, J = 7.5 Hz, HC-8), 1.82 (1H, dq, J = 15, 7.5 Hz, HCC-5), 1.60 (1H, 
dq, J = 15, 7.5 Hz, HCC-3), 1.57 (1H, dq, J = 15, 7.5 Hz, HCC-5), 1.45 (1H, dq, J = 15, 7.5 
Hz, HCC-3), 1.18 (3H, d, J = 7.5 Hz, H3CC-8), 1.08 (3H, d, J = 7.5 Hz, H3CC-9), 1.07 (3H, 
t, J = 7.5 Hz, H3CCC-5), 1.01 (3H, t, J = 7.5 Hz, H3CCC-3), 0.63 (3H, d, J = 7 Hz, H3CC-
10), 0.30 (9H, s, H3CSi ×3). 
13C NMR (125 MHz, C6D6): δ 103.3 (s, C-3), 102.6 (s, C-5), 101.0 (s, C-1), 79.2 (d, C-7), 
46.3 (d, C-9), 38.2 (d, C-10), 37.3 (d, C-8), 30.5 (t, CH2C-5), 30.2 (t, CH2C-3), 14.8 (q, 
CH3C-8), 13.1 (q, CH3C-10), 11.2 (q, CH3C-9), 7.0 (q, CH3CC-5), 6.9 (q, CH3CC-3), 2.7 (q 
×3, CH3Si). 
LRMS: m/z (relative intensity) 328 ([M]+, 4), 239 (13), 203 (72), 197 (22), 187 (18), 113 
(25), 73 (38), 57 (100) (EI). 
HRMS: m/z calcd for C17H32O4Si 328.2070, found 328.2062 (EI). 
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(1R,3R,5R,7R,8S,9S,10S)-3,5-Diethyl-8,9,10-trimethyl-2,4,6-trioxatricyclo [3.3.1.13,7] 
dec-1-yloxy(triethyl)silane (175b) 
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A suspension of Raney nickel (W2; 2 mL settled volume) in EtOH (10 mL) was added to 
174b (72 mg, 0.17 mmol) and the mixture was heated under reflux with vigorous stirring. 
After 30 min, the mixture was decanted and the solid suspended in ethanol and heated under 
reflux with rapid stirring for several min. This washing procedure was repeated three times 
with EtOH and once with ethyl acetate. The combined organic layers were filter through 
Celite®, concentrated, and fractionated by FCC (10% ethyl acetate in hexane) to give the 
titled compound (51 mg, 83%). 
 
1H NMR (500 MHz, CDCl3): δ 3.81 (1H, br d, J = 3.5 Hz, HC-7) 2.11 (1H, dq, J = 3.5, 7 Hz, 
HC-10) 1.99 (1H, br q, J = 7.5 Hz, HC-8) 1.87 (1H, br q, J = 7.5 Hz, HC-9) 1.67-1.46 (4H, 
m, H2C ×2) 1.13 (3H, d, J = 7.5 Hz, H3CC-8) 1.01 (3H, d, J = 7.5 Hz, H3CC-9) 0.97 (9H, t, J 
= 8 Hz, H3CCSi ×3) 0.92 (3H, t, J = 7.5 Hz, H3CCC-3 or H3CCC-5) 0.91 (3H, t, J = 7.5 Hz, 
H3CCC-3 or H3CCC-5) 0.87 (3H, d, J = 7 Hz, H3CC-10) 0.64 (6H, ap q, J = 8 Hz, H2CSi 
×3). 
13C NMR (125 MHz, CDCl3): δ 102.8 (s, C-3), 102.2 (s, C-5) 99.8 (s, C-1), 79.3 (d, C-7) 
45.6 (d, C-9), 37.8 (d, C-10) 36.8 (d, C-8), 29.9 (t, CH2C-5 or CH2C-3) 29.7 (t, CH2C-3 or 
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CH2C-5), 14.5 (q, CH3C-8) 13.1 (q, CH3C-10), 10.7 (q, CH3C-9) 7.2 (q ×3, CH3CSi), 6.7 (t 
×3, CH2Si) 6.6 (q, CH3CC-5 or CH3CC-3), 6.4 (q, CH3CC-3 or CH3CC-5). 
LRMS: m/z (relative intensity) 370 ([M]+, 7) 267 (47) 245 (92) 229 (23) 171 (23) 75 
(22) 71 (60) 57 (100) (EI). 
HRMS: m/z calcd for C20H38O4Si 370.2539, found 370.2538 (EI). 
 
2-(2-Ethyl-1,3-dithiolan-2-yl)propanal (179) 
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IBX (2.5 g, 8.9 mmol) was added to a stirred solution of 186 (1.13 g, 5.88 mmol) in 
anhydrous DMSO (30 mL) at rt. Reaction progress was monitored by TLC and after 2 h, the 
mixture was diluted with ethyl acetate (200 mL) and washed sequentially with sat. NaHCO3, 
water, and brine. The organic layer was dried over Na2SO4 and concentrated to give the titled 
compound as a clear oil (1.10 g, 98%) that was homogeneous by NMR. 
 
IR νmax: 1718 cm-1. 
1H NMR (500 MHz, CDCl3): δ 9.87 (1H, d, J = 2 Hz, HC-1), 3.35-3.23 (4H, m, H2CS ×2), 
2.80 (1H, dq, J = 2,7 Hz, HC-2), 2.01 (1H, dq, J = 14.5, 7 Hz, HC-1''), 1.93 (1H, dq, J = 14.5, 
7 Hz, HC-1''), 1.25 (3H, d, J = 7 Hz, H3C-3), 1.08 (3H, t, J = 7 Hz, H3C-2''). 
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13C NMR (125 MHz, CDCl3): δ 204.1 (s, C-1), 72.4 (s, C-2'), 54.3 (d, C-2), 40.3 (t, CH2S), 
40.2 (t, CH2S), 36.5 (t, C-1''), 13.2 (q, C-3), 10.7 (q, C-2''). 
LRMS: m/z (relative intensity): 190 ([M]+, 7), 161 (10), 133 (100), 102 (12), 73 (25), 61 
(18) (EI). 
HRMS: m/z calcd for C8H14OS2 190.0486, found 190.0484 (EI). 
 
Ethyl 2-(2-Ethyl-1,3-dithiolan-2-yl)propanoate (185)  
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BF3OEt2 (7.8 mL, 8.8 g, 6.2 mmol) was added to a stirred solution of 184 (8.91 g, 56.4 
mmol) and 1,2-dithioethane (5.0 mL, 5.6 g, 5.9 mmol) in CH2Cl2 (80 mL) at rt under Ar. 
Reaction progress was monitored by TLC and after 10 min, the mixture was diluted with 
ether (300 mL) and sat. NaHCO3 (200 mL) (CAUTION! effervescence) and the two-phase 
mixture was stirred for 30 min at rt. The organic layer was washed with brine, dried over 
Na2SO4, and concentrated to give the titled compound as a pale yellow oil (13.07 g, 99%) 
that was homogeneous by NMR. 
 
IR νmax: 1731 cm-1. 
1H NMR (500 MHz, CDCl3): δ 4.18 (2H, q, J = 7 Hz, H2CO), 3.25-3.20 (4H, m, H2CS ×2), 
3.02 (1H, q, J = 7 Hz, HC-2), 2.09 (1H, dq, J = 14.5, 7 Hz, HC-1''), 1.94 (1H, dq, J = 14.5, 7 
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Hz, HC-1''), 1.42 (3H, d, J = 7 Hz, H3C-3), 1.27 (3H, t, J = 7 Hz, H3CCH2O), 1.12 (3H, t, J = 
7 Hz, H3C-2''). 
13C NMR (125 MHz, CDCl3): δ 174.4 (s, C-1), 74.3 (s, C-2'), 60.7 (t, CH2O), 50.7 (d, C-2), 
40.5 (t, CH2S), 40.2 (t, CH2S), 34.8 (t, C-1''), 15.7 (q, C-3), 14.4 (q, CH3CH2O), 10.7 (q, C-
2''). 
LRMS: m/z (relative intensity) 234 ([M]+, 17), 205 (44), 133 (100), 105 (10), 89 (12), 73 
(19) (EI). 
HRMS: m/z calcd for C10H18O2S2 234.0748, found 234.0745 (EI). 
 
2-(2-Ethyl-1,3-dithiolan-2-yl)propan-1-ol (186) 
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A solution of 185 (13.2 g, 56.4 mmol) in THF (20 mL + 2×5 mL rinses) was added dropwise 
via syringe to a stirred suspension of LiAlH4 (2.6 g, 68 mmol) in THF (100 mL) at 0 °C 
under Ar. The mixture was allowed to warm to ambient temperature and the reaction 
progress was monitored by TLC. After 3 h, the mixture was cooled to 0 °C and then water 
(2.6 mL) (CAUTION! H2 evolution), 15% aqueous NaOH (w/v; 2.6 mL), and water (7.8 mL) 
were sequentially added with vigorous stirring. The cooling bath was removed and the 
grayish suspension turned white over 1 h. The mixture was filtered through a short pad of 
Na2SO4 and Celite and washed with ethyl acetate. The combined filtrate and washings 
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were concentrated to give the titled compound as a pale yellow oil (9.97 g, 92%) that was 
homogeneous by NMR. 
 
IR νmax: 3377 cm-1. 
1H NMR (500 MHz, CDCl3): δ 3.95 (1H, dd, J = 5.5, 11 Hz, HC-1), 3.70 (1H, br dd, J = 5, 
11 Hz, HC-1), 3.28-3.23 (4H, m, H2CS ×2), 2.52 (1H, br s, HO), 2.17 (1H, ddq, J = 5, 5.5, 7 
Hz, HC-2), 2.03 (1H, dq, J = 14.5, 7 Hz, HC-1''), 1.93 (1H, dq, J = 14.5, 7 Hz, HC-1''), 1.12 
(3H, d, J = 7 Hz, H3C-3), 1.07 (3H, t, J = 7 Hz, H3C-2''). 
13C NMR (125 MHz, CDCl3): δ 76.5 (s, C-2'), 66.7 (t, C-1), 44.5 (d, C-2), 40.1 (t, CH2S), 
39.8 (t, CH2S), 36.4 (t, C-1''), 15.7 (q, C-3), 10.8 (q, C-2''). 
LRMS: m/z (relative intensity) 192 ([M]+, 3), 163 (13), 133 (100), 105 (9), 73 (8) (EI). 
HRMS: m/z calcd for C8H16OS2 192.0643, found 192.0638 (EI). 
 
(6R,10S)-1,4-Dioxa-8-thiaspiro[4.5]decane-6,10-dicarboxaldehyde (meso-196); (6R,10R)-
rel-1,4-Dioxa-8-thiaspiro[4.5]decane-6,10-dicarboxaldehyde ((±)-196) 
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IBX (23.2 g, 82.9 mmol) was added to a stirred solution of (±)-19470 (7.6 g, 35 mmol) in 
MeCN (250 mL) at 80 °C (oil bath temperature). After 2.5 h, the suspension was cooled and 
then filtered through a medium-porosity sintered glass funnel. The combined filtrate and 
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ethyl acetate washings were concentrated and fractionated by FCC (50% ethyl acetate in 
hexanes) to give the titled compound (7.18 g, 96%) as a variable mixture of meso/dl isomers 
(dl:meso, 4-25:1) by 1H NMR (C6D6). The recovered solid (20.1 g, mainly IBA, >90%) could 
be reoxidized to IBX with Oxone in>80% yield.78 
 
Data included here for completeness. 
 
meso-196: 
1H NMR (500 MHz, C6D6): δ 9.46 (2H, s, HC=O ×2), 3.11 (4H, br s, H2CO ×2), 2.82 (2H, 
ap dd, J = 13, 13 Hz, HC-7, HC-9), 2.42-239 (4H, m, HC-6, HC-7, HC-9, HC-10).  
13C NMR (125 MHz, C6D6): δ 199.0 (×2, C=O), 110.2 (C-5), 66.5 (CH2O), 66.3 (CH2O), 
60.3 (×2, C-6, C-10), 26.6 (×2, C-7, C-9).  
LRMS: (EI), m/z (relative intensity): 216 ([M]+, 12), 188 (9), 160 (6), 113 (11), 99 (100), 86 
(5), 54 (18).  
HRMS: m/z calcd for C9H12O4S 216.0456, found 216.0458. Anal. Calcd for C9H12O4S: C, 
49.99; H, 5.59. Found: C, 49.79; H, 5.59. 
 
()-196: 
1H NMR (500 MHz, C6D6): δ 9.62 (2H, br s, HC=O ×2), 3.12-3.02 (4H, m, H2CO ×2), 2.73 
(2H, dd, J = 7.5,14 Hz, HC-2, HC-6), 2.56 (2H, ddd, J = 1.5, 3.5, 14 Hz, HC-2, HC-6), 2.23 
(2H, dd, J = 3.5, 7.5 Hz, HC-3, HC-5).  
13C NMR (125 MHz, C6D6): δ 199.4 (×2, C=O), 108.3, 65.1 (×2, CH2O), 55.1 (×2, C-3. C-
5), 27.1 (×2, C-2, C-6). 
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3-oxa-7-thiaspiro[bicyclo[3.3.1]nonane-9,2'-[1,3]dioxolan]-2-one (197) 
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Isolated as a minor component in the IBX oxidation of mixtures of ()-195 and ()-194. ()-
197 was not detected when pure ()-194 was used. 
IR νmax: 1734 cm-1. 
1
H NMR (500 MHz, CDCl3): δ 4.59 (1H, ddd, J = 2, 6, 11.5 Hz, HC-4), 4.43 (1H, d, J = 11.5 
Hz, HC-4), 4.06-3.93 (4H, m, H2CO x2), 3.34 (1H, ddd, J = 2, 2, 13.5 Hz, HC-6), 3.32 (1H, 
dd, J = 2.5, 13 Hz, HC-8), 2.94 (1H, ddd, J = 2, 2.5, 4 Hz, HC-1), 2.78 (1H, ddd, J = 2.5, 4, 
13 Hz, HC-8), 2.54 (1H, ddd, J = 2.5, 4, 13.5 Hz, HC-6), 2.26-2.21 (1H, m, HC-5). 
13
C NMR (125 MHz, CDCl3): δ 171.0 (s, C-2), 105.1 (s, C-9), 71.1 (t, C-4), 65.4 (t, CH2O), 
64.9 (t, CH2O), 47.8 (d, C-1), 36.4 (d, C-5), 32.3 (t, C-6), 30.5 (t, C-8). 
LRMS: m/z (relative intensity) 216 ([M]+, 65), 183 (24), 169 (7), 144 (80), 131 (8), 115 (18), 
99 (100) (EI). 
HRMS: m/z calcd. for C9H12O4S 216.0456, found 216.0460 (EI). 
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 (1S,2R,4RS,5R)-2-((S)-4-Oxotetrahydro-2H-thiopyran-3-yl)-3-oxa-7-thiaspiro[bicycle 
[3.3.1]nonane-9,2'-[1,3]dioxolan]-4-yl Pivalate (198) 
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Trimethylacetyl chloride (1.5 mL, 1.5 g, 12 mmol), DMAP (1.3 g, 10 mmol), and Et3N (4 
mL, 2.9 g, 29 mmol) were added to a stirred solution of 190 (3.5 g, 10 mmol) in CH2Cl2 (100 
mL) at rt. After ca. 16 h, the mixture was diluted with ethyl acetate and washed sequentially 
with 1N aq. HCl, sat. NaHCO3, and brine. The aqueous layers were back extracted with ethyl 
acetate. The combined organic layers were dried over Na2SO4, concentrated, and fractionated 
by FCC (40% ethyl acetate in hexanes) to give the titled compound as a ca. 1:1 mixture of 
anomers (3.56 g, 81%). 
 
IR νmax: 1737, 1715 cm-1. 
1H NMR (500 MHz, CDCl3): δ 6.08 (1H, s, HC-4 (4R)), 6.05 (1H, br s, HC-4 (4S)), 5.19 
(1H, br d, J = 10 Hz, HC-2 (4R)), 4.90 (1H, br d, J = 10 Hz, HC-2 (4S)), 4.19-3.92 (8H, m, 
H2CO ×4), 3.48 (1H, dd, J = 3, 13 Hz, HC-6 (4R)), 3.45 (1H, m, J = 4. 14 Hz, HC-8 (4S)), 
3.41 (1H, dd, J = 2.5, 14 Hz, HC-8 (4R)), 3.31 (1H, dd, J = 3, 13.5 Hz, HC-6 (4S)), 3.17-3.11 
(2H, m, HC-3' (4R & 4S)), 3.08-2.80 (10H, m), 2.75-2.49 (8H, m), 2.11 (1H, br s, HC-5 
(4R)), 2.01 (1H, br s, HC-5 (4R)), 1.78 (2H, br s, HC-1 (4R & 4S)), 1.26 (9H, s, (H3C)3C), 
1.20 (9H, s, (H3C)3C). 
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13C NMR (125 MHz, CDCl3): δ 207.8 (s, C-4'), 207.7 (s, C-4'), 177.0 (s, Piv), 176.7 (s, 
OC=O), 107.1 (s, C-9), 105.7 (s, C-9), 96.6 (d, C-4 (4R)), 94.1 (d, C-4 (4S)), 72.9 (d, C- 2 
(4S)), 72.1 (d, C-2 (4R)), 64.9 (t, CH2O), 64.7 (t, CH2O), 64.6 (t, CH2O), 64.2 (t, CH2O), 53.9 
(d, C-3' (4R)), 53.3 (d, C-3' (4S)), 43.0 (t, C-5'), 42.3 (t, C-5'), 40.7 (d, C-5 (4S)), 39.1 (s ×2, 
C(CH3)3), 39.0 (d, C-5 (4R)), 36.9 (d, C-1), 36.8 (d, C-1), 32.9 (t, C-2' or C-6'), 32.7 (t, C-2' 
or C-6'), 32.2 (t, C-2' or C-6'), 32.0 (t, C-2' or C-6'), 29.7 (t, C-6 (4R)), 27.2 (q ×6, (CH3)3C 
×2), 25.9 (t, C-8 (4S)), 25.6 (t, C-8 (4R)), 25.0 (t, C-6 (4S)). 
LRMS: m/z (relative intensity) 416 ([M]+, 10), 314 (18), 226 (6), 199 (10), 131 (12), 99 
(100) (EI). 
HRMS: m/z calcd for C19H28O6S2 416.1327, found 416.1348 (EI). 
 
(6R,7RS,9R,10S)-6,10-Dimethyl-9-((S)-3-oxopentan-2-yl)-1,4,8-trioxaspiro[4.5]decan-7-
yl Pivalate (199) 
 
OO O
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Raney Nickel (W2; 60 mL settled volume) was washed with THF (x3) and THF (150 mL) 
and 198 (2.76 g, 6.6 mmol) were added. The resulting suspension was heated under reflux 
with vigorous stirring. After 3 h, the mixture was allowed to settle and then was decanted. 
The solid was suspended in ethyl acetate, heated under reflux for 10 min, and decanted. This 
washing procedure was repeated with ethyl acetate and then acetone. The combined organic 
layers were filtered through Celite and concentrated to give the crude desulfurized product 
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that contained a variable amount (up to 10% by 1H NMR) of alcohol (from hydrogenation of 
the ketone). IBX (1.73 g, 6.2 mmol) was added to a stirred solution of the crude reaction 
mixture in DMSO (30 mL) at rt. After 15 h, the mixture was diluted with ethyl acetate and 
washed sequentially with sat. NaHCO3, water, and brine. The aqueous layers were back 
extracted with ethyl acetate. The organic layers were combined, dried over Na2SO4, 
concentrated, and fractionated by FCC (30% diethyl ether in hexanes) to give the titled 
compounds as a 1:1 mixture of anomers (2.02 g, 86%). Pure samples of the individual 
anomers could be obtained by fractionation of the mixture by PTLC (30% diethyl ether in 
hexanes). 
 
(6R,7S,9R,10S)-6,10-Dimethyl-9-((S)-3-oxopentan-2-yl)-1,4,8-trioxaspiro[4.5]decan-7-yl 
Pivalate (-199) 
 
O O
-199
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92
3
5
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[α]D ~0 (c 0.9, CHCl3).  
IR νmax:1735, 1718 cm-1. 
1H NMR (500 MHz, CDCl3): δ 5.70 (1H, d, J = 3 Hz, HC-7), 3.98-3.92 (4H, m, H2CO ×2), 
3.90 (1H, dd, J = 2, 10.5 Hz, HC-9), 2.73 (1H, dq, J = 10.5, 7 Hz, HC-1'), 2.59-2.43 (2H, m, 
HC-3'), 1.95 (1H, dq, J = 1.5, 7.5 Hz, HC-6), 1.68 (1H, br q, J = 7.5 Hz, HC-10), 1.17 (9H, 
s), 1.06 (3H, d, J = 7.5 Hz, H3CC-6), 1.03 (3H, d, J = 7.5 Hz, H3CC-10), 1.00 (3H, t, J = 7 
Hz, HC-4'), 0.93 (3H, d, J = 7 Hz, H3CC-1'). 
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13C NMR (125 MHz, CDCl3): δ 213.9 (s, C-3'), 176.5 (s, OC=O), 110.8 (s, C-5), 94.7 (d, C-
7), 77.9 (d, C-9), 64.7 (t, CH2O), 64.5 (t, CH2O), 47.4 (d, C-1'), 41.4 (d, C-6), 39.1 (s, 
C(CH3)3), 38.6 (d, C-10), 35.0 (t, C-4'), 27.2 (q ×3, (CH3)3C), 12.6 (q, C-1'), 9.1 (q, CH3C-
10), 8.9 (q, CH3C-6), 7.5 (q, C-5'). 
LRMS: m/z (relative intensity) 374 ([M+18]+, 47), 272 (11), 255 (100), 185 (5), 129 (19), 
100 (8) (CI, NH3). 
HRMS: m/z calcd for C19H32O6 356.2199 (374.2543 for M+NH4), found 374.2454 (CI, 
NH3). 
 
(6R,7R,9R,10S)-6,10-Dimethyl-9-((S)-3-oxopentan-2-yl)-1,4,8-trioxaspiro[4.5]decan-7-yl 
Pivalate (-199) 
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[α]D +67 (c 0.9, CHCl3). 
IR νmax: 1735, 1718 cm-1. 
1H NMR (500 MHz, CDCl3): δ 5.74 (1H, br s, HC-7), 4.35 (1H, dd, J = 2, 10.5 Hz, HC-9), 
3.99-3.87 (4H, m, H2CO ×2), 2.73 (1H, dq, J = 10.5, 7 Hz, HC-2'), 2.56 (1H, dq, J = 18, 7 
Hz, HC-4'), 2.46 (1H, dq, J = 18, 7 Hz, HC-4'), 1.91 (1H, br q, J = 7.5 Hz, HC-6), 1.80 (1H, 
br q, J = 7.5 Hz, HC-10), 1.22 (9H, s, (H3C)3C), 1.11 (3H, d, J = 7.5 Hz, H3CC-6), 1.03 (3H, 
d, J = 7.5 Hz, H3CC-10), 0.99 (3H, t, J = 7 Hz, H3C-5'), 0.92 (3H, d, J = 7 Hz, H3C-1'). 
13C NMR (125 MHz, CDCl3): δ 213.8 (s, C-3'), 177.4 (s, OC=O), 109.3 (s, C-5), 96.8 (d, C-
7), 74.4 (d, C-9), 64.7 (t, CH2O), 64.5 (t, CH2O), 46.9 (d, C-2'), 39.9 (d, C-6), 39.1 (s, 
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C(CH3)3), 38.7 (d, C-10), 36.3 (t, C-3'), 27.2 (q ×3, (CH3)3C), 14.2 (q, CH3C-6), 12.5 (q, C-
1'), 8.8 (q, CH3C-10), 7.5 (q, C-5'). 
LRMS: m/z (relative intensity) 374 ([M+18]+, 19), 272 (22), 255 (100), 197 (6), 129 (12). 
(CI, NH3). 
HRMS: m/z calcd for C19H32O6 356.2199 (374.2543 for M+NH4), found 374.2543 (CI, 
NH3). 
2-((S)-1-((2R,3S)-3,5-Dimethyl-4-oxo-3,4-dihydro-2H-pyran-2-yl)ethyl)-6-ethyl-3,5-
dimethyl-4H-pyran-4-one (202) 
 
 
O
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A solution of 199 (ca. 1:1 mixture of anomers; 2.04 g, 5.7 mmol) in THF (20 mL plus 2x10 
mL rinses) was added to a stirred solution of LDA [freshly prepared from DIPA (1.0 mL, 
0.74 g, 7.3 mmol) and n-BuLi (2.2 M in hexanes, 2.9 mL, 6.3 mmol)] in THF (100 mL) at -
78 C under Ar. After 30 min, neat 179 (3.3 g, 17.4 mmol) was added dropwise over 3 - 5 
min. After 30 min, the mixture was diluted with ethyl acetate and washed sequentially with 
1M HCl (x2), sat. NaHCO3, and brine. The organic layer was dried over Na2SO4, 
concentrated, and fractionated by FCC (30-80% diethyl ether in hexanes) to give a complex 
mixture of aldol diastereomers (200) (2.84 g, 91%) and recovered aldehyde (2.2 g, 67%).  
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IBX (2.8 g, 10 mmol) was added to a stirred solution of the above aldol mixture (200) (2.67 
g, 4.9 mmol) in dry DMSO (100 mL) at rt. After 24 h, the mixture was diluted with ethyl 
acetate and washed sequentially with sat. NaHCO3, water, and brine. The aqueous layers 
were back extracted with ethyl acetate. The combined organic layers were dried over 
Na2SO4, concentrated, and fractionated by FCC (25% ethyl acetate in hexanes) to give a 
mixture of diketones (201) (keto and enol forms) (2.53 g, 95%). 
 
IBX (2.5 g, 8.9 mmol) and CF3SO3H (0.39 mL, 660 mg, 4.4 mmol) were added to a stirred 
solution of the above 201 (2.41 g, 4.4 mmol) in MeCN (120 mL) at rt. After 17 h, the mixture 
was diluted with ethyl acetate and washed with sat. NaHCO3 (x2) and brine. The aqueous 
layers were back extracted with ethyl acetate. The combined organic layers were dried over 
Na2SO4, concentrated, and fractionated by FCC (40% acetone in hexanes) to give the titled 
compound (961 mg, 71%; 62% from 199 over 3 steps): [α]D -35 (c 0.7, CH2Cl2).  
 
IR νmax: 1659, 1611 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.09 (1H, s, HC-6''), 4.45 (1H, br d, J = 10 Hz, HC-2''), 3.39 
(1H, dq, J = 10, 7 Hz, HC-1'), 2.59 (2H, q, J = 7.5 Hz, H2CCH3), 2.52 (1H, dq, J = 1.5, 7 Hz, 
HC-3''), 1.99 (3H, s, H3CC-3 or H3CC-5), 1.94 (3H, s, H3CC-5 or H3CC-3), 1.64 (3H, s, 
H3CC-5''), 1.17 (3H, t, J = 7.5 Hz, H3CCH2), 1.16 (3H, d, J = 7 Hz, H3CC-1'), 1.13 (3H, d, J 
= 7 Hz, H3CC-3''). 
13C NMR (125 MHz, CDCl3): δ 197.2 (s, C-4''), 179.9 (s, C-4), 164.4 (s, C-6), 162.2 (s, C-2), 
159.0 (d, C-6''), 120.0 (s, C-3), 118.3 (s, C-5), 112.7 (s, C-5''), 82.4 (d, C-2''), 41.2 (d, C-7''), 
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36.2 (d, C-1'), 24.9 (t, CH2C-6), 13.6 (q, CH3-C1'), 11.5 (q, CH3CH2), 10.7 (q, CH3C-5''), 9.7 
(q ×2, CH3C-3, CH3C-5), 9.4 (q, CH3C-3''). 
LRMS: m/z (relative intensity) 304 ([M]+, 41), 256 (50), 180 (100), 129 (29), 73 (75) (EI). 
HRMS: m/z calcd for C18H24O4 304.1675, found 304.1682 (EI). 
 
(2R,3S)-3,5-dimethyl-2-((S)-3-oxopentan-2-yl)-2H-pyran-4(3H)-one (208) 
 
O O
208
O
 
 
 
IBX (24 mg, 0.086 mmol) and ethanedithiol (6 L, 6 mg, 0.07 mmol) were added to a stirred 
solution of 199 (ca. 1:1 mixture of anomers; 24 mg, 0.7 mmol) in MeCN (4 mL) at 80 C (oil 
bath temperature). After 1 d, the solution was diluted with ethyl acetate and washed with sat. 
NaHCO3 (x2) and brine, dried over Na2SO4, concentrated, and fractionated by PTLC (50% 
ethyl acetate in hexanes) to give the titled compound (8 mg, 56%, unoptimized).  
 
IR νmax: 1718, 1672, 1623 cm-1. 
1
H NMR (500 MHz, CDCl3): δ 7.12 (1H, s, HC-6), 4.49 (1H, dd, J = 3, 10.5 Hz, HC-2), 3.03 
(1H, dq, J = 10.5, 7 Hz, HC-2'), 2.64-2.49 (2H, m, H2C-4'), 2.40 (1H, dq, J = 3, 7.5 Hz, HC-
3), 1.64 (3H, s, H3CC-5), 1.08 (3H, t, J = 7 Hz, H3C-5'), 1.07 (3H, d, J = 7.5 Hz, H3CC-3), 
0.99 (3H, d, J = 7 Hz, H3C-1'). 
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13
C NMR (125 MHz, CDCl3): δ 212.4 (s, C-3'), 197.2 (s, C-4), 159.0 (d, C-6), 112.8 (s, C-5), 
83.2 (d, C-2), 56.0 (d, C-2'), 41.0 (d, C-3'), 36.8 (t, C-4'), 12.6 (q, C-1'), 10.7 (q, CH3C-5), 9.7 
(q, CH3C-3), 7.6 (q, C-5'). 
LRMS: m/z (relative intensity) 210 ([M]+, 15), 195 (12), 153 (12), 141 (9), 125 (19), 85 (52), 
69 (13), 57 (100) (EI). 
HRMS: m/z calcd. for C12H18O3 210.1256, found 210.1248 (EI). 
 
2-((S)-1-((2S,3R,4S)-4-Hydroxy-3,5-dimethyl-3,4-dihydro-2H-pyran-2-yl)ethyl)-6-ethyl-
3,5-dimethyl-4H-pyran-4-one (209) 
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CeCl37H2O (2.3 g, 6.1 mmol) was added to a stirred solution of 202 (460 mg, 1.5 mmol) in 
EtOH (50 mL) at 0 C. After 20 min, NaBH4 (150 mg, 3.9 mmol) was added and the 
suspension stirred at 0 C for 3 h. The cooling bath was removed and after 3 h, the mixture 
was diluted with ethyl acetate and washed sequentially with sat. NaHCO3 and brine. The 
organic layer was dried over Na2SO4 and concentrated to give the titled compound (437 mg, 
94%): [α]D -29 (c 0.5, CHCl3). 
 
IR νmax: 3364, 1720, 1655, 1610 cm-1. 
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1H NMR (500 MHz, CDCl3): δ 5.96 (br s, 1H, HC-6''), 4.50 (br d, 1H, J = 6 Hz, HC-4''), 
4.04 (br d, 1H, J = 10.5 Hz, HC-2''), 3.27 (dq, 1H, J = 10.5, 7 Hz, HC-1'), 2.60 (q, 2H, J = 
7.5 Hz, H2CC-6), 2.25 (dq, 1H, J = 6, 7 Hz, HC-3''), 1.96 (s, 3H, H3CC-3), 1.94 (s, 3H, 
H3CC-5), 1.57 (s, 3H, H3CC-5''), 1.20 (t, 3H, J = 7.5 Hz, H3CCH2), 1.15 (d, 3H, J = 7 Hz, 
H3CC-1'), 0.98 (d, 3H, J = 7 Hz, H3CC-3''). 
13C NMR (125 MHz, CDCl3): δ 180.1 (s, C-4), 164.3 (s, C-6), 164.0 (s, C-2), 139.7 (d, C-
6''), 119.6 (s, C-3), 118.0 (s, C-5), 109.7 (s, C-5''), 79.4 (d, C-2''), 69.4 (d, C-4''), 36.9 (d, C-
1'), 33.2 (d, C-3''), 25.0 (t, CH2C-6), 14.1 (q, CH3C-1'), 13.6 (q, CH3C-5''), 11.6 (q, CH3CH2), 
9.7 (q ×2, CH3C-3, CH3C-5), 5.0 (q, CH3C-3''). 
LRMS: m/z (relative intensity) 306 ([M]+, 55), 221 (24), 205 (15), 180 (100), 109 (7) (EI). 
HRMS: m/z calcd for C18H26O4 306.1831, found 306.1828 (EI). 
 
2-((S)-1-((2S,3S,4S)-4-(Benzyloxy)-3,5-dimethyl-3,4-dihydro-2H-pyran-2-yl)ethyl)-6-
ethyl-3,5-dimethyl-4H-pyran-4-one (210) 
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KHMDS (0.5 M in toluene; 3 mL, 1.5 mmol) was added portion-wise (1 mL every 10 min) to 
a stirred solution of 209 (170 mg, 0.56 mmol), HMPA (2 mL), BnBr (0.4 mL, 0.57 g, 3.3 
mmol), and t-BuOH (130 mg, 1.8 mmol) in THF (20 mL) at 0 °C under Ar. After 10 min, the 
mixture was diluted with ethyl acetate and washed sequentially with water, sat. NaHCO3 and 
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brine, dried over Na2SO4, concentrated, and fractionated by FCC (40% ethyl acetate in 
hexanes) to give the titled compound (183 mg, 83%): [α]D -10 (c 1.7, C6H6). 
 
IR νmax: 1658, 1610 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.42-7.28 (5H, m, ArH), 5.96 (1H, s, HC-6''), 4.70 (1H, d, J 
= 12 Hz, H2CO), 4.47 (1H, d, J = 12 Hz, H2CO), 4.22 (1H, br d, J = 6 Hz, HC-4''), 4.00 (1H, 
d, J = 10.5 Hz, HC-2''), 3.27 (1H, dq, J = 10.5, 7 Hz, HC-1'), 2.59 (2H, q, J = 7.5 Hz, H2CC-
6), 2.36 (1H, dq, J = 6, 7 Hz, HC-3''), 1.97 (3H, s, H3CC-3), 1.94 (3H, s, H3CC-5), 1.58 (3H, 
s, H3CC-5'), 1.19 (3H, t, J = 7.5 Hz, H3CCH2), 1.16 (3H, d, J = 7 Hz, H3CC-1'), 0.99 (3H, d, 
J = 7 Hz, H3CC-3''). 
13C NMR (125 MHz, CDCl3): δ 180.1 (s, C-4), 164.2 (s, C-6), 163.9 (s, C-2), 139.8 (d, C-
6''), 138.8 (s, Ph), 128.6 (d ×2, Ph), 127.8 (d, Ph), 127.7 (d ×2, Ph), 119.7 (s, C-3), 118.0 (s, 
C-5), 109.4 (s, C-5''), 79.0 (d, C-2''), 76.2 (d, C-4''), 70.9 (t, CH2O), 37.0 (d, C-1'), 29.8 (d, C-
4''), 25.0 (t, CH2C-6), 14.2 (q, CH3C-1' or CH3C-5''), 14.1 (q, CH3C-1' or CH3C-5''), 11.6 (q, 
CH3CH2), 9.7 (q ×2, CH3C-3, CH3C-5), 5.2 (q, CH3C-4''). 
LRMS: m/z (relative intensity): 396 ([M]+, 8), 305 (17), 221 (41), 180 (69), 91 (100) (EI). 
HRMS: m/z calcd for C25H32O4 396.2301, found 396.2293 (EI). 
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(2S,3S,4S)-2-((S)-1-(6-ethyl-3,5-dimethyl-4-oxo-4H-pyran-2-yl)ethyl)-3,5-dimethyl-3,4-
dihydro-2H-pyran-4-yl acetate (211) 
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Ac2O (ca. 50 L, 46 mg, 0.45 mmol) and DMAP (10 mg, 0.08 mmol) were added to a stirred 
solution of 209 (16 mg, 0.05 mmol) in CH2Cl2 (1 mL) at room temperature. After 1 h, the 
mixture was concentrated and fractionated by PTLC (80% ethyl acetate in hexanes) to give 
the titled compound (19 mg, 100%): [α]D -15 (c 0.6, C6H6). 
 
IR νmax: 1735, 1659, 1610 cm-1. 
1
H NMR (500 MHz, CDCl3): δ 6.12 (1H, s, HC-6), 5.62 (1H, br d, J = 6.5 Hz, HC-4), 4.16 
(1H, br d, J = 10 Hz, HC-2), 3.12 (1H, dq, J = 10, 7 Hz, HC-1'), 2.67 (2H, q, J = 7.5 Hz, 
H2CCH3), 2.52 (1H, dq, J = 6.5, 7.5 Hz, HC-3), 2.20 (3H, s, H3CC(O)), 2.03 (3H, s, H3CC-
3''), 2.01 (3H, s, H3CC-5''), 1.56 (3H, s, H3CC-5), 1.27 (3H, t, J = 7.5 Hz, H3CCH2), 1.21 
(3H, d, J = 7 Hz, H3CC-1'), 1.00 (3H, d, J = 7 Hz, H3CC-3). 
13
C NMR (125 MHz, CDCl3): δ 180.1 (s, C-4''), 171.2 (s, COO), 164.3 (s, C-6''), 163.6 (s, C-
2''), 141.2 (d, C-6), 119.7 (s, C-5''), 118.0 (s, C-3''), 106.7 (s, C-5), 78.8 (d, C-2), 71.7 (d, C-
4), 36.8 (d, C-1'), 30.1 (d, C-3), 25.0 (t, CH2CH3), 21.2 (q, CH3C(O)), 14.0 (q, CH3C-1'), 13.6 
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(q, CH3C-5'), 11.5 (q, CH3CH2), 9.7 (q, CH3C-3''or CH3C-5''), 9.7 (q, CH3C-3''or CH3C-5''), 
5.7 (q, CH3C-3). 
LRMS: m/z (relative intensity) 348 ([M]+, 38), 289 (16), 221 (13), 180 (100), 109 (82) (EI). 
HRMS: m/z calcd. for C20H28O5 348.1937, found 348.1933 (EI). 
 
2-ethyl-6-((S)-1-((2S,3R,6S)-6-methoxy-3,5-dimethyl-3,6-dihydro-2H-pyran-2-yl)ethyl)- 
3,5-dimethyl-4H-pyran-4-one (212) 
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Triphenylphosphine hydrobromide (ca. 1 mg) and MeOH (20 L) were added to a stirred 
solution of 211 (6 mg, 0.17 mmol) in CH2Cl2 (1 mL). The solution was stirred for 1 day and 
added to ethyl acetate. The organic layer was washed with sat. NaHCO3 and brine, dried over 
Na2SO4, concentrated, and fractionated by PTLC (30% acetone in hexanes; 2 elutions) to 
give the titled compound (4 mg, 73%). 
IR νmax: 1657, 1613 cm-1. 
1
H NMR (500 MHz, CDCl3):  5.69 (1H, d, J = 5.5 Hz, HC-4''), 4.44 (1H, s, HC-6''), 4.08 
(1H, dd, J = 2, 10.5 Hz, HC-2''), 3.12 (1H, dq, J = 10.5, 7 Hz, HC-1'), 2.97 (3H, s, H3CO), 
2.68-2.55 (2H, m, H2CCH3), 2.17-2.09 (1H, m, HC-3''), 2.01 (3H, s, H3C-5), 1.95 (3H, s, 
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H3C-3), 1.66 (3H, s, H3C-5''), 1.23 (3H, t, J = 7.5 Hz, H3CCH2), 1.15 (3H, d, J = 5 Hz, H3C-
1'), 0.98 (3H, d, J = 5 Hz, H3C-3''). 
13
C NMR (125 MHz, CDCl3):  180.1, 164.8, 164.3, 131.6, 129.7, 119.8, 118.0, 99.3, 71.1, 
55.2, 37.0, 30.3, 25.0, 25.0, 13.8, 12.1, 11.6, 9.9, 9.8. 
LRMS: m/z (relative intensity): 320 ([M]+, 31), 289 (28), 180 (100), 141 (9), 113 (62), 83 
(35) (EI). 
HRMS: m/z calcd. for C19H28O4 320.1988, found 320.1979 (EI). 
 
 
2-((2S,3S,4S,5R,6R)-5-(Benzyloxy)-3,7-dihydroxy-4,6-dimethylheptan-2-yl)-6-ethyl-3,5-
dimethyl-4H-pyran-4-one (213) 
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A solution of Hg(OAc)2 (130 mg, 0.41 mmol) in water (14 mL) was added to a stirred 
solution of 210 (139 mg, 0.35 mmol) in THF (14 mL) at rt. The resulting yellow suspension 
was stirred at this temperature for 2 h and then a solution of Na2CO3 (120 mg, 1.1 mmol) in 
water (10 mL) was added in one portion. After 10 min, a solution of NaBH4 (32 mg, 0.84 
mmol) in water (2 mL) was added. After 1 min, the mixture was diluted with water and 
extracted with CH2Cl2. The combined organic layers were dried over Na2SO4, concentrated, 
and the residue taken up in ethanol (10 mL), and then NaBH4 (105 mg, 2.8 mmol) was added 
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to the stirred solution at rt. After ca. 16 h, the mixture was diluted with water and extracted 
with CH2Cl2. The combined organic layers were dried over Na2SO4, concentrated, and 
fractionated by FCC (100% ethyl acetate) to give 214 (24 mg, 16%) and the titled compound 
(91 mg, 62%): [α]D -9 (c 0.6, CHCl3).  
 
IR νmax: 3401, 1652, 1589 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.33-7.26 (5H, m, ArH), 4.72-4.66 (2H, m, H2CPh), 4.22 
(1H, br d, J = 10 Hz, HC-3'), 3.84-3.77 (1H, m, HC-7'), 3.75-3.68 (1H, m, HC-7'), 3.59 (1H, 
dd, J = 4, 7.5 Hz, HC-5'), 3.13 (1H, br s, HOC-3'), 3.11 (1H, dq, J = 10, 7 Hz, HC-2'), 2.64-
2.51 (2H, m, H2CC-6), 2.22 (1H, br s, HOC-7'), 2.09-2.03 (1H, m, HC-6'), 2.03-1.97 (1H, m, 
HC-4'), 1.98 (3H, s, H3CC-3), 1.90 (3H, s, H3CC-5), 1.17 (3H, t, J = 7.5 Hz, H3CCH2), 1.14 
(3H, d, J = 7 Hz, H3CC-4'), 1.10 (3H, d, J = 7 Hz, H3C-1'), 1.07 (3H, d, J = 7 Hz, H3CC-6'). 
13C NMR (125 MHz, CDCl3): δ 180.0 (s, C-4), 164.8 (s, C-2), 164.2 (s, C-6), 137.8 (s, Ph), 
128.8 (d ×2, Ph), 128.3 (d, Ph), 128.0 (d ×2, Ph), 119.6 (s, C-3), 118.0 (s, C-5), 88.2 (d, C-
5'), 76.6 (t, CH2Ph), 72.1 (s, C-3'), 65.3 (d, C-7'), 39.1 (d, C-2'), 38.0 (d, C-6'), 35.6 (d, C-4'), 
25.0 (t, CH2C-6), 15.2 (q, CH3C-6'), 14.7 (q, C-1'), 11.4 (q, CH3CH2), 11.0 (q, CH3C-4'), 9.9 
(q, CH3C-3 or CH3C-5), 9.7 (q, CH3C-3 or CH3C-5). 
LRMS: m/z (relative intensity) 416 ([M]+, 0.4), 357 (2), 270 (3), 180 (100), 91 (56) (EI). 
HRMS: m/z calcd for C25H36O5 416.2563, found 416.2559 (EI). 
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2-((2S,3S,4S,5R,6S)-5-(Benzyloxy)-3,7-dihydroxy-4,6-dimethylheptan-2-yl)-6-ethyl-3,5-
dimethyl-4H-pyran-4-one (214) 
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Isolated as a minor compound in the preceding reaction. 
 
 
[α]D -19 (c 1.0, CHCl3). 
IR νmax (Thin Film): 3399, 1653, 1592, 1557 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.25-7.26 (5H, m, ArH), 4.67 (1H, d, J = 11 Hz, CHPh), 4.63 
(1H, d, J = 11 Hz, CHPh), 4.22 (1H, br d, J = 10 Hz, HC-3'), 3.70-3.61 (3H, m, HC-5', H2C-
7'), 3.11 (1H, dq, J = 10, 7 Hz, HC-2'), 2.64-2.49 (2H, m, H2CC-6), 2.10-2.03 (2H, m, HC-
6'), 2.03-1.96 (1H, m, HC-4'), 1.98 (3H, s, H3CC-3), 1.91 (3H, s, J = 7.5 Hz, H3CC-5), 1.14 
(3H, t, J = 7 Hz, H3CCH2), 1.11 (3H, d, J = 7 Hz, H3C-1'), 1.03 (3H, d, J = 7 Hz, H3CC-6'), 
1.02 (3H, d, H3CC-4'). 
13C NMR (125 MHz, CDCl3): δ 180.0 (s, C-4), 164.9 (s, C-2), 164.3 (s, C-6), 138.5 (s, Ph), 
128.0 (d ×2, Ph), 127.9 (d, Ph), 127.9 (d ×2, Ph), 119.7 (s, C-3), 118.1 (s, C-5), 83.8 (d, C-
5'), 75.6 (t, CH2Ph), 72.4 (d, C-3'), 66.2 (t, C-7'), 39.5 (d, C-2'), 38.5 (d, C-6'), 35.6 (d, C-4'), 
25.0 (t, CH2C-6), 14.8 (q, C-1'), 12.0 (q, CH3C-6'), 11.4 (q, CH3CH2), 10.2 (q, CH3C-4'), 9.9 
(q, CH3C-3 or CH3C-5), 9.7 (q, CH3C-3 or CH3C-5). 
LRMS: m/z (relative intensity) 417 ([M+1]+, 100), 236 (7), 209 (10), 181 (31) (CI, NH3). 
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HRMS: m/z calcd for C25H36O5 416.2563 (417.2641 for M+H), found 417.2636 (CI, NH3). 
 
6-Ethyl-2-((S)-1-((2S,3S,4S)-4-((4-methoxybenzyl)oxy)-3,5-dimethyl-3,4-dihydro-2H-
pyran-2-yl)ethyl)-3,5-dimethyl-4H-pyran-4-one (215) 
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KHMDS (0.40 mL, 0.20 mmol; 0.5 M in toluene) was added in 3 portions (0.16, 0.16 and 
0.08 mL) over 20 min to a solution of 210 (24 mg, 0.08 mmol), HMPA (0.5 mL), PMBCl (50 
L, 56 mg, 0.36 mmol), and t-BuOH (20 mg, 0.27 mmol) in THF (5 mL) at rt under Ar. 
After 10 min, the mixture was diluted with ethyl acetate, washed sequentially with sat. 
NaHCO3, water, and brine, dried over Na2SO4, concentrated, and fractionated by PTLC (80% 
ethyl acetate in hexanes) to give the titled compound (24 mg, 74%; unoptimized): [α]D -14 (c 
1.5, C6H6).  
 
IR νmax: 1656, 1610 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.31 (2H, ap d, J = 8.5 Hz, ArH), 6.90 (2H, ap d, J = 8.5 Hz, 
ArH), 5.94 (1H, s, HC-6''), 4.62 (1H, d, J = 11.5 Hz, H2CO), 4.39 (1H, d, J = 11.5 Hz, 
H2CO), 4.19 (1H, d, J = 6 Hz, HC-4''), 3.99 (1H, br d, J = 10.5 Hz, HC-2''), 3.80 (3H, s, 
H3CO), 3.26 (1H, dq, J = 10.5, 7 Hz, HC-1'), 2.59 (2H, q, J = 7.5 Hz, H2CC-6), 2.34 (1H, 
ddq, J = 1.5, 6, 7 Hz, HC-3''), 1.96 (3H, s, H3CC-3), 1.93 (3H, s, H3CC-5), 1.54 (3H, s, 
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H3CC-5''), 1.18 (3H, t, J = 7.5 Hz, H3CCH2), 1.15 (3H, d, J = 7 Hz, H3CC-1'), 0.97 (3H, d, J 
= 7 Hz, H3CC-3''). 
13C NMR (125 MHz, CDCl3): δ 180.1 (s, C-4), 164.2 (s, C-6), 164.0 (s, C-2), 159.4 (s, Ar), 
139.7 (d, C-6''), 130.9 (s, Ar), 129.3 (d ×2, Ar), 119.6 (s, C-3), 118.0 (s, C-5), 114.0 (d ×2, 
Ar), 109.4 (s, C-5''), 79.1 (d, C-2''), 75.8 (d, C-4''), 70.6 (t, CH2O), 55.5 (q, CH3O), 37.0 (d, 
C-1'), 29.8 (d, C-3''), 25.0 (t, CH2C-6), 14.2 (q, CH3C-1' or CH3C-5'), 14.1 (q, CH3C-1' or 
CH3C-5'), 11.6 (q, CH3CH2), 9.7 (q ×2, CH3C-3, CH3C-5), 5.2 (q, CH3C-3''). 
LRMS: m/z (relative intensity) 426 ([M]+, 6), 290 (50), 221 (26), 180 (39), 121 (100) (EI). 
HRMS: m/z calcd for C26H34O5 426.2406, found 426.2391 (EI). 
 
2-((2S,3S,4S,5R,6S)-3,7-Dihydroxy-5-((4-methoxybenzyl)oxy)-4,6-dimethylheptan-2-yl)-
6-ethyl-3,5-dimethyl-4H-pyran-4-one (216) 
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Further fractionation of 80 by PTLC (10% MeOH in CH2Cl2) gave a pure sample (2.5 mg, 
16%). 
 
IR νmax: 3397, 1651, 1588 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.24 (2H, ap d, J = 8.5 Hz, ArH), 6.84 (2H, ap d, J = 8.5 Hz, 
ArH), 4.60 (1H, d, J = 11 Hz, CHAr), 4.55 (1H, d, J = 11 Hz, CHAr), 4.21 (1H, br d, J = 10 
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Hz, HC-3'), 3.78 (3H, s, H3CO), 3.64-3.61 (3H, m, HC-5', H2C-7'), 3.15-3.07 (1H, m, HC-2'), 
2.65-2.53 (2H, m, H2CC-6), 2.41 (1H, br s, HOC-3'), 2.10-2.03 (1H, m, HC-6'), 2.01-1.91 
(1H, m, HC-4'), 1.99 (3H, s, H3CC-3), 1.93 (3H, s, H3CC-5), 1.17 (3H, t, J = 7.5 Hz, 
H3CCH2), 1.11 (3H, d, J = 7 Hz, H3C-1'), 1.03 (3H, d, J = 7 Hz, H3CC-6'), 1.01 (3H, d, J = 7 
Hz, H3CC-4'). 
13C NMR (125 MHz, CDCl3): δ 180.0 (s, C-4), 164.8 (s, C-2), 164.2 (s, C-6), 159.6 (s, Ar), 
130.5 (s, Ar), 129.6 (d x 2, Ar), 119.7 (s, C-3), 118.1 (s, C-5), 114.1 (d x 2, Ar), 83.8 (d, C-
5'), 75.2 (t, CH2Ar), 72.4 (d, C-3'), 66.2 (t, C-7'), 55.5 (q, CH3O), 39.4 (d, C-2'), 38.5 (d, C-
6'), 36.4 (d, C-4'), 25.0 (t, CH2C-6), 14.8 (q, C-1'), 12.2 (q, CH3C-6'), 11.5 (q, CH3CH2), 10.4 
(q, CH3C-4'), 9.9 (q, CH3C-3 or CH3C-5), 9.8 (q, CH3C-3 or CH3C-5). 
LRMS: m/z (relative intensity) 446 ([M]+, 1), 310 (7), 209 (12), 180 (55), 121 (100) (EI). 
HRMS: m/z calcd for C26H38O6 446.2668, found 446.2672 (EI). 
 
2-((2S,3S,4R,5R,6R)-5-(Benzyloxy)-7-hydroxy-3-(methoxymethoxy)-4,6-
dimethylheptan-2-yl)-6-ethyl-3,5-dimethyl-4H-pyran-4-one (217) 
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2,6-Lutidine (35 L, 38 mg, 0.36 mmol) and Et3SiOTf (57 L, 67 mg, 0.25 mmol) were 
sequentially added to a stirred solution of 216 (100 mg, 0.24 mmol) in CH2Cl2 (2 mL) at 
room temperature under Ar. After 1 h, DIPEA (0.42 mL, 0.31 g, 2.4 mmol), 
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tetrabutylammonium iodide (95 mg, 0.26 mmol) and MOMCl (0.2 mL, 0.2 g, 2.4 mmol) 
were sequentially added and then the flask was fitted with a stopper. After 4 d, MeOH (2 
mL) and tetrabutylammonium fluoride (100 mg, 0.38 mmol) were sequentially added. After 
3 h, the mixture was diluted with ethyl acetate and washed sequentially with HCl (1 M), sat. 
NaHCO3, and brine. The organic layer was dried over Na2SO4, concentrated, and fractionated 
by FCC (80% ethyl acetate) to give the titled compound (102 mg, 92%): [α]D -77 (c 1.5, 
CH2Cl2). 
 
IR νmax: 3419, 1654, 1609, 1593 cm-1. 
1H NMR (500 MHz, CDCl3): δ 7.36-7.23 (5H, m, ArH), 4.82 (1H, d, J = 11 Hz, HCPh), 4.73 
(1H, d, J = 11 Hz, HCPh), 4.29 (1H, d, J = 7 Hz, OCHO), 4.26 (1H, d, J = 7 Hz, OCHO), 
4.03 (1H, br d, J = 9.5 Hz, HC-3'), 3.89 (1H, dd, J = 3, 11 Hz, HC-7'), 3.67-3.61 (1H, m, HC-
7'), 3.53 (1H, br d, J = 8 Hz, HC-5'), 3.22-3.16 (1H, m, HC-2'), 3.21 (3H, s, H3CO), 2.89 (1H, 
br s, HO), 2.55-2.40 (2H, m, H2CCH3), 2.07-1.95 (2H, m, HC-4', HC-6'), 1.97 (3H, s, H3CC-
3), 1.91 (3H, s, H3CC-5), 1.25 (3H, d, J = 7 Hz, H3CC-6'), 1.12 (3H, d, J = 7 Hz, H3C-1'), 
1.06 (3H, t, J = 7.5 Hz, H3CCH2), 0.94 (3H, d, J = 7 Hz, H3CC-4'). 
13C NMR (125 MHz, CDCl3): δ 180.0 (s, C-4), 164.7 (s, C-2), 164.2 (s, C-6), 138.8 (s, Ph), 
128.6 (d ×2, Ph), 127.8 (d, Ph), 127.3 (d ×2, Ph), 119.7 (s, C-3), 118.1 (s, C-5), 98.0 (t, 
OCH2O), 86.5 (d, C-5'), 82.0 (d, C-3'), 75.4 (t, CH2Ph), 64.7 (t, C-7'), 55.7 (q, CH3O), 39.2 
(d, C-2'), 38.8 (d, C-4'), 36.5 (d, C-6'), 24.9 (t, CH2C-6), 16.8 (q, CH3C-6'), 15.1 (q, C-1'), 
11.5 (q, CH3CH2), 10.5 (q, CH3C-4'), 9.8 (q, CH3C-3 or CH3C-5), 9.7 (q, CH3C-3 or CH3C-
5). 
LRMS: m/z (relative intensity) 461 ([M+1]+, 100), 224 (43), 180 (37), 91 (15) (CI, NH3). 
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HRMS: m/z calcd for C27H40O6 460.2903 (461.2903 for M+H), found 461.2918 (CI, NH3).  
 
(2S,3S,4R,5S,6S)-3-(Benzyloxy)-6-(6-ethyl-3,5-dimethyl-4-oxo-4Hpyran-2-yl)-5-
(methoxymethoxy)-2,4-dimethylheptanal (218) 
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IBX (50 mg, 0.14 mmol) was added to a stirred solution of 217 (56 mg, 0.12 mmol) in dry 
DMSO (2 mL) at room temperature under Ar. After 3 h, the mixture was diluted with ethyl 
acetate and washed sequentially with sat. NaHCO3, water and brine, dried over Na2SO4, and 
concentrated to give the titled compound (56 mg, 100%): [α]D -52 (c 0.8, C6H6). 
 
IR νmax: 1721, 1655, 1609 cm-1. 
1H NMR (500 MHz, C6D6): δ 9.64 (1H, s, HC-1), 7.32 (2H, ap d, J = 7.5 Hz, ArH), 7.20 
(2H, ap t, J = 7.5 Hz, ArH), 7.15-7.10 (1H, ap t, J = 7.5 Hz, ArH), 4.47 (1H, d, J = 11 Hz, 
HCPh), 4.43 (1H, d, J = 11 Hz, HCPh), 4.19 (1H, br d, J = 9.5 Hz, HC-5), 4.19 (1H, d, J = 7 
Hz, OCHO), 4.14 (1H, d, J = 7 Hz, OCHO), 3.84 (1H, dd, J = 3.5, 10 Hz, HC-3), 3.00 (3H, s, 
H3CO), 2.98 (1H, dq, J = 10, 7 Hz, HC-6), 2.50 (1H, ap dq, J = 2, 7 Hz, HC-2), 2.11 (3H, s, 
H3CC-3'), 2.10-2.00 (2H, m, H2CCH3), 1.95 (3H, s, H3CC-5'), 1.94-1.82 (1H, m, HC-4), 1.11 
(3H, d, J = 7 Hz, H3CC-2), 0.84 (3H, d, J = 7 Hz, H3C-7), 0.83 (3H, t, J = 7.5 Hz, H3CCH2), 
0.73 (3H, d, J = 7 Hz, H3CC-4). 
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13C NMR (125 MHz, C6D6): δ 202.5 (d, C-1), 179.3 (s, C-4'), 164.2 (s, C-2'), 163.5 (s, C-6'), 
139.4 (s, Ph), 129.0 (d ×2, Ph), 128.7 (d, Ph), 128.1 (d ×2, Ph), 120.1 (s, C-3'), 118.4 (s, C-
5'), 98.6 (t, OCH2O), 82.3 (d, C-5), 81.6 (d, C-3), 72.8 (t, CH2Ph), 55.9 (q, CH3O), 48.6 (d, 
C-2), 39.3 (d, C-6), 38.2 (d, C-4), 24.9 (t, CH2C-6'), 15.0 (q, C-7), 11.7 (q, CH3CH2), 10.2 (q, 
CH3), 10.1 (q ×2, CH3 ×2), 9.6 (q, CH3C-2). 
LRMS: m/z (relative intensity) 459 ([M+1]+, 100), 351 (51), 224 (76), 180 (16), 91 (14) (CI, 
NH3). 
HRMS: m/z calcd for C27H38O6 458.2668 (459.2747 for M+H), found 459.2741 (CI, NH3). 
 
(2R,3R,4R,5S,6S)-3-(Benzyloxy)-6-(6-ethyl-3,5-dimethyl-4-oxo-4H-pyran-2-yl)-2,4-
dimethylheptane-1,5-diyl Diacetate (219) 
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Acetic anhydride (0.2 mL, 0.2 g, 2 mmol) and DMAP (70 mg, 0.57 mmol) were added to a 
stirred solution of 216 (67 mg, 0.16 mmol) in CH2Cl2 (5 mL) at room temperature. After 3 h, 
the mixture was concentrated and the residue fractionated by FCC (80% ethyl acetate in 
hexanes) to give the titled compound (78 mg, 97%). 
 
IR νmax: 1737, 1656, 1610 cm-1. 
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1
H NMR (500 MHz, CDCl3):  7.38-7.34 (2H, m, Ph), 7.32 (2H, m, Ph), 7.29-7.24 (1H, m, 
Ph), 5.50 (1H, br d, J = 10 Hz, HC-5), 4.60-4.54 (2H, m, H2CPh), 4.29 (1H, dd, J = 5, 11 Hz, 
HC-1), 4.04 (1H, dd, J = 8, 11 Hz, HC-1), 3.23 (1H, dq, J = 10, 7 Hz, HC-6), 3.16 (1H, dd, J 
= 3.5, 8.5 Hz, HC-3), 2.61-2.47 (2H, m, H2CCH3), 2.24 (1H, dddq, J = 3.5, 5, 8, 7 Hz, HC-
2), 2.09 (1H, ddq, J = 8.5, 10, 7 Hz, HC-4), 2.05 (3H, s, H3CCOOC-5), 1.96 (3H, s, H3CC-
3'), 1.91 (3H, s, H3CC-5'), 1.76 (3H, s, H3CCOOC-1), 1.17 (3H, d, J = 7 Hz, H3CC-2), 1.15 
(3H, t, J = 7.5 Hz, H3CCH2), 1.14 (3H, d, J = 7 Hz, H3CC-6), 1.05 (3H, d, J = 7 Hz, H3CC-
4). 
13
C NMR (125 MHz, CDCl3):  179.9 (s, C-4'), 171.3 (s, COOC-5 ), 169.9 (s, COOC-1), 
164.9 (s, C-6'), 163.1 (s, C-2'), 138.9 (s, Ph), 128.4 (d x2, Ph), 127.8 (d x2, Ph), 127.7 (d, Ph), 
119.5 (d, C-3'), 117.9 (d, C-5'), 83.9 (d, C-3), 75.6 (t, CH2Ph), 74.3 (d, C-5), 66.0 (t, C-1), 
37.7 (d, C-6), 37.1 (d, C-4), 35.3 (d, C-2), 24.9 (t, CH2CH3), 21.2 (q, CH3COOC-5 ), 20.8 (q, 
CH3COOC-1), 16.3 (q, CH3C-6), 14.5 (q, CH3C-2), 11.2 (q, CH3CH2), 10.4 (q, CH3C-4), 9.8 
(q, CH3C-3' or CH3C-5'), 9.7 (q, CH3C-3' or CH3C-5'). 
LRMS: m/z (relative intensity) 500 ([M]+, 4), 394 (19), 335 (34), 251 (13), 180 (86), 91 
(100) (EI) 
HRMS: m/z calcd. for C29H40O7 500.2774, found 500.2774 (EI). 
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(2S,3S,4R,5R,6R)-5-(Benzyloxy)-2-(6-ethyl-3,5-dimethyl-4-oxo-4H-pyran-2-yl)-7-
hydroxy-4,6-dimethylheptan-3-yl Acetate (220) 
 
Ac
O
220
O
O
Bn
O
HO
6' 4'
3'
2'
2 3
5
6
5'7'
 
 
K2CO3 (109 mg, 0.79 mmol) was added to a stirred solution of 219 (78 mg, 0.16 mmol) in 
MeOH (8 mL) and water (0.4 mL). After 3 h at rt, the mixture was diluted with water and 
extracted with CH2Cl2. The combined organic layers were dried over Na2SO4, and 
concentrated to give the titled compound (71 mg, 99%): [α]D -84 (c 1.5, C6H6). 
 
IR νmax: 3432, 1737, 1653, 1609, 1593 cm-1. 
1
H NMR (500 MHz, CDCl3):  7.38 (2H, ap d, J = 7 Hz, Ph), 7.35-7.27 (3H, m, Ph), 5.53 
(1H, br d, J = 10 Hz, HC-3), 4.65 (1H, d, J = 10 Hz, HCPh), 4.58 (1H, d, J = 10 Hz, HCPh), 
3.86 (1H, dd, J = 4, 11 Hz, HC-7), 3.64 (1H, dd, J = 4, 11 Hz, HC-7), 3.28-3.20 (2H, m, HC-
2, HC-4), 2.71 (1H, br s, HO), 2.62-2.49 (2H, m, H2CCH3), 2.12 (1H, dq, J = 8.5, 7 Hz, HC-
4), 2.05-2.12 (1H, m, HC-6), 1.96 (3H, s, H3CC-3'), 1.92 (3H, s, H3CC-5'), 1.77 (3H, s, 
H3CCO), 1.23 (3H, d, J = 7 Hz, H3CC-6), 1.17 (3H, d, J = 7 Hz, H3CC-2), 1.17 (3H, t, J = 
7.5 Hz, H3CCH2), 1.02 (3H, d, J = 7 Hz, H3CC-4). 
13
C NMR (125 MHz, CDCl3):  179.9 (s, C-4'), 169.9 (s, COOC-3), 164.9 (s, C-6'), 163.0 (s, 
C-2'), 138.4 (s, Ph), 128.6 (d x2, Ph), 128.1 (d x2, Ph), 128.0 (d, Ph), 119.5 (s, C-3'), 117.9 (s, 
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C-5'), 86.1 (d, C-5), 76.1 (t, CH2Ph), 74.2 (d, C-3), 64.6 (t, C-7), 37.7 (d, C-2), 37.5 (d, C-4), 
36.8 (d, C-6), 24.9 (t, CH2CH3), 20.8 (q, CH3COOC-3), 16.5 (q, CH3C-6), 14.5 (q, CH3C-2), 
11.3 (q, CH3CH2), 10.6 (q, CH3C-4), 9.8 (q, CH3C-3' or CH3C-5'), 9.7 (q, CH3C-3' or CH3C-
5'). 
LRMS: m/z (relative intensity) 458 ([M]+, 5), 399 (12), 352 (19), 293 (17), 251 (10), 180 
(100), 91 (90) (EI). 
HRMS: m/z calcd. for C27H38O6 458.2668, found 458.2669 (EI). 
 
(2S,3S,4R,5S,6S)-5-(Benzyloxy)-2-(6-ethyl-3,5-dimethyl-4-oxo-4H-pyran-2-yl)-4,6-
dimethyl-7-oxoheptan-3-yl Acetate (221) 
 
Ac
O
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O
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31
 
 
IBX (30 mg, 0.11 mmol) was added to a stirred solution of 220 (30 mg, 0.066 mmol) in dry 
DMSO (2 mL) at rt. The solution was stirred for 5 hours at rt and added to ethyl acetate. The 
organic layer was washed with sat. NaHCO3, water, and brine, dried over Na2SO4, and 
concentrated to give the titled compound (26 mg, 87%). 
 
1
H NMR (500 MHz, CDCl3):  9.81 (1H, br s, HC-7), 7.38 (2H, ap d, J = 7.5 Hz, Ph), 7.35-
7.27 (3H, m, Ph), 5.62 (1H, br d, J = 10 Hz, HC-3), 4.56-4.49 (2H, m, H2CPh), 3.57 (1H, dd, 
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J = 3, 9 Hz, HC-5), 3.27 (1H, dq, J = 10, 7 Hz, HC-2), 2.84 (1H, ddq, J = <1, 3, 7 Hz, HC-6), 
2.65-2.49 (2H, m, H2CCH3), 2.08 (1H, dq, J = 9, 7 Hz, HC-4), 1.95 (3H, s), 1.93 (3H, s), 
1.81 (3H, s), 1.25 (3H, d, J = 7 Hz), 1.18 (3H, t, J = 7.5 Hz, H3CCH2), 1.16 (3H, d, J = 7 Hz), 
0.91 (3H, d, J = 7 Hz). 
13
C NMR (125 MHz, CDCl3):  203.9, 180.0, 169.9, 165.0, 163.0, 138.2, 128.5, 128.2, 
128.0, 119.5, 117.9, 81.7, 74.0, 73.9, 48.6, 37.5, 37.0, 24.9, 20.8, 14.4, 11.2, 10.1, 9.9, 9.8, 
9.7. 
LRMS: m/z (relative intensity) 456 ([M]+, 1), 321 (8), 180 (100), 91 (58) (EI). 
HRMS: m/z calcd. for C27H36O6 456.2512, found 456.2491 (EI). 
 
2-((2S,3S,4R,5R,6R,7R)-5-(Benzyloxy)-7-hydroxy-3-(methoxymethoxy)-7-((3S,5S)-5-
((R)-(methoxymethoxy)((S)-1,4-dioxa-8-thiaspiro[4.5]decan-6-yl)methyl)-4-
oxotetrahydro-2H-thiopyran-3-yl)-4,6-dimethylheptan-2-yl)-6-ethyl-3,5-dimethyl-4H-
pyran-4-one (223) 
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A solution of TiCl4 (30 L, 52 mg, 0.27 mmol) in CH2Cl2 (0.3 mL) was added to a stirred 
solution of 222 (88 mg, 0.25 mmol) in CH2Cl2 (6 mL) at -78 °C under Ar. The resulting 
yellow suspension was stirred for 2 min and then DIPEA (130 L, 96 mg, 0.74 mmol) was 
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added. The resulting red solution was stirred for 1.5 hrs and then a solution of 218 (56 mg, 
0.12 mmol) in CH2Cl2 (0.5 mL plus 2 x 0.5 mL rinses) was added dropwise via syringe. Over 
the course of 3 h, the red color faded to orange. The mixture was diluted with ethyl acetate 
and washed sequentially with sat. NH4Cl (x2), sat. NaHCO3, water, and brine. The aqueous 
layers were back extracted with ethyl acetate. The combined organic layers were dried over 
Na2SO4, concentrated, and fractionated by FCC (50-70% ethyl acetate in hexanes) to give 
recovered ketone (46 mg, 52%) and the titled compound essentially as a single diastereomer 
(dr>20:1 by 1H NMR) (78 mg, 79%): [α]D -69 (c 0.7, C6H6). 
 
IR νmax: 3456, 1706, 1654, 1609 cm-1.  
1H NMR (500 MHz, CDCl3): δ 7.35-7.26 (5H, m, ArH), 4.85 (1H, d, J = 11 Hz, HCPh), 4.81 
(1H, d, J = 11 Hz, HCPh), 4.68 (1H, d, J = 5.5 Hz, HCOC-1'''), 4.57 (1H, d, J = 5.5 Hz, 
HCOC-1'''), 4.47 (1H, br d, J = 9.5 Hz, HC-7'), 4.29-4.23 (2H, m, HC-1''', HCOC-3'), 4.15 
(1H, d, J = 7 Hz, HCOC-3'), 4.14-3.92 (5H, m, HC-3', H2CO ×2), 4.12 (1H, s, HO), 3.60 
(1H, br d, J = 10 Hz, HC-5'), 3.35 (3H, s, H3CO), 3.25 (3H, s, H3CO), 3.27-3.17 (2H, m, HC-
2', HC-2''), 3.11-3.00 (2H, m, HC-3'', HC-6''), 2.92-2.81 (3H, m, HC-2'', HC-5'', HC-6''), 
2.81-2.71 (3H, m, H2C-7''', HC-9'''), 2.56-2.37 (3H, m, H2CC-6. HC-9'''), 2.22-2.09 (3H, m, 
HC-4', HC-6''', HC-10'''), 2.02-1.94 (1H, m, HC-6'), 1.97 (3H, s, H3CC-3), 1.91 (3H, s, 
H3CC-5), 1.65 (1H, ddd, J = 3, 12, 13.5 Hz, HC-10'''), 1.24 (3H, d, J = 7 Hz, H3CC-6'), 1.15 
(3H, d, J = 7 Hz, H3C-1'), 1.04 (3H, t, J = 7.5 Hz, H3CCH2), 1.00 (3H, d, J = 7 Hz, H3CC 4'). 
13C NMR (125 MHz, CDCl3): δ 210.1 (d, C-4''), 180.0 (s, C-4), 164.7 (s, C-2), 164.1 (s, C-
6), 138.4 (s, Ph), 128.7 (d ×2, Ph), 127.9 (d, Ph), 127.2 (d ×2, Ph), 119.8 (s, C-3), 118.2 (s, 
C-5), 108.7 (s, C-5'''), 97.8 (t, CH2OC-3'), 97.4 (t, CH2OC-1'''), 88.4 (d, C-5'), 82.3 (d, C-3'), 
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75.9 (t, CH2Ph), 74.2 (d, C-1'''), 68.5 (d, C-7'), 64.9 (t, CH2O), 64.7 (t, CH2O), 59.1 (d, C-5''), 
56.3 (q, CH3O), 55.7 (q, CH3O), 53.7 (d, C-3''), 50.2 (d, C-6'''), 39.2 (d, C-2'), 38.4 (d, C-4'), 
36.1 (t, C-10'''), 35.6 (d, C-6'), 32.0 (t, C-6''), 31.9 (t, C-2''), 28.4 (t, C-7'''), 26.8 (t, C-9'''), 
24.9 (t, CH2C-6), 15.3 (q, C-1'), 13.0 (q, CH3C-6'), 11.6 (q, CH3CH2), 10.2 (q, CH3C-4'), 9.8 
(q, CH3C-3 or CH3C-5), 9.7 (q, CH3C-3 or CH3C-5). 
LRMS: m/z (relative intensity) 829 ([M+23]+, 35), 807 ([M+1]+, 100), 459 (4), 351 (6) (ESI). 
HRMS: m/z calcd for C42H62O11S2 806.3634 (807.3812 for [M+H]+), found 807.3816 (ESI). 
 
 
2-((S)-1-((2S,3R,4S,5S,6S)-4-(Benzyloxy)-6-methoxy-3,5-dimethyltetrahydro-2H-pyran-
2-yl)ethyl)-6-ethyl-3,5-dimethyl-4H-pyran-4-one (226) 
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FeCl36H2O (34 mg, 0.13 mmol) was added to a stirred solution of 223 (34 mg, 0.042 mmol) 
in acetone (12 mL) and methanol (0.6 mL) and the resulting yellow solution was heated 
under reflux. After 3.5 h, the mixture was diluted with CH2Cl2 and washed sequentially with 
water and brine. The aqueous layers were back extracted with CH2Cl2. The combined organic 
layers were dried over Na2SO4, concentrated, and fractionated by PTLC (90% ethyl acetate 
in hexanes) to give the putative deprotected compound (12 mg, crude) that was insufficiently 
pure for characterization (and could not be purified further) and the titled compound (7 mg, 
39%): [α]D 34 (c 0.4, C6H6).  
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IR νmax: 1656, 1612 cm-1. 
1
H NMR (500 MHz, C6D6):  7.31 (2H, ap d, J = 7.5 Hz, Ph), 7.19 (2H, ap d, J = 7.5 Hz, 
Ph), 7.10 (1H, ap t, J = 7.5 Hz, Ph), 4.32-4.16 (3H, m, HC-6', H2CPh), 3.97 (1H, dd, J = 2.5, 
10.5 Hz, HC-2'), 3.89 (1H, dd, J = 5.5, 5.5 Hz, HC-4'), 3.12 (1H, dq, J = 10.5, 7 Hz, HC-1'), 
2.81 (3H, s, H3CO), 2.24 (3H, s, H3CC-3), 2.26-2.05 (4H, m, HC-5', 3', H2CCH3), 1.99 (3H, 
s, H3CC-5), 1.06 (3H, d, J = 7 Hz, H3CC-5'), 1.06 (3H, d, J = 7 Hz, H3CC-3'), 0.92 (3H, t, J = 
7.5 Hz, H3CCH2), 0.88 (3H, d, J = 7 Hz, H3CC-1'). 
13
C NMR (125 MHz, C6D6):  179.3 (s, C-4), 164.1 (s, C-2), 163.2 (s, C-6), 139.8 (s, Ph), 
128.9 (d x2, Ph (DEPT)), 128.0 (d, Ph), 127.9 (d x2, Ph (DEPT)), 120.5 (s, C-3), 118.6 (s, C-
5), 104.7 (d, C-6'), 76.0 (d, C-4'), 71.9 (d, C-2'), 70.1 (t, CH2Ph), 54.5 (q, CH3O), 37.3 (d, C-
1'), 37.1 (d, C-5'), 34.0 (d, C-3'), 25.0 (t, CH2CH3), 13.7 (q, CH3C-5'), 13.5 (q, CH3C-1'), 11.8 
(q, CH3CH2), 10.5 (q, CH3C-3), 10.2 (q, CH3C-5), 8.1 (q, CH3C-3'). 
LRMS: m/z (relative intensity): 429 ([M+1]+, 100) (ESI). 
HRMS: m/z calcd. for C26H36O5 428.2563 (429.2635 for [M+H]+), found 429.2635 (ESI). 
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(4S,5S,6S,8S,9R,10R,11S,12S,13S,14S)-11-(Benzyloxy)-14-(6-ethyl-3,5-dimethyl-4-oxo-
4H-pyran-2-yl)-5,9,13-trihydroxy-4,6,8,10,12-pentamethylpentadecane-3,7-dione (227) 
 
OH
227
O
O
Bn
OOH OHO
6 8
9 11 13 2'
5'
5
O
73
 
 
 
From aldol 223. Raney nickel (W2; 0.5 mL settled volume) was washed with THF (x3) and 
then transferred to a solution of 223 (42 mg, 0.052 mmol) in THF (5 mL) and the resulting 
suspension was heated under reflux with vigorous stirring. After 3 h, the mixture was 
allowed to settle and then decanted. The solid was suspended in THF (10 mL), heated under 
reflux for 10 min, and decanted. This washing procedure was repeated with ethyl acetate and 
then acetone. The combined organic layers were filtered through Celite and concentrated to 
give the crude desulfurized product (40 mg). A solution of FeCl36H2O (40 mg, 0.15 mmol) 
in acetone (1 mL) was added to a solution of the residue (40 mg) in acetone (5 mL) and 
methanol (0.3 mL) and the resulting yellow solution was heated under flux reflux. After 5 h, 
the mixture was diluted with ethyl acetate and washed sequentially with sat. NH4Cl (x2), sat. 
NaHCO3, and brine. The aqueous layers were back extracted with ethyl acetate. The 
combined organic layers were dried over Na2SO4, concentrated, and fractionated by PTLC 
(80% ethyl acetate in hexanes) to give the titled compound (27 mg, 84%): [α]D -33 (c 1, 
C6H6).  
From bisTES 229. HFpyridine (0.13 mL) was added to a stirred solution of 229 (20 mg, 
0.024 mmol) in THF (2 mL), pyridine (0.4 mL), and water (50 L) at room temperature. 
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After 24 h, the mixture was diluted with ethyl acetate and washed sequentially with 0.2 M aq. 
citric acid (x2), sat. NaHCO3, and brine. The organic layer was concentrated and fractionated 
by PTLC (80% ethyl acetate in hexanes) to give the titled compound (14 mg, 96%). 
 
IR νmax: 3450, 1708, 1652, 1588 cm-1. 
1H NMR (500 MHz, C6D6): δ 7.52 (2H, ap d, J = 7.5 Hz, ArH), 7.22-7.12 (3H, m, ArH), 
5.14 (1H, d, J = 11 Hz, HCPh), 4.75 (1H, d, J = 11 Hz, HCPh), 4.60 (1H, br d, J = 9.5 Hz, 
HC-9), 4.46 (1H, br d, J = 9.5 Hz, HC-13), 4.19 (1H, dd, J = 4, 8 Hz, HC-5), 3.92 (1H, br d, 
J = 9 Hz, HC-11), 3.11 (1H, dq, J = 9.5, 7 Hz, HC-14), 2.88 (1H, dq, J = 9.5, 7 Hz, HC-8), 
2.67 (1H, dq, J = 8, 7 Hz, HC-6), 2.39 (1H, br dq, J = 9, 7 Hz, HC-12), 2.22 (1H, dq, J = 4, 7 
Hz, HC-4), 2.18-1.87 (8H, m, H2C-2, HC-10, H2CC-6), 2.09 (3H, s, H3CC-3'), 1.60 (3H, s, 
H3CC-5'), 1.45 (3H, d, J = 7 Hz, H3CC-8), 1.23 (3H, d, J = 7 Hz, H3CC-10), 1.22 (3H, d, J = 
7 Hz, H3CC-12), 0.96 (3H, d, J = 7 Hz, H3CC-4), 0.91 (3H, d, J = 7 Hz, H3CC-14), 0.90 (3H, 
t, J = 7.5 Hz, H3C-1), 0.85 (3H, t, J = 7.5 Hz, H3CCH2), 0.80 (3H, d, J = 7 Hz, H3CC-6). 
13C NMR (125 MHz, C6D6): δ 217.5 (s, C-7), 214.1 (s, C-3), 180.3 (s, C-4'), 166.3, 
164.4 (s, C-6'), 139.7 (s, Ph), 129.1 (d ×2, Ph), 128.6 (d ×2), 128.2 (d, Ph), 120.3 (s, C-3'), 
117.9 (s, C-5'), 88.2 (d, C-11), 77.0 (t, CH2Ph), 73.3 (d, C-5), 72.1 (d, C-13), 71.4 (d, C-9), 
50.6 (d, C-8), 48.5 (d, C-6), 48.0 (d, C-4), 40.8 (d, C-14), 38.1 (d, C-12), 36.8 (d, C-10), 34.7 
(t, C-2), 25.2 (t, CH2C-6'), 14.9 (q, H3CC-8), 14.4 (q, H3CC-14), 14.0 (q, H3CC-6), 12.9 (q, 
H3CC-10), 11.5 (q, H3CCH2), 10.7 (q, H3CC-3'), 10.5 (q, H3CC-4), 9.9 (q, H3CC-5'), 9.3 (q, 
H3CC-12), 8.1 (q, H3C-1). 
LRMS: m/z (relative intensity) 637 ([M+23]+, 25), 615 ([M+1]+, 100), 599 (15), 501 (20) 
(ESI). 
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HRMS: m/z calcd for C36H54O8 614.3819 (615.3897 for [M+H]+), found 615.3883 (ESI). 
 
(4S,5S,6S,8S,9R,10R,11S,12S,13S,14S)-11-(Benzyloxy)-14-(6-ethyl-3,5-dimethyl-4-oxo-
4H-pyran-2-yl)-9,13-dihydroxy-4,6,8,10,12-pentamethyl-5-((triethylsilyl)oxy) 
pentadecane-3,7-dione (228) 
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Triethylsilyltriflate (25 L, 29 mg, 0.11 mmol) was added to a stirred solution of 2,6-lutidine 
(50 L, 50 mg, 0.47 mmol) and 227 (33 mg, 0.054 mmol) in dry CH2Cl2 (3 mL) at 0 °C 
under Ar. After 1 h, the mixture was diluted with ethyl acetate and washed with 0.2 M citric 
acid (x2), sat. NaHCO3, and brine. The organic layer was dried over Na2SO4, concentrated, 
and fractionated by PTLC (80% ethyl acetate in hexanes) to give the 229 (20 mg, 44%) and 
the titled compound (18 mg, 46% [80% BORSM]): [α]D 1.0 (c 1.3, C6H6).  
 
IR νmax: 3422, 1711,1652, 1590 cm-1. 
1H NMR (500 MHz, C6D6): δ 7.49 (2H, ap d, J = 7 Hz, ArH), 7.22-7.10 (3H, m, ArH), 
5.08 (1H, d, J = 11 Hz, CHPh), 4.71 (1H, d, J = 11 Hz, CHPh), 4.64 (1H, dd, J = 4, 7 Hz, 
HC-5), 4.54 (1H, br d, J = 9 Hz, HC-9), 4.42 (1H, br d, J = 10 Hz, HC-13), 3.89-3.81 (2H, m, 
HC-11, HOC-11), 3.11-3.08 (1H, m, HC-14), 2.93 (1H, dq, J = 9, 7 Hz, HC-8), 2.88 (1H, dq, 
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J = 7, 7 Hz, HC-6), 2.47 (1H, dq, J = 4, 7 Hz, HC-4), 2.41-2.29 (2H, m, HC-2, HC-12), 2.16-
2.06 (3H, m, HC-2, H2CC-6'), 2.08 (3H, s, H3CC-3'), 2.00 (1H, br q, J = 7 Hz, HC-10), 1.63 
(3H, s, H3CC-5'), 1.46 (3H, d, J = 7 Hz, H3CC-8), 1.20 (3H, d, J = 7 Hz, H3CC-10), 1.15 
(3H, d, J = 7 Hz, H3CC-12), 1.08-1.04 (6H, m, H3C-1, H3C-4), 1.05 (9H, t, J = 8 Hz, H3CCSi 
×3), 0.94 (3H, d, J = 7 Hz, H3CC-6), 0.87 (3H, d, J = 7.5 Hz, H3CC-14), 0.84 (3H, t, 
H3CCH2), 0.76-0.70 (6H, m, H2CSi ×3). 
13C NMR (125 MHz, C6D6): δ 214.5 (s, C-7), 211.8 (s, C-3), 180.1 (s, C-4'), 166.0 (s, C-2'), 
164.2 (s, C-6'), 139.6 (s, Ph), 129.1 (d ×2, Ph), 128.7 (d ×2, Ph), 128.6 (d, Ph), 120.3 (s, C-3), 
117.9 (s, C-5), 88.2 (d, C-11), 77.0 (t, CH2Ph), 73.3 (d, C-5), 72.1 (d, C-13), 71.8 (d, C-9), 
52.1 (d, C-6), 50.1 (d, C-8), 49.1 (d, C-4), 40.7 (d, C-14), 38.0 (d, C-12), 36.6 (d, C-10), 35.3 
(t, C-2), 25.1 (t, CH2C-6'), 14.7 (q, CH3C-8), 14.4 (q, CH3C-14), 13.00 (q, CH3C-6 or CH3C-
10), 12.96 (q, CH3C-6 or CH3C-10), 12.4 (q, CH3C-4), 11.5 (q, CH3CH2), 10.7 (q, CH3C-3'), 
9.9 (q, CH3C-5'), 9.3 (q, CH3C-12), 8.2 (q, C-1), 7.7 (q ×3, (CH3CH2)3Si), 5.9 (t ×3, 
(CH3CH2)3Si). 
LRMS: m/z (relative intensity) 751 ([M+23]+, 10), 729 ([M+1]+,100) (ESI). 
HRMS: m/z calcd for C42H68O8Si 728.4883 (729.4756 for [M+H]+), found 729.4762 (ESI). 
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(4S,5S,6S,8S,9R,10S,11S,12S,13S,14S)-11-(Benzyloxy)-14-(6-ethyl-3,5-dimethyl-4-oxo-
4H-pyran-2-yl)-13-hydroxy-4,6,8,10,12-pentamethyl-5,9-bis((triethylsilyl)oxy) 
pentadecane-3,7-dione (229) 
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[α]D 30 (c 1.3, C6H6). 
IR νmax: 3374, 1713, 1655, 1610, 1593 cm-1. 
1H NMR (500 MHz, C6D6): δ 7.41 (2H, ap d, J = 7.5 Hz, ArH), 7.20-7.10 (2H, m, ArH), 
7.05 (1H, ap t, J = 7 Hz, ArH), 4.74-4.66 (2H, m, H2CPh), 4.61 (1H, dd, J = 5, 6 Hz, HC-5), 
4.44 (1H, br d, J = 6.5 Hz, HC-9), 4.32 (1H, br d, J = 10 Hz, HC-13), 3.52 (1H, br d, J = 8.5 
Hz, HC-11), 3.40 (1H, br s, HO), 3.07 (1H, dq, J = 6, 7 Hz, HC-14), 2.96-2.89 (2H, m, HC-6, 
HC-8), 2.53 (1H, dq, J = 5, 7 Hz, HC-4), 2.33 (1H, dq, J = 18, 7.5 Hz, HC-2), 2.24 (3H, s, 
H3CC-16), 2.17 (2H, ap q, J = 7.5 Hz, H2CC-6'), 2.15-2.03 (2H, m, HC-2, HC-10), 2.01-1.94 
(1H, m, HC-12), 1.97 (3H, s, H3CC-5'), 1.25 (3H, d, J = 7 Hz, H3CC-8), 1.15 (3H, d, J = 7 
Hz, H3CC-12), 1.09-0.95 (27H, m, H3C-1, H3C-4, H3C-6, H3CCSi ×6), 1.00-0.95 (9H, m, 
H3C-10, H3C-14, H3CCH2C-6'), 1.76-0.68 (12H, m, H2CSi ×6). 
13C NMR (125 MHz, C6D6): δ 213.6 (s, C-7), 212.0 (s, C-3), 179.4 (s, C-4'), 164.4 (s, C-2'), 
163.2 (s, C-6'), 138.4 (s, Ph), 129.2 (d ×2, Ph), 128.7 (d, Ph), 128.1 (d ×2, Ph), 120.1 
(s, C-3'), 118.4 (s, C-5'), 88.4 (d, C-11), 76.8 (t, CH2Ph), 74.4 (d, C-9), 73.0 (d, C-5), 72.5 (d, 
C-13), 53.1 (d, C-6), 52.2 (d, C-8), 48.9 (d, C-4), 41.7 (d, C-10), 39.5 (d, C-14), 35.5 (d, C-
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12), 35.4 (t, C-2), 25.0 (t, CH2C-6'), 14.6 (q, CH3C-8 or CH3C-14), 14.5 (q, CH3C-8 or 
CH3C-14), 13.1 (q, CH3C-4), 12.4 (q ×2, CH3C-6, CH3C-10 or CH3C-12), 11.9 (q, CH3C-10 
or CH3C-12), 11.6 (q, CH3CH2), 10.5 (q, CH3C-3'), 10.2 (q, CH3C-5'), 8.2 (q, C-1), 7.8 (q ×3, 
(CH3CH2)3Si), 7.7 (q ×3, (CH3CH2)3Si), 6.7 (t ×3, (CH3CH2)3Si), 5.9 (t ×3, (CH3CH2)3Si). 
LRMS: m/z (relative intensity) 865 ([M+23]+, 25), 843 ([M+1]+, 100) (ESI). 
HRMS: m/z calcd for C48H82O8Si2 842.5548 (843.5626 for [M+H]+), found 843.5630 (ESI). 
 
(4S,5S,6S,10S,11S,12R,14R)-11-(Benzyloxy)-14-(6-ethyl-3,5-dimethyl-4-oxo-4H-pyran-2-
yl)-4,6,8,10,12-pentamethyl-5-((triethylsilyl)oxy)pentadecane-3,7,9,13-tetraone (230) 
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IBX (70 mg, 0.25 mmol) was added to a solution of 228 (22 mg, 0.03 mmol) in anhydrous 
DMSO (4 mL) at rt. After 2 d, the mixture was diluted with ethyl acetate and washed 
sequentially with sat. NaHCO3, water, and brine. The aqueous layers were back extracted 
with ethyl acetate. The combined organic layers were dried over Na2SO4, concentrated, and 
fractionated by PTLC (60% ethyl acetate in hexanes) to give the titled compound (18 mg, 
82%) as a 25:65:10 mixture of enol and 2 keto forms (by 1H NMR), respectively. 
 
Only partial data reported. 
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1H NMR (500 MHz, CDCl3): δ 17.22 (0.25H, s), 7.39-7.12 (5H, m), 4.57-4.28 (3H, m), 4.20-
3.84 (2.7H, m), 3.38-2.78 (3H, m), 2.78-2.40 (5H, m), 2.03 (3H, s), 1.96 (3H, s), 1.90 (0.7H, 
s), 1.32-0.85 (33H, m), 0.65-0.45 (6H, m). 
13C NMR (125 MHz, CDCl3) partial data: δ 195.8 & 194.5 (enol form), 84.5 & 84.3 & 83.7 
(C-11, 3 major forms), 60.8 & 60.6 (C-8 of β-diketone form, 2 diastereomers). 
LRMS: m/z (relative intensity) 747 ([M+23]+, 100), 725 ([M+1]+, 40), 543 (5), 521 (2), 255 
(4) (ESI). 
HRMS: m/z calcd for C42H64O8Si 724.4371 (725.4443 for [M+H]+), found 725.4454 (ESI). 
 
(4S,5S,6S,8RS,10S,11S,12R,14R)-14-(6-Ethyl-3,5-dimethyl-4-oxo-4H-pyran-2-yl)-5,11-
dihydroxy-4,6,8,10,12-pentamethylpentadecane-3,7,9,13-tetraone (14/15) 
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Raney nickel (W2; 0.2 mL settled volume) was added to a solution of 230 (8 mg, 0.011 
mmol) in EtOH (2 mL) at rt and the resulting suspension was heated under reflux with 
vigorous stirring. After 50 min, the mixture was allowed to settle and then was decanted. The 
solid was suspended in ethyl acetate, heated under reflux for 10 min, and decanted. This 
washing procedure was repeated with ethyl acetate and then acetone. The organic layers were 
filtered over Celite and the combined filtrates were concentrated. The residue was taken up 
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in THF (2 mL) and pyridine (0.4 mL, 0.4 g, 5 mmol), water (50 L, 50 mg, 3 mmol), and 
HFpyridine (0.13 mL) were sequentially added to the stirred solution at rt. After 4 h, the 
mixture was diluted with ethyl acetate and washed with 0.2 M citric acid (x2), sat. NaHCO3, 
and brine. The aqueous layers were back extracted with ethyl acetate. The combined organic 
layers were dried over Na2SO4, concentrated and fractionated by PTLC (40% acetone in 
hexanes) to give the titled compound (5 mg, 87%) that was a complicated 8: 3: 1: 16 mixture 
of hemiacetals along with small amounts of keto-enol tautomers and a trace of siphonarin B 
(4) (by NMR).  
The ratio of isomers present remained essentially unchanged on standing in CDCl3 solution 
at ambient temperature; however, after 28 days the ratio of the major hemiacetals was 3:2:1 
and the amount of siphonarin B (4) present had increased to ca. 9%. 
 
Only partial data reported. 
1H NMR (500 MHz, CDCl3): δ 17.05 (0.02H, s, HO-enol), 6.46 (0.2H, s, HO-hemiacetal), 
6.39 (0.1H, s, HO-hemiacetal), 6.19 (0.4H, s, HO-hemiacetal), 5.12 (0.02, s, HO-4), 4.6-3.6 
(4H, m), 3.00-2.25 (8H, m), 2.15-1.95 (6H, several s), 1.50-0.58 (24H, m). 
13C NMR (125 MHz, CDCl3): δ numerous tautomers. 
LRMS: m/z (relative intensity) 543 ([M+23]+, 25), 521 ([M+1]+, 100), 139 (7) (ESI). 
HRMS: m/z calcd for C29H44O8 520.3036 (521.3108 for [M+H]+), found 521.3096 (ESI).  
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14-epi-Baconipyrone C (235) 
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From 14/15: DBU (ca. 1 L) was added to a solution of 14/15 (5 mg, 0.01 mmol) in C6D6 
(0.4 mL) at rt. After 1 h, 14/15 was consumed (by 1H NMR). The mixture was diluted with 
ethyl acetate and washed sequentially with 0.2 M citric acid, sat. NaHCO3, and brine. The 
aqueous layers were back extracted with ethyl acetate. The combined organic layers were 
dried over Na2SO4, concentrated, and fractionated by PTLC (40% acetone in hexanes) to 
give the baconipyrone C (8) (2.5 mg, 50%) and 14-epi-baconipyrone C (235) (1.5 mg, 30%). 
From baconipyrone C (8): DBU (1 L) was added to a solution of baconipyrone C (8) (6.2 
mg) in C6D6 (0.4 mL). After 45 min, the presence of a 1.3:1 mixture of 8 and 235 was 
detected by 1H NMR. The mixture was concentrated and fractionated by PTLC (40% acetone 
in hexanes) to give baconipyrone C (8) (3.4 mg, 55%) and 14-epi-baconipyrone C (235) (2.4 
mg, 39%): [α]D -6 (c 0.1, CHCl3).  
 
IR νmax: 3412, 1716, 1653, 1608 cm-1. 
1H NMR (500 MHz, CDCl3): δ 5.48 (1H, dd, J = 3.5, 9 Hz, HC-5), 4.20 (1H, q, J = 7 Hz, 
HC-14), 3.64 (1H, ddd, J = 4.5, 8, 10 Hz, HC-11), 3.14 (1H, d, J = 10 Hz, HO), 2.93-2.86 
(2H, m, HC-4 or HC-6, HC-12), 2.83 (1H, dq, J = 3.5, 7 Hz, HC-6 or HC-4), 2.78 (1H, dq, J 
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= 18, 7.5 Hz, HC-2 or HC-8), 2.65-2.48 (4H, m, HC-2 or HC-8, HC-10, H2CC-19), 2.47-2.36 
(2H, m, HC-2, HC-8), 2.03 (3H, s, H3C-16), 1.94 (3H, s, H3C-18), 1.45 (3H, d, J = 7 Hz, 
H3C-14), 1.20 (3H, t, J = 7.5 Hz, H3CCH2C-19), 1.11 (3H, d, J = 7 Hz, H3C-4), 1.09 (3H, d, 
J = 7 Hz, H3C-10), 1.06 (3H, d, J = 7 Hz, H3C-12), 1.03 (3H, t, J = 7.5 Hz, H3C-2 or H3C-8), 
1.02 (3H, d, J = 7 Hz, H3C-6), 1.01 (3H, t, J = 7.5 Hz, H3C-2 or H3C-8). 
13C NMR (125 MHz, CDCl3): δ 212.3 (s, C-7 or C-3), 211.6 (s, C-3 or C-7), 210.6 (s, C-13), 
179.9 (s, C-17), 173.8 (s, C-9), 165.0 (s, C-19), 160.0 (s, C-15), 120.4 (s, C-16), 118.4 (s, C-
18), 76.6 (d, C-11), 74.1 (d, C-5), 48.7 (d, C-14), 47.8 (d, C-12), 47.6 (d, C-4 or C-6), 46.1 
(d, C-6 or C-4), 42.4 (d, C-10), 35.5 (t, C-2 or C-8), 35.4 (t, C-2 or C-8), 25.0 (t, CH2C-19), 
15.1 (q, CH3C-10 or CH3C-12), 14.9 (q, CH3C-10 or CH3C-12), 13.7 (q, CH3C-4 or CH3C-
6), 13.5 (q, C-14), 11.5 (q, CH3CH2C-19), 10.03 (q, CH3C-16), 9.99 (q, CH3C-6 or CH3C-4), 
9.7 (q, CH3C-18), 7.9 (q, CH3C-8 or CH3C-2), 7.7 (q, CH3C-2 or CH3C-8). 
LRMS: m/z (relative intensity) 543 ([M+23]+, 30), 521 ([M+1]+, 100), 503 (3), 485 (3), 242 
(3), 132 (2) (ESI). 
HRMS: m/z calcd for C29H44O8 520.3036 (521.3108 for [M+H]+), found 521.3098 (ESI). 
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(2S,3S,4S)-(2R,4R,5R,6S)-2-(6-Ethyl-3,5-dimethyl-4-oxo-4H-pyran-2-yl)-4,6-dimethyl-
3,7-dioxononan-5-yl-3-hydroxy-2,4-dimethyl-5-oxoheptanoate (237) 
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Activated neutral aluminum oxide (50 mg; Brockmann I, standard grade, ca. 150 mesh, 58 Å) 
was added to a solution of 14/15 (5 mg, 0.01 mmol) in EtOH (2 mL) and the resulting 
suspension was heated under reflux. After 1 h, the suspension was filtered through Celite 
washing with ethyl acetate. The combined filtrate and washings were concentrated. 1H NMR 
of the residue indicated the presence of a 10:7:5:3 mixture of 237, baconipyrone C (8), 
siphonarin B (4), and baconipyrone A (6), respectively. Fractionation of the residue by PTLC 
(80% ethyl acetate in hexanes) gave a 1:1 mixture of siphonarin B (4) and baconipyrone C 
(8), respectively (2 mg), and a 4:1 mixture of 237 and baconipyrone A (6), respectively (2.5 
mg). Further fractionation of the latter mixture by PTLC (50% ethyl ether in CH2Cl2) gave 
baconipyrone A (6) (0.5 mg) and the titled compound (2 mg, 40%): [α]D -92 (c 0.1, CHCl3). 
 
IR νmax: 3401, 1712, 1653, 1610 cm-1. 
1H NMR (500 MHz, CDCl3): δ 5.37 (1H, dd, J = 5, 7.5 Hz, HC-5'), 4.03 (1H, q, HC-2'), 4.01 
(1H, ddd, J = 4, 4.5, 7.5 Hz, HC-3), 3.15 (1H, d, J = 4.5 Hz, HO), 3.06 (1H, dq, J = 7.5, 7 
Hz, HC-4'), 2.89 (1H, dq, J = 5, 7 Hz, HC-6'), 2.66 (1H, dq, J = 4, 7 Hz, HC-4), 2.62-2.49 
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(6H, m, H2C-6, H2C-8', H2C-6''), 2.46 (1H, dq, J = 7.5, 7 Hz, HC-2), 2.08 (3H, s, H3CC-3''), 
1.95 (3H, s, H3CC-5''), 1.37 (3H, d, J = 7 Hz, H3CC-2'), 1.15 (3H, t, J = 7.5 Hz, H3CCH2C-
6''), 1.14 (3H, d, J = 7 Hz, H3CC-4), 1.10 (3H, d, J = 7 Hz, H3CC-6'), 1.07 (3H, d, J = 7 Hz, 
H3CC-2), 1.06 (3H, t, J = 7.5 Hz, H3C-7), 1.02 (3H, t, J = 7.5 Hz, H3C-9'), 0.89 (3H, d, J = 7 
Hz, H3CC-4'). 
13C NMR (125 MHz, CDCl3) δ: 215.4 (s, C-5), 211.4 (s, C-7'), 207.6 (s, C-3'), 179.8 (s, C-
4''), 174.3 (s, C-1), 165.0 (s, C-6''), 159.9 (s, C-2''), 120.5 (s, C-3''), 118.7 (s, C-5''), 76.1 (d, 
C-5'), 73.1 (d, C-3), 50.2 (d, C-2'), 48.1 (d, C-6'), 47.4 (d, C-4), 45.8 (d, C-4'), 43.4 (d, C-2), 
35.0 (d, C-6 or 8'), 35.0 (t, C-6 or 8'), 24.9 (t, CH2C-6''), 14.3 (q, C-1), 13.7 (q, CH3C-4'), 
13.5 (q, CH3C-2'), 12.4 (q, CH3C-6'), 11.5 (q, CH3CH2C-6''), 10.3 (q, CH3C-3'' or CH3C-4), 
10.2 (q, CH3C-3'' or CH3C-4), 9.8 (q, CH3C-5''), 7.8 (q ×2, C-7, C-9'). 
LRMS: m/z (relative intensity) 543 ([M+23]+, 100), 521 ([M+1]+, 20), 355 (6), 333 (6) (ESI). 
HRMS: m/z calcd for C29H44O8 520.3036 (521.3108 for [M+H]+), found 531.3127 (ESI). 
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(4S,5S,6S,10S,11S,12R,14R)-11-(Benzyloxy)-14-(6-ethyl-3,5-dimethyl-4-oxo-4H-pyran-2-
yl)-4,6,8,10,12-pentamethyl-5-hydroxy-4,6,8,10,12-pentamethylpentadecane-3,7,9,13-
tetraone (238) 
 
O
238
O
O
Bn
OOH OO
6 8
9 11 13 2'
5'
5 73
O
 
 
IBX (50 mg, 0.18 mmol) was added to a solution of 228 (15 mg, 0.021 mmol) in anhydrous 
DMSO (2 mL) at rt. After 2 d, the mixture was diluted with ethyl acetate and washed 
sequentially with sat. NaHCO3, water, and brine. The aqueous layers were back extracted 
with ethyl acetate. The combined organic layers were dried over Na2SO4 and concentrated. 
The residue that was taken up in THF (2 mL) and pyridine (0.4 mL, 0.4 g, 5 mmol), water 
(50 μL, 50 mg, 3 mmol), and HFpyridine (0.13 mL) were added sequentially to the stirred 
solution at rt. After 4 h, the mixture was diluted with ethyl acetate and washed sequentially 
with 0.2 M citric acid (0.2 M; ×2), sat. NaHCO3, and brine. The aqueous layers were back 
extracted with ethyl acetate. The combined organic layers were dried over Na2SO4, 
concentrated, and fractionated by PTLC (60% ethyl acetate in hexanes) to give the titled 
compound (11 mg, 88%) as a complicated mixture consisting of enol (ca. 5%), hemiacetal 
(one diastereomer, ca. 40%), and β-diketone (ca. 55% as a 4:3 mixture of diastereomers) 
forms (by NMR). 
 
Only partial data reported. 
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1H NMR (500 MHz, CDCl3). δ 17.14 (0.05H, s, HO (enol)), 7.42-7.12 (5H, m, ArH), 6.13 
(0.4H, br s, hemiacetal OH), 4.60-3.70 (4H, m), 3.20-2.30 (8H, m), 2.17-1.80 (6H, several s, 
pyrone CH3's), 1.35-0.80 (24H, m). 
13C NMR (125 MHz, CDCl3) (partial data): δ 104.6 (C-9 hemiacetal), 85.3 & 84.8 & 84.3 
(C-11, 3 major forms), 61.8 & 61.4 (C-8 keto form, 2 diastereomers). 
LRMS: m/z (relative intensity) 633 ([M+23]+, 45), 611 ([M+1]+, 100), 593 (10) (ESI). 
HRMS: m/z calcd for C36H50O8 610.3506 (611.3578 for [M+H]+), found 611.3597 (ESI). 
 
 
Siphonarin B (4) 
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From 238: Raney nickel (W2; 0.2 mL settled volume in EtOH) was transferred to a solution 
of 238 (6 mg, 0.01 mmol) in EtOH (3 mL) at rt and the resulting suspension was heated 
under reflux with vigorous stirring. After 45 min, the mixture was allowed to settle and then 
was decanted. The solid was suspended in EtOH (10 mL), heated under reflux for 10 min, 
and decanted. This washing procedure was repeated with ethyl acetate. The organic layers 
were passed over Celite, combined, concentrated, and fractionated by PTLC (70% ether in 
CH2Cl2) to give baconipyrone C (8) (1 mg, 20%) and siphonarin B (4) (1.5 mg, 27%). 
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From 14/15: Imidazole (10 mg, 0.15 mmol) was added to a solution of 14/15 (3.5 mg, 6.7 
μmol) in CDCl3 (0.4 mL) at rt. After 24 hr, the mixture was diluted with ethyl acetate and 
washed with 0.2 M citric acid, sat. NaHCO3, and brine. The aqueous layers were back 
extracted with ethyl acetate. The combined organic layers were dried over Na2SO4, and 
concentrated to give the crude product that, by 1H NMR, contained a mixture of 4 (δH 5.12) 
and hemiacetals (δH 6.46, 6.39, 6.19 in a 0.1:1.5:1 ratio). [Note: similar mixtures were also 
obtained from similar reactions starting from 14/15 and from 4 after 48 h.] Fractionation of 
the residue by PTLC (50% ether in CH2Cl2) gave the titled compound containing ca. 10% of 
a δH 5.01 impurity (3 mg, 85%). Further fractionation by PTLC (7% iPrOH in CH2Cl2) gave 
the titled compound (2.5 mg, 70%): [α]D +12 (c 0.1, CHCl3). 
 
1H NMR (500 MHz, CDCl3): δ 5.12 (1H, s), 3.91 (1H, d, J = 10.5 Hz), 3.81 (1H, br s), 3.27 
(1H, q, J = 7 Hz), 3.08 (1H, br s), 2.77 (2H, ap q, J = 7 Hz), 2.66 (1H, q, J = 7 Hz), 2.61 (1H, 
q, J = 6.5 Hz), 2.48 (1H, dq, J = 18.5, 7 Hz), 2.32-2.18 (2H, m), 2.05 (1H, dq, J = 2.5, 7.5 
Hz), 1.97 (3H, s), 1.96 (3H, s), 1.86 (1H, dq, J = 2, 7 Hz), 1.25 (3H, d, J = 7 Hz), 1.21 (3H, d, 
J = 7 Hz), 1.20 (3H, t, J = 7.5 Hz), 1.19 (3H, d, J = 7 Hz), 1.07 (3H, d, J = 6.5 Hz), 1.07 (3H, 
d, J = 7 Hz), 0.94 (3H, t, J = 7 Hz), 0.77 (3H, d, J = 6.5 Hz). 
13C NMR (125 MHz, CDCl3): δ 213.5, 206.7, 180.1, 165.7, 161.8, 121.8, 117.5, 105.4, 
103.4, 74.82, 74.80, 50.2, 46.8, 45.5, 42.7, 38.9, 38.6, 35.9, 24.9, 13.2, 12.8, 12.1, 11.6, 11.1, 
9.6, 9.5, 8.8, 8.4, 7.6. 
 
 
 
 
 
 
216
Baconipyrone A (6) 
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Activated basic aluminum oxide (50 mg; Brockmann I, standard grade, 58 Å) was added to a 
stirred solution of 238 (10 mg, 0.016 mmol) in EtOH (2 mL) and the resulting suspension 
was heated under reflux. After 7 h, the cooled mixture was filtered through Celite, washing 
with ethyl acetate. The combined filtrate and washings were concentrated and the residue 
taken up in EtOH (2 mL) and 5% Pd-C (10 mg) was added. The resulting black suspension 
was stirred under a H2 atmosphere 24 h and then was filtered through Celite, washing with 
ethyl acetate. The combined filtrate and washings were concentrated and fractionated by 
PTLC (80% ethyl acetate in hexanes) to give baconipyrone A (6) (1.5 mg, 18%) and 
baconipyrone C (8) (6 mg, 70%): [α]D -96 (c 0.13, CHCl3). 
 
IR νmax: 1718, 1652, 1597 cm-1. 
1H NMR (500 MHz, CDCl3): δ 5.00 (1H, dd, J = 4.5, 6 Hz, HC-5), 4.04 (1H, q, J = 7 Hz, 
HC-14), 3.62 (1H, ddd, J = 3.5, 8.5, 9.5 Hz, HC-11), 3.35 (1H, d, J = 9.5 Hz, HOC-11), 2.96 
(1H, dq, J = 4.5, 7 Hz, HC-6), 2.79 (1H, dq, J = 8.5, 7 Hz, HC-12), 2.64 (1H, dq, J = 3.5, 7 
Hz, HC-10), 2.62-2.51 (2H, m, HC-8. H2CC-19), 2.13 (1H, dq, J = 6.5, 7 Hz, HC-4), 2.05 
(3H, s, H3CC-16), 1.95 (3H, s, H3CC-18), 1.66 (1H, dq, J = 14.5, 7 Hz, HC-2), 1.52 (1H, dq, 
J = 14.5, 7 Hz, HC-2), 1.38 (3H, d, J = 7 Hz, H3CC-14), 1.29 (3H, d, J = 7 Hz, H3CC-10), 
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1.16 (3H, t, J = 7.5 Hz, H3CCH2C-19), 1.07 (3H, d, J = 7 Hz, H3CC-4 or H3CC-8), 1.06 (3H, 
d, J = 7 Hz, H3CC-4 or H3CC-8), 1.00 (3H, d, J = 7 Hz, H3CC-6), 0.90 (3H, d, J = 7 Hz, 
H3CC-12), 0.86 (3H, d, J = 7 Hz, H3C-1). 
13C NMR (125 MHz, CDCl3): δ 211.5 (s, C-7), 210.5 (s, C-13), 179.8 (s, C-17), 175.0 (s, C-
9), 165.0 (s, C-19), 160.5 (s, C-15), 120.5 (s, C-16), 118.7 (s, C-18), 77.5 (d, C-5 or C-11), 
77.4 (d, C-5 or C-11), 76.6 (s, C-3), 51.4 (d, C-14), 48.3 (d, C-12), 46.4 (d, C-8), 44.8 (d, C-
6), 41.6 (d, C-10), 38.0 (d, C-4), 30.5 (t, C-2), 25.0 (t, CH2C-19), 15.4 (q, CH3C-10), 14.5 (q, 
CH3C-12), 13.2 (q, CH3C-14), 12.1 (q, CH3C-4 or CH3C-6), 11.8 (q, CH3C-4 or CH3C-6), 
11.5 (q, CH3CH2C-19), 10.2 (q, CH3C-18), 9.8 (q, CH3C-18), 9.0 (q, C-1), 7.6 (q, CH3C-8). 
LRMS: m/z (relative intensity) 543 ([M+23]+, 90), 521 ([M+1]+, 100) (ESI). 
HRMS: m/z calcd for C29H44O8 520.3036 (521.3108 for [M+H]+), found 521.3104 (ESI). 
 
 
Baconipyrone C (8) 
 
OH O O
O
baconipyrone C (8)
O
O
O
O
8
5
3
9 11 13 15
18
 
 
From 238: Activated basic aluminum oxide (Brockmann I, standard grade, 58 Å; 50 mg) was 
added to a stirred solution of 238 (10 mg, 0.016 mmol) in EtOH (2 mL) and the resulting 
suspension was heated under reflux. After 7 h, the cooled mixture was filtered through 
Celite, washing with ethyl acetate. The combined filtrate and washings were concentrated 
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and the residue taken up in EtOH (2 mL) and 5% Pd-C (10 mg) was added. The resulting 
black suspension was stirred under a H2 atmosphere 24 h and then was filtered through 
Celite, washing with ethyl acetate. The combined filtrate and washings were concentrated 
and fractionated by PTLC (80% ethyl acetate in hexanes) to give baconipyrone A (6) (1.5 
mg, 18%) and baconipyrone C (8) (6 mg, 70%): []D -81 (c 0.1, MeOH). 
 
From 14/15: DBU (ca. 1 μL) was added to a solution of 14/15 (5 mg, 0.01 mmol) in C6D6 
(0.4 mL) at rt. After 1 h, the mixture was diluted with ethyl acetate and washed with 0.2 M 
citric acid, sat. NaHCO3, and brine. Each aq. layer was sequentially back extracted with ethyl 
acetate. The combined organic layers were dried over Na2SO4, concentrated, and fractionated 
by PTLC (40% acetone in hexanes) to give the titled compound (2.5 mg, 50%) and 14-epi-
baconipyrone C (235) (1.5 mg, 30%). 
 
1H NMR (500 MHz, CDCl3): δ 5.47 (1H, dd, J = 3.5, 9 Hz, HC-5), 4.15 (1H, q, J = 7 Hz, 
HC-4), 3.55 (1H, ddd, J = 3, 9, 10 Hz, HC-11), 3.38 (1H, d, J = 10 Hz, HO), 2.89-2.19 (3H, 
m, HC-4, HC-6, HC-12), 2.75 (1H, dq, J = 18, 7 Hz, HC-8 or HC-2), 2.60-2.45 (4H, m, HC-
2 or HC-8, HC-10, H2CC-19), 2.44-2.29 (2H, m, HC-2, HC-8), 2.09 (3H, s, H3CC-16), 1.93 
(3H, s, H3CC-18), 1.38 (3H, d, J = 7 Hz, H3CC-14), 1.22 (3H, d, J = 7 Hz, H3CC-10), 1.16 
(3H, t, J = 7.5 Hz, H3CCH2C-19), 1.09 (3H, d, J = 7 Hz, H3CC-4 or H3CC-6), 1.02 (3H, d, J 
= 7 Hz, H3CC-6 or H3CC-4), 1.01 (3H, t, J = 7.5 Hz, H3CC-8 or H3CC-2), 0.91 (3H, t, J = 7 
Hz, H3CC-2 or H3CC-8), 0.86 (3H, d, J = 7 Hz, H3CC-12). 
13C NMR (125 MHz, CDCl3): δ 212.1 (s, C-7 or C-3), 211.0 (s, C-3 or C-7), 210.7 (s, C-13), 
179.9 (s, C-17), 174.3 (s, C-9), 164.8 (s, C-19), 160.8 (s, C-16), 120.6 (s, C-16), 118.5 (s, C-
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18), 77.8 (d, C-11), 74.0 (d, C-5), 51.2 (d, C-14), 48.8 (d, C-12), 47.5 (d, C-4 or C-6), 46.0 
(d, C-6 or C-4), 41.3 (d, C-10), 35.32 (t, C-2 or C-8), 35.28 (t, C-2 or C-8), 24.9 (t, CH2C-
19), 15.3 (q, CH3C-10), 14.4 (q, CH3C-12), 13.7 (q, CH3C-4 or CH3C-6), 13.4 (q, CH3C-14), 
11.5 (q, CH3CH2C-19), 10.4 (q, CH3C-16), 9.9 (q, CH3C-6 or CH3C-4), 9.7 (q, CH3C-18), 
7.9 (q, CH3C-8 or CH3C-2), 7.5 (q, CH3C-2 or CH3C-8). 
LRMS: m/z (relative intensity): 520 ([M]+, 2), 339 (3), 236 (8), 209 (5), 180 (100), 151 (10), 
121 (43), 57 (54) (EI). 
HRMS: m/z calcd for C29H44O8 520.3036, found 520.3028 (EI). 
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